=== ИНДЕКС CHRONOBIOTICSDB (полный) ===

ID: 6 | Resveratrol
FDA: Approved
Описание: Resveratrol, a naturally occurring polyphenol predominantly found in grapes, red wine, and certain berries, has been extensively studied for its antioxidant, anti-inflammatory, and cardioprotective properties. Recent investigations have expanded its potential therapeutic applications to include i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Resveratrol
KEGG: https://www.kegg.jp/entry/C03582
Классы: radioprotector, chronobiotic
Эффекты: Resveratrol can influence the expression of key clock genes like CLOCK, BMAL1, PER, and CRY, which are involved in establishing and maintaining the 24
Механизмы: SIRT1, Serine/threonine-protein kinase mTOR, Altering Circadian Metabolism via the SIRT1-AMPK-PP2A Axis, mTOR signaling inhibition, AMPK-PP2A axis suppresses mTOR, advancing circadian phase in muscle., Repression of PER/CRY feedback loops via deacetylation.
Цели: T60529 (https://idrblab.net/ttd/data/target/details/t60529), MTOR (Human) (https://www.uniprot.org/uniprotkb/P42345/entry), CLOCK-BMAL1 COMPLEX (https://www.e-enm.org/journal/view.php?doi=10.3803/enm.2014.29.3.379)
Статьи: Sun, L., Wang, Y., Song, Y., Cheng, X.R., Xia, S., Rahman, M.R., Shi, Y. and Le, G., 2015. Resveratrol restores the circadian rhythmic disorder of lipid metabolism induced by high-fat diet in mice. Biochemical and Biophysical Research Communications, 458(1), pp.86–91.: https://pubmed.ncbi.nlm.nih.gov/25640840/, Spaleniak, W. and Cuendet, M., 2023. Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applications. Molecular Biology Reports, 50, pp.6159–6170.: https://link.springer.com/article/10.1007/s11033-023-08513-2, Avital-Cohen, N., Chapnik, N. and Froy, O., 2024. Resveratrol induces myotube development by altering circadian metabolism via the SIRT1-AMPK-PP2A axis. Cells, 13, p.1069.: https://www.mdpi.com/2073-4409/13/12/1069
------------------------------------------------------------

ID: 7 | Rosiglitazone
FDA: Approved
Описание: Rosiglitazone, a PPARγ agonist, has been shown to affect circadian rhythms, particularly in the context of vascular diseases and metabolic regulation. Regulation of Clock Genes: Rosiglitazone administration can alter the expression of core clock genes such as BMAL1 and CLOCK. In a study, rosiglit...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Rosiglitazone
KEGG: https://www.kegg.jp/entry/D08491
Классы: chronobiotic
Эффекты: shifted the phases, restores normal circadian rhythms
Механизмы: protect
Цели: T58921 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (https://idrblab.net/ttd/data/target/details/t58921), CLOCK gene expression (https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLOCK), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tian, Y., Luan, X. and Yang, K., 2024. Chronotherapy involving rosiglitazone regulates the phenotypic switch of vascular smooth muscle cells by shifting the phase of TNF-α rhythm through triglyceride accumulation in macrophages. Heliyon, 10(10), p.e30708.: https://pubmed.ncbi.nlm.nih.gov/38803898/, Tian, Y., Luan, X. and Yang, K., 2024. Chronotherapy involving rosiglitazone regulates the phenotypic switch of vascular smooth muscle cells by shifting the phase of TNF-α rhythm through triglyceride accumulation in macrophages. Heliyon, 10(10), p.e30708.: https://www.sciencedirect.com/science/article/pii/S2405844024067392
------------------------------------------------------------

ID: 8 | Melatonin
FDA: Approved
Описание: Melatonin is a naturally occurring hormone primarily produced by the pineal gland, playing a crucial role in regulating circadian rhythms and sleep-wake cycles. As a chronobiotic, it helps synchronize the body's internal clock with external environmental cues, such as light and darkness. Melatoni...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Melatonin
KEGG: https://www.kegg.jp/entry/D08170
Классы: chronobiotic
Эффекты: restores normal circadian rhythms
Механизмы: SIRT1, ROR, Melatonin receptor agonist, RORγ binding, Antioxidant, Melatonin receptor binding, RORyt/RORc inhibitor
Цели: T58921 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (https://idrblab.net/ttd/data/target/details/t58921), Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), PEPT2 (https://www.rcsb.org/structure/7NQK), GLUT1 (https://www.rcsb.org/structure/4PYP), HBS (https://www.uniprot.org/citations/10791557), CaM (https://www.rcsb.org/structure/6HCS), TUBULIN (https://www.rcsb.org/structure/1TUB), Calreticulin (https://www.rcsb.org/structure/3POW), MT3 (https://www.rcsb.org/structure/4gr9), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7), RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA), Mel1C (https://www.uniprot.org/uniprotkb/I2E116/entry), CAND2 (https://www.rcsb.org/structure/8VVY), VDR (https://www.rcsb.org/structure/5E7V), QR2 (https://www.rcsb.org/structure/1SG0), MMP9 (https://www.rcsb.org/structure/1L6J), PEPSIN (https://www.rcsb.org/structure/1PSO), PP2A (https://www.rcsb.org/structure/2IAE), mPTP (https://www.rcsb.org/structure/5A0E), PEPT1 (https://www.rcsb.org/structure/7S8U)
Статьи: Arendt, J. and Skene, D.J., 2005. Melatonin as a chronobiotic. Sleep Medicine Reviews, 9(1), pp.25–39.: https://pubmed.ncbi.nlm.nih.gov/15649736/, Pévet, P., Bothorel, B., Slotten, H. and Saboureau, M., 2002. The chronobiotic properties of melatonin. Cell and Tissue Research, 309, pp.183–191.: https://link.springer.com/article/10.1007/s00441-002-0584-1, Cardinali, D.P., 2024. Melatonin as a chronobiotic/cytoprotective agent in bone. Doses involved. Journal of Pineal Research, 76(1), p.e12931.: https://pubmed.ncbi.nlm.nih.gov/38083808/
------------------------------------------------------------

ID: 9 | Indole
FDA: not approved
Описание: Indole, a heterocyclic organic compound, has emerged as a potential chronobiotic agent due to its influence on circadian rhythms. Structurally related to melatonin, indole derivatives exhibit modulatory effects on the circadian clock by interacting with key regulatory proteins, such as CLOCK and ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/798
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase-shift
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Axelrod, J., 1983. Regulation of circadian rhythms of indoleamines in the pineal gland. In The pineal gland and its endocrine role (pp. 1-13). Boston, MA: Springer US.: https://link.springer.com/chapter/10.1007/978-1-4757-1451-7_1
------------------------------------------------------------

ID: 10 | Ramelteon
FDA: Approved
Описание: Ramelteon, a melatonin receptor agonist, demonstrates circadian phase-shifting effects, primarily by influencing the body's natural sleep-wake cycle. It can shift the phase of the circadian rhythm, effectively advancing it, especially when facing disturbances like eastward jet lag. This effect is...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Ramelteon
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase advance in humans, 5-h phase advance in the sleep-wake cycle
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Richardson, G.S., Zee, P.C., Wang-Weigand, S., Rodriguez, L. and Peng, X., 2008. Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. Journal of Clinical Sleep Medicine, 4(5), pp.456–461.: https://pmc.ncbi.nlm.nih.gov/articles/PMC2576313/#:~:text=Conclusion,treatment%20of%20specific%20clinical%20conditions., Takeshima, M., Shimizu, T., Ishikawa, H. and Kanbayashi, T., 2020. Ramelteon for delayed sleep-wake phase disorder: a case report. Clinical Psychopharmacology and Neuroscience, 18(1), pp.167–169.: https://pmc.ncbi.nlm.nih.gov/articles/PMC7006983/#:~:text=In%20a%20previous%20study%20investigating,to%20have%20remained%20in%20remission., Zammit, G.K., 2007. Ramelteon: a novel hypnotic indicated for the treatment of insomnia. Psychiatry (Edgmont), 4(9), pp.36–42.: https://pmc.ncbi.nlm.nih.gov/articles/PMC2880941/#:~:text=Unlike%20other%20sedative%2Dhypnotics%2C%20which,for%20addiction%20to%20traditional%20hypnotics.
------------------------------------------------------------

ID: 11 | Luzindole
FDA: not approved
Описание: Luzindole acts as a selective melatonin receptor antagonist, with approximately 11- to 25-fold greater affinity for the MT2 over the MT1 receptor. In animal studies, it has been observed to disrupt the circadian rhythm as well as produce antidepressant effects.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/122162
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase shift disruption in animals
Механизмы: Melatonin receptor binding, antagonist of melatonin receptors
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Dubocovich, M.L., 1988. Luzindole (N-0774): a novel melatonin receptor antagonist. Journal of Pharmacology and Experimental Therapeutics, 246(3), pp.902–910.: https://pubmed.ncbi.nlm.nih.gov/2843633/, Estarás, M., Ameur, F.Z., Roncero, V., Fernández-Bermejo, M., Blanco, G., López, D., Mateos, J.M., Salido, G.M. and González, A., 2019. The melatonin receptor antagonist luzindole induces Ca²⁺ mobilization, reactive oxygen species generation and impairs trypsin secretion in mouse pancreatic acinar cells. Biochimica et Biophysica Acta (BBA) - General Subjects, 1863(11), p.129407.: https://pubmed.ncbi.nlm.nih.gov/31381958/
------------------------------------------------------------

ID: 12 | 4-P-PDOT (N-(4-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propanamide)
FDA: not approved
Описание: 4-P-PDOT is primarily known as a melatonin receptor antagonist, with a high selectivity for the MT2 receptor subtype over the MT1 subtype7. While melatonin itself is a chronobiotic, meaning it influences biological rhythms and has sleep-promoting properties3, 4-P-PDOT's role as an antagonist sugg...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3976006
KEGG: NULL
Классы: chronobiotic
Эффекты: blocks melatonin-induced phase shifts
Механизмы: antagonist of melatonin receptors
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Liu, W., Chen, Z., Li, R., Zheng, M., Pang, X., Wen, A., Yang, B. and Wang, S., 2023. High and low dose of luzindole or 4-phenyl-2-propionamidotetralin (4-P-PDOT) reverse bovine granulosa cell response to melatonin. PeerJ, 11, p.e14612.: https://pubmed.ncbi.nlm.nih.gov/36684672/
------------------------------------------------------------

ID: 13 | Agomelatine
FDA: Aapproved
Описание: Agomelatine is recognized as a chronobiotic, it has the ability to influence and regulate the body's internal biological clock. This property is primarily attributed to its agonistic action on melatonin MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), which is the part of the brain res...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/82148
KEGG: https://www.kegg.jp/entry/D02578
Классы: chronobiotic
Эффекты: Agomelatine has been shown to induce robust circadian phase shifts, can improve sleep continuity and quality, shorten sleep latency (time it takes to fall asleep, Phase shift in humans via MT1/MT2 receptor agonism, advance the timing of sleep onset and other circadian rhythms like core body temperature and heart rate.
Механизмы: antagonist of melatonin receptors
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Souza, L.C., Martynhak, B.J., Bassani, T.B., Turnes, J.D.M., Machado, M.M., Moura, E., Andreatini, R. and Vital, M.A., 2018. Agomelatine's effect on circadian locomotor rhythm alteration and depressive-like behavior in 6-OHDA lesioned rats. Physiology & Behavior, 188, pp.298-310.: https://www.sciencedirect.com/science/article/abs/pii/S0031938418301264, Pandi-Perumal, S.R., Moscovitch, A., Srinivasan, V., Spence, D.W., Cardinali, D.P. and Brown, G.M., 2009. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Progress in Neurobiology, 88(4), pp.264–271.: https://www.sciencedirect.com/science/article/abs/pii/S0301008209000628#:~:text=Because%20agomelatine%20is%20a%20specific,SCN%20is%20a%20prolonged%20one., Tchekalarova, J., Stoynova, T., Ilieva, K., Mitreva, R. and Atanasova, M., 2018. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light. Pharmacology Biochemistry and Behavior, 171, pp.1–9.: https://pubmed.ncbi.nlm.nih.gov/29807067/
------------------------------------------------------------

ID: 14 | N-[(6-Methoxy-9-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl)methyl]acetamide (UCM 549)
FDA: not approved
Описание: UCM549 is an antagonist of melatonin MT2 receptors
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11185529
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase shift disruption in mammals
Механизмы: antagonist of melatonin receptors
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Spadoni, G., Bedini, A., Diamantini, G., Tarzia, G., Rivara, S., Lorenzi, S., Lodola, A., Mor, M., Lucini, V., Pannacci, M., Caronno, A. and Fraschini, F., 2007. Synthesis, enantiomeric resolution, and structure–activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists. ChemMedChem, 2(12), pp.1741–1749.: https://pubmed.ncbi.nlm.nih.gov/17907131/, Lucini, V., Pannacci, M., Scaglione, F., Fraschini, F., Rivara, S., Mor, M., Bordi, F., Plazzi, P.V., Spadoni, G., Bedini, A., Piersanti, G., Diamantini, G. and Tarzia, G., 2004. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity. Journal of Medicinal Chemistry, 47(17), pp.4202–4212.: https://pubmed.ncbi.nlm.nih.gov/15293992/
------------------------------------------------------------

ID: 15 | 5-MCA-NAT
FDA: not approved
Описание: 5-MCA-NAT (5-methoxycarbonylamino-N-acetyltryptamine) is a melatonin analog with several pharmacological properties, but there is no direct evidence in the provided sources to classify it explicitly as a "chronobiotic." A chronobiotic is a substance that can modify the timing of biological rhythm...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4284525
KEGG: NULL
Классы: chronobiotic
Эффекты: Melatonin receptor agonism
Механизмы: MT3 receptor ligand
Цели: MT3 (https://www.rcsb.org/structure/4gr9)
Статьи: Pintor, J., Peláez, T., Hoyle, C.H. and Peral, A., 2003. Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor. British Journal of Pharmacology, 138(5), pp.831–836.: https://pubmed.ncbi.nlm.nih.gov/12642384/, Crooke, A., Huete-Toral, F., Martínez-Águila, A., Martín-Gil, A. and Pintor, J., 2012. Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT. Journal of Pineal Research, 52(3), pp.265–270.: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-079X.2011.00938.x?casa_token=7Ryr8cVAOGsAAAAA%3AjR8DYkfYN1Efvc5BeD_j0VhbDFkuvUgjuB6XXDzKIn9jwdivrMzocs77wTaft_ml96vEKnXoGseZt957
------------------------------------------------------------

ID: 16 | S26131
FDA: not approved
Описание: S26131 (two molecules of agomelatine) is a melatonin receptor ligand that acts as an antagonist on both MT1 and MT2 receptors. It is particularly noted for its selectivity towards the MT1 receptor, with a Ki value of 0.5 nM for MT1 and 112 nM for MT245. This makes it a useful tool in pharmacologi...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9870523
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase shift disruption in mammals via MT1/MT2 receptor antagonism
Механизмы: MT1 receptor binding, Melatonin receptor binding, MT2 receptor antagonist
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Descamps-François, C., Yous, S., Chavatte, P., Audinot, V., Bonnaud, A., Boutin, J.A., Delagrange, P., Bennejean, C., Renard, P. and Lesieur, D., 2003. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands. Journal of Medicinal Chemistry, 46(7), pp.1127–1129.: https://pubmed.ncbi.nlm.nih.gov/12646022/, Audinot, V., Mailliet, F., Lahaye-Brasseur, C., Bonnaud, A., Le Gall, A., Amossé, C., Dromaint, S., Rodriguez, M., Nagel, N., Galizzi, J.P., Malpaux, B., Guillaumet, G., Lesieur, D., Lefoulon, F., Renard, P., Delagrange, P. and Boutin, J.A., 2003. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn–Schmiedeberg’s Archives of Pharmacology, 367(6), pp.553–561.: https://pubmed.ncbi.nlm.nih.gov/12764576/
------------------------------------------------------------

ID: 17 | Melatonin-d4
FDA: Approved
Описание: Melatonin-d4 is deuterium labeled Melatonin. Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Antioxidative and anti-inflammatory properties. Melatonin is a selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Melatonin-d4
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase shift induction in mammals via MT1/MT2 receptor agonism
Механизмы: Melatonin receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: González, S., Moreno-Delgado, D., Moreno, E., Pérez-Capote, K., Franco, R., Mallol, J., Cortés, A., Casadó, V., Lluís, C., Ortiz, J., Ferré, S., Canela, E. and McCormick, P.J., 2012. Circadian-related heteromerization of adrenergic and dopamine D₄ receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biology, 10(6), p.e1001347.: https://pubmed.ncbi.nlm.nih.gov/22723743/
------------------------------------------------------------

ID: 18 | 2-Iodomelatonin
FDA: not approved
Описание: 2-Iodomelatonin is a melatonin analog used as a radiolabelled ligand for the melatonin receptors, MT1, MT2, and MT3. It acts as a full agonist at both MT1 and MT2 receptors.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/115348
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase shift induction in mammals via MT1/MT2 receptor agonism
Механизмы: MT1 receptor binding, SIRT1, Melatonin receptor binding, MT2 receptor antagonist
Цели: MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Masana, M.I., Benloucif, S. and Dubocovich, M.L., 2000. Circadian rhythm of MT1 melatonin receptor expression in the suprachiasmatic nucleus of the C3H/HeN mouse. Journal of Pineal Research, 28(3), pp.185–192.: https://pubmed.ncbi.nlm.nih.gov/10739306/#:~:text=2%2D%5B125I%5D%2DIodomelatonin,cycle%20and%20constant%20dark%20conditions., Larson-Prior, L.J., Siuciak, J.A. and Dubocovich, M.L., 1996. Localization of 2-[¹²⁵I]iodomelatonin binding sites in visual areas of the turtle brain. European Journal of Pharmacology, 297(1–2), pp.181–185.: https://pubmed.ncbi.nlm.nih.gov/8851181/#:~:text=Abstract,within%20the%20central%20nervous%20system.
------------------------------------------------------------

ID: 19 | 8-M-PDOT
FDA: Not approved
Описание: 8-M-PDOT (AH-002) is a selective melatonin MT2 receptor agonist. 8-M-PDOT is 5.2-fold selective for MT2 over MT1 receptors. 8-M-PDOT binds human recombinant MT2 and MT2 receptors with pKi values of 8.23 and 8.95 respectively. 8-M-PDOT has anxiolytic-like activity. Experimental drug.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5170952
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase shift modulation in mammals via selective MT2 receptor agonism
Механизмы: MT2 receptor ligand
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Ambriz-Tututi, M. and Granados-Soto, V., 2007. Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors. Pain, 132(3), pp.273–280.: https://pubmed.ncbi.nlm.nih.gov/17346886/, Mendoza-Vargas, L., Solís-Chagoyán, H., Benítez-King, G. and Fuentes-Pardo, B., 2009. MT2-like melatonin receptor modulates amplitude receptor potential in visual cells of crayfish during a 24-hour cycle. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 154(4), pp.486–492.: https://pubmed.ncbi.nlm.nih.gov/19666131/
------------------------------------------------------------

ID: 20 | Tasimelteon
FDA: Approved
Описание: Tasimelteon is considered a chronobiotic due to its ability to regulate circadian rhythms. It is a selective dual agonist of the melatonin receptors MT1 and MT2, which are key in controlling the body's internal clock. By activating these receptors in the suprachiasmatic nucleus of the brain, tasi...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/10220503
KEGG: https://www.kegg.jp/entry/D09388
Классы: chronobiotic
Эффекты: Circadian phase entrainment via MT1/MT2 receptor agonism
Механизмы: MT1 receptor binding, MT2 receptor ligand, Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Nishimon, S., Nishimon, M. and Nishino, S., 2019. Tasimelteon for treating non-24-h sleep–wake rhythm disorder. Expert Opinion on Pharmacotherapy, 20(9), pp.1065–1073.: https://pubmed.ncbi.nlm.nih.gov/30990759/#:~:text=Tasimelteon%20entrains%20circadian%20rhythms%20and,continued%20it%20maintained%20circadian%20entrainment., Torres, R., Kramer, W.G. and Baroldi, P., 2015. Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment. Journal of Clinical Pharmacology, 55(5), pp.525–533.: https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.440
------------------------------------------------------------

ID: 21 | Agomelatine hydrochloride
FDA: approved
Описание: Salt of agomelatine. Agomelatine hydrochloride, a novel antidepressant, has a significant impact on circadian rhythms. It works by acting on melatonin receptors, particularly MT1 and MT2, which play a crucial role in regulating the circadian cycle. This action leads to resynchronization of the ci...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/66980040
KEGG: NULL
Классы: chronobiotic
Эффекты: Resynchronization of the circadian clock, potentially improving sleep quality and alleviating symptoms associated with sleep disturbances., restores normal circadian rhythms
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Tchekalarova, J., Stoynova, T., Ilieva, K., Mitreva, R. and Atanasova, M., 2018. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light. Pharmacology Biochemistry and Behavior, 171, pp.1–9.: https://pubmed.ncbi.nlm.nih.gov/29807067/, Mairesse, J., Silletti, V., Laloux, C., Zuena, A.R., Giovine, A., Consolazione, M., van Camp, G., Malagodi, M., Gaetani, S., Cianci, S., Catalani, A., Mennuni, G., Mazzetta, A., van Reeth, O., Gabriel, C., Mocaër, E., Nicoletti, F., Morley-Fletcher, S. and Maccari, S., 2013. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats. International Journal of Neuropsychopharmacology, 16: https://pubmed.ncbi.nlm.nih.gov/22310059/#:~:text=PRS%20was%20delivered%20to%20the,circadian%20rhythms%20under%20pathological%20conditions.
------------------------------------------------------------

ID: 22 | ACH-000143
FDA: not approved
Описание: ACH-000143 is a potent and orally active melatonin receptor agonist, with EC50 values of 0.06 nM and 0.32 nM for MT1 and MT2, respectively. ACH-000143 reduces liver triglycerides and steatosis in diet-Induced obese rats. ACH-000143 is devoid of hERG binding, genotoxicity, and behavioral alteratio...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/139451790
KEGG: NULL
Классы: chronobiotic
Эффекты: Circadian rhythm entrainment in diet-induced obese rats via MT1/MT2 agonism
Механизмы: MT1 receptor binding, MT2 receptor ligand
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Ferreira, M.A. Jr, Azevedo, H., Mascarello, A., Segretti, N.D., Russo, E., Russo, V. and Guimarães, C.R.W., 2021. Discovery of ACH-000143: a novel potent and peripherally preferred melatonin receptor agonist that reduces liver triglycerides and steatosis in diet-induced obese rats. Journal of Medicinal Chemistry, 64(4), pp.1904–1929.: https://pubmed.ncbi.nlm.nih.gov/33626870/
------------------------------------------------------------

ID: 23 | Piromelatine
FDA: Not approved
Описание: Piromelatine is indeed considered a chronobiotic agent. Chronobiotics are substances that help regulate the body's internal clock and synchronize circadian rhythms. Piromelatine acts primarily as an agonist of melatonin receptors (MT1, MT2, and MT3), which are crucial for regulating the sleep-wak...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/24815904
KEGG: NULL
Классы: chronobiotic
Эффекты: Circadian rhythm synchronization via melatonin receptor agonism
Механизмы: MT3 receptor ligand, MT1 receptor binding, MT2 receptor ligand
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT3 (https://www.rcsb.org/structure/4gr9), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Tchekalarova, J., Kortenska, L., Marinov, P. and Ivanova, N., 2022. Sex-dependent effects of piromelatine treatment on sleep–wake cycle and sleep structure of prenatally stressed rats. International Journal of Molecular Sciences, 23(18), p.10349.: https://pubmed.ncbi.nlm.nih.gov/36142262/, She, M., Hu, X., Su, Z., Zhang, C., Yang, S., Ding, L., Laudon, M. and Yin, W., 2014. Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats. European Journal of Pharmacology, 727, pp.60–65.: https://pubmed.ncbi.nlm.nih.gov/24486392/
------------------------------------------------------------

ID: 24 | UCM 608 (N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide)
FDA: not approved
Описание: UCM 608 is a high affinity melatonin (MT) membrane receptor agonist. The pKi values for MT1 and MT2 are 10.7 and 10.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4018512
KEGG: NULL
Классы: chronobiotic
Эффекты: MT1/MT2 receptor agonist; potential circadian phase modulation in mammals
Механизмы: MT1 receptor binding, MT2 receptor ligand, Melatonin agonist
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Radogna, F., Paternoster, L., De Nicola, M., Cerella, C., Ammendola, S., Bedini, A., Tarzia, G., Aquilano, K., Ciriolo, M. and Ghibelli, L., 2009. Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicology and Applied Pharmacology, 239(1), pp.37–45.: https://pubmed.ncbi.nlm.nih.gov/19463840/, Mor, M., Spadoni, G., Di Giacomo, B., Diamantini, G., Bedini, A., Tarzia, G., Plazzi, P.V., Rivara, S., Nonno, R., Lucini, V., Pannacci, M., Fraschini, F. and Stankov, B.M., 2001. Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands. Bioorganic & Medicinal Chemistry, 9(4), pp.1045–1057.: https://pubmed.ncbi.nlm.nih.gov/11354661/
------------------------------------------------------------

ID: 25 | Ramelteon metabolite M-II-d3
FDA: Not approved
Описание: The duration of action of melatonin may be important for improvements in sleep efficiency in insomniacs. Ramelteon, a selective melatonin agonist, is primarily metabolized to the active metabolite M-II, which has a longer half-life and greater systemic exposure than ramelteon. Hence, M-II may con...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/71751961
KEGG: NULL
Классы: chronobiotic
Эффекты: improves sleep (cats)
Механизмы: MT1 receptor binding, MT2 receptor ligand, Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Richardson, G.S., Zee, P.C., Wang-Weigand, S., Rodriguez, L. and Peng, X., 2008. Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. Journal of Clinical Sleep Medicine, 4(5), pp.456–461.: https://pmc.ncbi.nlm.nih.gov/articles/PMC2576313/#:~:text=Ramelteon%20(1%2C%202%2C%20or,in%20the%20sleep%2Dwake%20cycle., Richardson, G.S., Zee, P.C., Wang-Weigand, S., Rodriguez, L. and Peng, X., 2008. Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. Journal of Clinical Sleep Medicine, 4(5), pp.456–461.: https://pubmed.ncbi.nlm.nih.gov/18853704/
------------------------------------------------------------

ID: 26 | N-Acetyltryptamine
FDA: Not approved
Описание: N-Acetyltryptamine is a partial agonist for melatonin receptors in the retina. N-Acetyltryptamine is also used for determination of serotonin N-acetyl transferase activity. Precursor of melatonin, N-acetyl-5-methoxytryptamine, is a hormone primarily synthesized by the pineal gland and plays a cru...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/70547
KEGG: NULL
Классы: chronobiotic
Эффекты: Partial MT2 receptor agonist; modulates circadian signaling in retina (mammals)
Механизмы: MT1 receptor binding, Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Backlund, P.S., Urbanski, H.F., Doll, M.A., Hein, D.W., Bozinoski, M., Mason, C.E., Coon, S.L. and Klein, D.C., 2017. Daily rhythm in plasma N-acetyltryptamine. Journal of Biological Rhythms, 32(3), pp.195–211.: https://pubmed.ncbi.nlm.nih.gov/28466676/#:~:text=Analysis%20of%2024%2Dh%20blood,among%20the%204%20animals%20studied., Pohanka, M., 2022. New uses of melatonin as a drug: a review. Current Medicinal Chemistry, 29(20), pp.3622–3637.: https://pubmed.ncbi.nlm.nih.gov/28466676/
------------------------------------------------------------

ID: 27 | Ramelteon metabolite M-II (DES(1-oxopropyl)-2-hydroxy-1-oxopropyl-ramelteon)
FDA: Approved
Описание: Ramelteon's major metabolite M-II contributes to its chronobiotic effects through its pharmacological profile and receptor interactions. While less potent than the parent compound, M-II's pharmacokinetic properties and receptor activity support its role in modulating circadian rhythms. Key Mechan...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/46783414
KEGG: NULL
Классы: chronobiotic
Эффекты: MT1/MT2 partial agonist
Механизмы: Melatonin agonist
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: ChatGPT сказал: Nishiyama, K., Nishikawa, H., Kato, K., Miyamoto, M., Tsukamoto, T. and Hirai, K., 2014. Pharmacological characterization of M-II, the major human metabolite of ramelteon. Pharmacology, 93(3–4), pp.197–201.: https://pubmed.ncbi.nlm.nih.gov/24923230/
------------------------------------------------------------

ID: 28 | Melatonin-d3
FDA: Approved
Описание: 3 Deuterium radiopreparation of melatonin.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/91235750
KEGG: NULL
Классы: chronobiotic
Механизмы: Melatonin receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Rajaratnam, S.M., Middleton, B., Stone, B.M., Arendt, J. and Dijk, D.J., 2004. Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans. Journal of Physiology, 561(1), pp.339–351.: https://pmc.ncbi.nlm.nih.gov/articles/PMC1665336/#:~:text=Each%20laboratory%20trial%20commenced%20at,2003).
------------------------------------------------------------

ID: 29 | Agomelatine-d4
FDA: Not approved
Описание: Agomelatine-d4 is a deuterated form of agomelatine, an atypical antidepressant primarily used to treat major depressive disorder and generalized anxiety disorder. Agomelatine itself acts as a melatonin receptor agonist and a serotonin receptor antagonist, which distinguishes it from other antidep...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/25174420
KEGG: NULL
Классы: chronobiotic
Эффекты: derivative of chronobiotic agomelatine (MT1/MT2)
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: De Berardis, D., Marini, S., Fornaro, M., Srinivasan, V., Iasevoli, F., Tomasetti, C., Valchera, A., Perna, G., Quera-Salva, M.A., Martinotti, G. and Di Giannantonio, M., 2013. The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. International Journal of Molecular Sciences, 14(6), pp.12458–12483.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3709794/
------------------------------------------------------------

ID: 30 | Melatonin receptor agonist 1
FDA: Not approved
Описание: Melatonin receptor agonist 1 (compound 20c) is a potent melatonin receptor (MT) agonist, with Ki values of 108 nM (MT2) and 1140 nM (MT1).
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/162661094
KEGG: NULL
Классы: chronobiotic
Механизмы: Melatonin receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Dubocovich, M.L., 2007. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Medicine, 8(Suppl 3), pp.34–42.: https://pubmed.ncbi.nlm.nih.gov/18032103/
------------------------------------------------------------

ID: 31 | Melatonin-d7
FDA: not approved
Описание: Melatonin-d7 is the deuterium labeled Melatonin (HY-B0075). Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties. Melatonin is a novel selective ATF-6 inhibitor...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Melatonin-D7
KEGG: NULL
Классы: chronobiotic
Эффекты: MT1/MT2 receptor agonist
Механизмы: MT1 receptor binding, MT2 receptor ligand, Melatonin receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Fourtillan, J.B., Brisson, A.M., Gobin, P., Ingrand, I., Decourt, J.P. and Girault, J., 2000. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin. Biopharmaceutics & Drug Disposition, 21(1), pp.15–22.: https://pubmed.ncbi.nlm.nih.gov/11038434/
------------------------------------------------------------

ID: 32 | Ramelteon-d5
FDA: Approved
Описание: Ramelteon-d5 is deuterium labeled Ramelteon. Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment,...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/25231404
KEGG: NULL
Классы: chronobiotic
Эффекты: MT1/MT2 receptor agonist
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: McGechan, A. and Wellington, K., 2005. Ramelteon. CNS Drugs, 19(12), pp.1057–1065; discussion 1066–1067.: https://pubmed.ncbi.nlm.nih.gov/16332146/
------------------------------------------------------------

ID: 33 | 7-Desmethyl-3-hydroxyagomelatine
FDA: NULL
Описание: 7-Desmethyl-3-hydroxyagomelatine (3-Hydroxy-7-desmethyl agomelatine), a metabolite of Agomelatine, has less activity than Agomelatine. Agomelatine is a melatonergic (MT1 and MT2) agonist and serotonergic (5HT2C) antagonist.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/23360888
KEGG: NULL
Классы: chronobiotic
Эффекты: Weak MT1/MT2 agonist
Механизмы: MT1 receptor binding, MT2 receptor ligand, Melatonin receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Bogaards, J.J., Hissink, E.M., Briggs, M., Weaver, R., Jochemsen, R., Jackson, P., Bertrand, M. and van Bladeren, P.J., 2000. Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling. European Journal of Pharmaceutical Sciences, 12(2), pp.117–124.: https://pubmed.ncbi.nlm.nih.gov/11102739/
------------------------------------------------------------

ID: 34 | Agomelatin-d3
FDA: Approved
Описание: Agomelatine-d3 is the deuterium labeled Agomelatine. Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 a...
PubChem: NULL
KEGG: NULL
Классы: chronobiotic
Эффекты: Phase shifting in humans (via MT1/MT2 receptor activation)
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Russak, E.M. and Bednarczyk, E.M., 2019. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals. Annals of Pharmacotherapy, 53(2), pp.211–216.: https://pubmed.ncbi.nlm.nih.gov/30136594/, Audinot, V., Mailliet, F., Lahaye-Brasseur, C., Bonnaud, A., Le Gall, A., Amossé, C., Dromaint, S., Rodriguez, M., Nagel, N., Galizzi, J.P., Malpaux, B., Guillaumet, G., Lesieur, D., Lefoulon, F., Renard, P., Delagrange, P. and Boutin, J.A., 2003. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology, 367(6), pp.553–561.: https://pubmed.ncbi.nlm.nih.gov/12764576/
------------------------------------------------------------

ID: 35 | TIK-301
FDA: Not approved
Описание: TIK-301 (LY-156735) is an agonist for the melatonin receptors MT1 and MT2 that is under development for the treatment of insomnia and other sleep disorders. Its agonist action on MT1 and MT2 receptors in the suprachiasmatic nucleus in the brain enables its action as a chronobiotic. It is in the s...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/219018
KEGG: NULL
Классы: chronobiotic
Эффекты: efficacy in readjusting phase shifts in all physiological systems. Reduces sleep latancy.
Механизмы: MT1 receptor binding, MT2 receptor ligand, Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Hardeland, R., 2016. Melatonin and synthetic melatoninergic agonists in psychiatric and age-associated disorders: successful and unsuccessful approaches. Current Pharmaceutical Design, 22(8), pp.1086–1101.: https://pubmed.ncbi.nlm.nih.gov/25248806/, Szabadi, E., 2015. Neuronal networks regulating sleep and arousal: effect of drugs. In: Guglietta, A. (ed.) Drug Treatment of Sleep Disorders. Milestones in Drug Therapy. Springer, Cham, pp.25–70.: https://link.springer.com/chapter/10.1007/978-3-319-11514-6_2#:~:text=The%20drugs%20to%20treat%20insomnia,classified%20as%20general%20(nonselective)%20CNS
------------------------------------------------------------

ID: 36 | S-20928
FDA: Not approved
Описание: S-20928 is an antagonist for melatonin receptor through inhibition of binding of melatonin to its receptors. S-20928 enhances the 2-Deoxy-D-glucose (2DG) (HY-13966)-induced increase in blood glucose and glucagon levels in rats brain. Masson‐Pévet, M., Recio, J., Guerrero, H.Y., Mocaer, E., Delag...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/127856
KEGG: NULL
Классы: chronobiotic
Механизмы: antagonist of melatonin receptors
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Masson-Pévet, M., Recio, J., Guerrero, H.Y., Mocaer, E., Delagrange, P., Guardiola-Lemaitre, B. and Pévet, P., 1998. Effects of two melatonin analogues, S-20098 and S-20928, on melatonin receptors in the pars tuberalis of the rat. Journal of Pineal Research, 25(3), pp.172–176.: https://pubmed.ncbi.nlm.nih.gov/9745986/, Willis, G.L. and Robertson, A.D., 2005. Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23. Pharmacology Biochemistry and Behavior, 80(1), pp.9–26.: https://pubmed.ncbi.nlm.nih.gov/15652376/
------------------------------------------------------------

ID: 37 | DH97
FDA: Not approved
Описание: N-Pentanoyl 2-benzyltryptamine is a potent and selective antagonist of MT2 melatonin receptor, with a pKi of 8.03 for human MT2. N-Pentanoyl 2-benzyltryptamine shows 89- and 229-fold selectivity for human MT2 over human mt1 and Xenopus mel1c receptor subtypes. N-Pentanoyl 2-benzyltryptamine can i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3467177
KEGG: NULL
Классы: chronobiotic
Эффекты: MT2 antagonist; disrupts melatonin signaling (in human receptor models)
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Behrens, U.D., Douglas, R.H., Sugden, D., Davies, D.J. and Wagner, H.J., 2000. Effect of melatonin agonists and antagonists on horizontal cell spinule formation and dopamine release in a fish retina. Cell and Tissue Research, 299(3), pp.299–306.: https://pubmed.ncbi.nlm.nih.gov/10772244/
------------------------------------------------------------

ID: 38 | Ramelteon-d3
FDA: Approved
Описание: Ramelteon-d3 is a deuterium-labelled Ramelteon (HY-A0014). For research use only.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/165437284
KEGG: NULL
Классы: chronobiotic
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Miyamoto, M., 2009. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS Neuroscience & Therapeutics, 15(1), pp.32–51.: https://pmc.ncbi.nlm.nih.gov/articles/PMC2871175/
------------------------------------------------------------

ID: 39 | 6-Chloromelatonin
FDA: Not approved
Описание: 6-Chloromelatonin is a potent melatonin receptor agonist with greater metabolic stability than melatonin. 6-Chloromelatonin compete for [3H]-melatonin and 2-[125I]-iodomelatonin binding to MT1 receptors (pKi=8.9 and 9.1, respectively). 6-Chloromelatonin compete for [3H]-melatonin binding to MT2 r...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/1858
KEGG: NULL
Классы: chronobiotic
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Kumari, Y., Choo, B.K.M., Shaikh, M.F. and Othman, I., 2019. Melatonin receptor agonist Piper betle L. ameliorates dexamethasone-induced early life stress in adult zebrafish. Experimental and Therapeutic Medicine, 18(2), pp.1095–1102.: https://www.researchgate.net/publication/333855278_Melatonin_receptor_agonist_Piper_betle_L_ameliorates_dexamethasone-induced_early_life_stress_in_adult_zebrafish/figures?lo=1&utm_source=google&utm_medium=organic
------------------------------------------------------------

ID: 40 | GR 196429
FDA: Not approved
Описание: GR-196429 is a melatonin receptor agonist with some selectivity for the MT1 subtype. It was one of the first synthetic melatonin agonists developed and continues to be used in scientific research, though it has never been developed for medical use. Studies in mice have shown GR-196429 to produce ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5311134
KEGG: NULL
Классы: chronobiotic
Эффекты: Sleep-promoting and circadian phase-altering effects in mice
Механизмы: MT1 receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Beresford, I.J., Harvey, F.J., Hall, D.A. and Giles, H., 1998. Pharmacological characterisation of melatonin MT1 receptor-mediated stimulation of [³⁵S]-GTPγS binding. Biochemical Pharmacology, 56(9), pp.1167–1174.: https://pubmed.ncbi.nlm.nih.gov/9802327/, Fratter, A., 2013. Nanoemulsion technology for sublingual delivery of melatonin: characterization and preliminary data on a new administration system. In: New Developments in Melatonin Research. Nova Science Publishers, New York. ISBN: 978-1-62618-880-8.: https://www.researchgate.net/publication/304172087_New_Development_in_Melatonine_Research
------------------------------------------------------------

ID: 41 | Agomelatine (L(+)-Tartaric acid)
FDA: Not approved
Описание: Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6...
PubChem: NULL
KEGG: NULL
Классы: chronobiotic
Эффекты: Circadian phase modulation via MT1/MT2 agonism
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Audinot, V., Mailliet, F., Lahaye-Brasseur, C., Bonnaud, A., Le Gall, A., Amossé, C., Dromaint, S., Rodriguez, M., Nagel, N., Galizzi, J.P., Malpaux, B., Guillaumet, G., Lesieur, D., Lefoulon, F., Renard, P., Delagrange, P. and Boutin, J.A., 2003. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn–Schmiedeberg’s Archives of Pharmacology, 367(6), pp.553–561.: https://pubmed.ncbi.nlm.nih.gov/12764576/, Millan, M.J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J.M. and Cussac, D., 2003. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. Journal of Pharmacology and Experimental Therapeutics, 306(3), pp.954–964.: https://pubmed.ncbi.nlm.nih.gov/12750432/, Aguiar, C.C., Almeida, A.B., Araújo, P.V., Vasconcelos, G.S., Chaves, E.M., do Vale, O.C., Macêdo, D.S., Leal, L.K., de Barros Viana, G.S. and Vasconcelos, S.M., 2013. Effects of agomelatine on oxidative stress in the brain of mice after chemically induced seizures. Cellular and Molecular Neurobiology, 33(6), pp.825–835.: https://pubmed.ncbi.nlm.nih.gov/23801192/
------------------------------------------------------------

ID: 42 | Tasimelteon-d5
FDA: not approved
Описание: Tasimelteon-d5 is the deuterium labeled Tasimelteon. Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the p...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/156588908
KEGG: NULL
Классы: chronobiotic
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Russak, E.M. and Bednarczyk, E.M., 2019. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals. Annals of Pharmacotherapy, 53(2), pp.211–216: https://pubmed.ncbi.nlm.nih.gov/30136594/, Lavedan, C., Forsberg, M. and Gentile, A.J., 2015. Tasimelteon: a selective and unique receptor binding profile. Neuropharmacology, 91, pp.142–147: https://pubmed.ncbi.nlm.nih.gov/25534555/
------------------------------------------------------------

ID: 43 | GR 128107
FDA: Not approved
Описание: GR 128107 is a competitive melatonin receptor antagonist (pKi: 9.6).
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/44208891
KEGG: NULL
Классы: chronobiotic
Эффекты: Circadian disruption via melatonin receptor antagonism
Механизмы: Melatonin receptor antagonist
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Teh, M.T. and Sugden, D., 1999. The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores. British Journal of Pharmacology, 126(5), pp.1237–1245.: https://pubmed.ncbi.nlm.nih.gov/10205014/, Teh, M.T. and Sugden, D., 1999. The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores. British Journal of Pharmacology, 126(5), pp.1237–1245.: https://pmc.ncbi.nlm.nih.gov/articles/PMC1565880/
------------------------------------------------------------

ID: 44 | ACH 000143
FDA: not approved
Описание: An early toxicological assessment indicated that 10b (also codified as ACH-000143) was devoid of hERG binding, genotoxicity, and behavioral alterations at doses up to 100 mg/kg p.o., supporting further investigation of this compound as a drug candidate. ACH-000143 is a novel, potent, and orally a...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/139451790
KEGG: NULL
Классы: chronobiotic
Эффекты: Melatonin receptor agonism
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Ferreira, M.A. Jr, Azevedo, H., Mascarello, A., Segretti, N.D., Russo, E., Russo, V. and Guimarães, C.R.W., 2021. Discovery of ACH-000143: a novel potent and peripherally preferred melatonin receptor agonist that reduces liver triglycerides and steatosis in diet-induced obese rats. Journal of Medicinal Chemistry, 64(4), pp.1904–1929.: https://pubmed.ncbi.nlm.nih.gov/33626870/
------------------------------------------------------------

ID: 45 | S24014
FDA: Not approved
Описание: S24014 acts as an agonist against melatonin receptors, indicating its potential use in conditions related to melatonin regulation. However, specific therapeutic applications or diseases targeted by S24014 are not widely detailed in the available literature. S24014 is classified as an investigati...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9998187
KEGG: NULL
Классы: chronobiotic
Эффекты: UNKNOWN
Механизмы: Melatonin receptor binding
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Jockers, R., Delagrange, P., Dubocovich, M.L., Markus, R.P., Renault, N., Tosini, G., Cecon, E. and Zlotos, D.P., 2016. Update on melatonin receptors: IUPHAR Review 20. British Journal of Pharmacology, 173(18), pp.2702–2725.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4995287/, Boutin, J.A., Witt-Enderby, P.A., Sotriffer, C. and Zlotos, D.P., 2020. Melatonin receptor ligands: a pharmaco-chemical perspective. Journal of Pineal Research, 69(2), p.e12672.: https://onlinelibrary.wiley.com/doi/10.1111/jpi.12672, Williams III, W.P., McLin III, D.E., Dressman, M.A. and Neubauer, D.N., 2016. Comparative review of approved melatonin agonists for the treatment of circadian rhythm sleep‐wake disorders. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(9), pp.1028-1041.: https://pmc.ncbi.nlm.nih.gov/articles/PMC5108473/
------------------------------------------------------------

ID: 46 | SP600125
FDA: NULL
Описание: The JNK inhibitor SP600125 has been shown to significantly impact mammalian circadian rhythms by modulating the phosphorylation of c-Jun N-terminal kinase (JNK), a key regulator of the circadian molecular machinery. Below is a summary of its effects: Key Findings on SP600125 and Circadian Rhythms...
PubChem: NULL
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Period lengthening
Механизмы: JNK kinase mediated circadian rhythm modulation
Цели: JNK (https://www.rcsb.org/structure/1JNK)
Статьи: Park, W.R., Choi, B., Kim, Y.J., Kim, Y.H., Park, M.J., Kim, D.I., Choi, H.S. and Kim, D.K., 2022. Melatonin regulates iron homeostasis by inducing hepcidin expression in hepatocytes. International Journal of Molecular Sciences, 23(7), p.3593.: https://pubmed.ncbi.nlm.nih.gov/35408955/, Wu, H.M., Shen, Q.Y., Fang, L., Zhang, S.H., Shen, P.T., Liu, Y.J. and Liu, R.Y., 2016. JNK-TLR9 signal pathway mediates allergic airway inflammation through suppressing melatonin biosynthesis. Journal of Pineal Research, 60(4), pp.415–423.: https://pubmed.ncbi.nlm.nih.gov/26914888/
------------------------------------------------------------

ID: 47 | Cannabidiol
FDA: Not approved
Описание: Cannabidiol (CBD) is the second major cannabinoid which is often said to improve anxiety and sleep with no psychoactive effect. then PER2 gene expression in the liver, kidney, and submandibular gland is observed by in-vivo imaging. Affects core circadian complex. Nuclear molecules show a deregu...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/644019#section=3D-Conformer
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Механизмы: Disruption of circadian clock, Core clock modulation
Цели: RORB (https://www.ncbi.nlm.nih.gov/gene/6096), RORA (https://www.ncbi.nlm.nih.gov/gene/6095), NR1D1 (https://www.ncbi.nlm.nih.gov/gene/9572)
Статьи: Lafaye, G., Desterke, C., Marulaz, L. and Benyamina, A., 2019. Cannabidiol affects circadian clock core complex and its regulation in microglia cells. Addiction Biology, 24(5), pp.921–934.: https://pubmed.ncbi.nlm.nih.gov/30307084/, Koch, M., Dehghani, F., Habazettl, I., Schomerus, C. and Korf, H.W., 2006. Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors. Journal of Neurochemistry, 98(1), pp.267–278.: https://pubmed.ncbi.nlm.nih.gov/30307084/
------------------------------------------------------------

ID: 48 | Cannabigerol
FDA: Not approved
Описание: Cannabigerol (CBG) has not been explicitly identified as a circadian clock modulator in the available research. However, its pharmacological profile suggests potential indirect effects on physiological processes that could influence circadian rhythms. CBG is a non-psychoactive cannabinoid that in...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5315659
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Unknown, Core clock modulation
Цели: Cannabinoid receptor (https://www.rcsb.org/structure/5TGZ)
Статьи: Pertwee, R.G. (Ed.), 2014. Handbook of Cannabis. Oxford University Press, USA.: https://books.google.ru/books?hl=ru&lr=&id=hPVwBAAAQBAJ&oi=fnd&pg=PP1&ots=yw8lCIUJZf&sig=8gbmjbBl9ssFNx-Hj0lrdbSVF3E&redir_esc=y#v=onepage&q&f=false
------------------------------------------------------------

ID: 49 | Cannabichromenes
FDA: Not approved
Описание: Cannabichromene (CBC) is one of four major cannabinoids in Cannabis sativa L. and is the second most abundant cannabinoid in drug-type cannabis. Cannabichromene and some of its homologs, analogs, and isomers were evaluated for antiinflammatory, antibacterial, and antifungal activity. Potential ch...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/30219
KEGG: NULL
Классы: Potential chronodisruptor
Эффекты: non-psychoactive cannabinoid, can influence circadian rhythms through its interaction with the endocannabinoid system (ECS) and potentially by modulat
Механизмы: Unknown
Цели: Cannabinoid receptor (https://www.rcsb.org/structure/5TGZ)
Статьи: Hodges, E.L. and Ashpole, N.M., 2019. Aging circadian rhythms and cannabinoids. Neurobiology of aging, 79, pp.110-118.: https://pmc.ncbi.nlm.nih.gov/articles/PMC6591053/
------------------------------------------------------------

ID: 50 | Dronabinol
FDA: Not approved
Описание: Tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, has several effects on the circadian rhythm and sleep patterns: Circadian Effects Disruption of Circadian Signaling: Chronic THC administration can disrupt circadian signaling at the molecular level, affecting the body's i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/16078
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Core clock modulation
Цели: Cannabinoid receptor (https://www.rcsb.org/structure/5TGZ)
Статьи: Kaul, M., Zee, P.C. and Sahni, A.S., 2021. Effects of cannabinoids on sleep and their therapeutic potential for sleep disorders. Neurotherapeutics, 18(1), pp.217–227.: https://pmc.ncbi.nlm.nih.gov/articles/PMC8116407/
------------------------------------------------------------

ID: 51 | 6,6,9-trimethyl-3-pentylbenzo[c]chromen-1-ol
FDA: Not approved
Описание: A cannabinoid isolated from the plant Cannabis that is a metabolite of tetrahydrocannabinol (THC), with potential immunosuppressive and anti-inflammatory activities. Cannabinol preferentially binds to the cannabinoid G-protein coupled receptor CB2, which is mainly expressed on a variety of immune...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2543
KEGG: NULL
Классы: Potential chronodisruptor
Эффекты: Circadian modulation potential via CB2 in mammals (indirect, immune-related pathways)
Механизмы: Unknown, Cannabinoid receptor stimulation, Disruption of circadian clock, Core clock modulation
Цели: Cannabinoid receptor (https://www.rcsb.org/structure/5TGZ), CB2 (https://www.rcsb.org/structure/6pt0)
Статьи: Lafaye G, Desterke C, Marulaz L, Benyamina A. Cannabidiol affects circadian clock core complex and its regulation in microglia cells. Addiction Biology. 2018.: https://pubmed.ncbi.nlm.nih.gov/30307084/
------------------------------------------------------------

ID: 52 | Cannabinodiol
FDA: Not approved
Описание: Cannabis sativa metabolite with potential of chronodisruptor. 1. Lafaye G, Desterke C, Marulaz L, Benyamina A. Cannabidiol affects circadian clock core complex and its regulation in microglia cells. Addiction Biology. 2018. 2Pisanti S, Malfitano AM, Ciaglia E, et al. Cannabidiol: state of the ar...
PubChem: NULL
KEGG: NULL
Классы: Potential chronodisruptor
Механизмы: Unknown, Cannabinoid receptor stimulation, Disruption of circadian clock, Core clock modulation
Цели: Cannabinoid receptor (https://www.rcsb.org/structure/5TGZ), CB2 (https://www.rcsb.org/structure/6pt0)
Статьи: Lafaye G, Desterke C, Marulaz L, Benyamina A. Cannabidiol affects circadian clock core complex and its regulation in microglia cells. Addiction Biology. 2018.: https://pubmed.ncbi.nlm.nih.gov/30307084/
------------------------------------------------------------

ID: 53 | Nabilone
FDA: Approved
Описание: Nabilone, a synthetic cannabinoid agonist, primarily interacts with the CB1 receptor, which is implicated in circadian rhythm regulation through its role in the endocannabinoid system (ECS). While direct studies on nabilone’s circadian effects are limited, evidence from related research provides ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284592
KEGG: NULL
Классы: circadian rhythm modulator, Potential chronodisruptor
Эффекты: Sleep improvement; potential indirect circadian stabilization via CB1 activation
Механизмы: Cannabinoid receptor stimulation
Цели: Cannabinoid receptor (https://www.rcsb.org/structure/5TGZ)
Статьи: Peball, M., Heim, B., Carbone, F., Schorr, O., Werkmann, M., Ellmerer, P., Marini, K., Krismer, F., Knaus, H.G., Poewe, W., Djamshidian, A. and Seppi, K., 2024. Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson’s disease. NPJ Parkinson’s Disease, 10(1), p.61.: https://pubmed.ncbi.nlm.nih.gov/38491070/
------------------------------------------------------------

ID: 54 | Nabiximols
FDA: Not approved
Описание: Potential chronodisruptor
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/44148067
KEGG: NULL
Классы: Potential chronodisruptor
Механизмы: Unknown, Cannabinoid receptor stimulation, Disruption of circadian clock, Core clock modulation
Цели: Cannabinoid receptor (https://www.rcsb.org/structure/5TGZ), CB2 (https://www.rcsb.org/structure/6pt0)
Статьи: Outen, J.D., Burhanullah, M.H., Vandrey, R., Amjad, H., Harper, D.G., Patrick, R.E., May, R.L., Agronin, M.E., Forester, B.P. and Rosenberg, P.B., 2021. Cannabinoids for agitation in Alzheimer's disease. American Journal of Geriatric Psychiatry, 29(12), pp.1253–1263: https://pmc.ncbi.nlm.nih.gov/articles/PMC8313629/
------------------------------------------------------------

ID: 55 | Oxycodone
FDA: Approved
Описание: Oxycodone, like other opioids, can disrupt circadian rhythms, which are closely linked to sleep patterns and overall physiological function. Here's how oxycodone affects circadian rhythms: Impact of Opioids on Circadian Rhythms Sleep Disruption: Opioids, including oxycodone, can negatively affect...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284603
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Oxycodone, like other opioids, can disrupt circadian rhythms, the body's natural 24-hour cycle.
Механизмы: Mu opioid receptor binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry)
Статьи: Gulledge, M., Carlezon, W.A. Jr, McHugh, R.K., Kinard, E.A., Prerau, M.J. and Chartoff, E.H., 2025. Spontaneous oxycodone withdrawal disrupts sleep, diurnal, and electrophysiological dynamics in rats. PLoS One, 20(1), p.e0312794.: https://pubmed.ncbi.nlm.nih.gov/39823427/#:~:text=We%20continuously%20recorded%20EEG%20and,mechanisms%20of%20opioid%2Dsleep%20interactions., Pierce, B.E., Holter, K., Morton, A., Lekander, A., Bedingham, E., Curry, R. and Gould, R.W., 2022. Effects of oxycodone self-administration on sleep duration and quality in male and female rats. The FASEB Journal, 36(S1), p.R3946.: https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.2022.36.S1.R3946
------------------------------------------------------------

ID: 56 | Oxymorphone
FDA: Approved
Описание: There is limited specific information available on the circadian effects of oxymorphone. However, we can infer potential impacts based on the broader context of opioids and circadian rhythms. Opioids and Circadian Disruption: Opioids, including morphine, can disrupt circadian rhythms. This disrup...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284604
KEGG: NULL
Классы: Potential chronodisruptor
Механизмы: Unknown, Kappa opioid receptor binding, delta opioid receptor binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
------------------------------------------------------------

ID: 57 | Hydrocodone
FDA: Approved
Описание: Potential chronodisruptor much alike Oxycodone
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284569
KEGG: NULL
Классы: Potential chronodisruptor
Механизмы: Mu opioid receptor binding, Kappa opioid receptor binding, delta opioid receptor binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
------------------------------------------------------------

ID: 58 | Hydromorphone
FDA: Approved
Описание: Chronodisruptor much alike Oxymorphone.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284570
KEGG: NULL
Классы: Potential chronodisruptor
Механизмы: Mu opioid receptor binding, Kappa opioid receptor binding, delta opioid receptor binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
Статьи: Shin, S.H., Lee, H.S., Kim, Y.S., Choi, Y.J., Kim, S.H., Kwon, H.C., Oh, S.Y., Kang, J.H., Sohn, C.H., Lee, S.M., Baek, J.H., Min, Y.J., Kim, C. and Chung, J.S., 2014. Clinical usefulness of hydromorphone-OROS in improving sleep disturbances in Korean cancer patients: a multicenter, prospective, open-label study. Cancer Research and Treatment, 46(4), pp.331–338.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4206066/
------------------------------------------------------------

ID: 59 | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
FDA: Approved
Описание: Adult female Sprague–Dawley rats housed under constant light in cages with attached running wheels received repeated low, medium, or high doses of either fentanyl or haloperidol on a 24-h administration schedule followed by a 31-h schedule (Experiment 1) or solely on a 31-h schedule . The results...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3345#section=MolGenie-Organic-Chemistry-Ontology
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Эффекты: Circadian entrainment of activity episodes
Механизмы: Mu opioid receptor binding, Kappa opioid receptor binding, delta opioid receptor binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
Статьи: Du, K., Shi, Q., Zhou, X., Zhang, L., Su, H., Zhang, C., Wei, Z., Liu, T., Wang, L., Wang, X., Cong, B. and Yun, K., 2024. Melatonin attenuates fentanyl-induced behavioral sensitization and circadian rhythm disorders in mice. Physiology & Behavior, 279, p.114523: https://www.sciencedirect.com/science/article/abs/pii/S0031938424000684, Gillman, A.G., Leffel, J.K. 2nd, Kosobud, A.E. and Timberlake, W., 2009. Fentanyl, but not haloperidol, entrains persisting circadian activity episodes when administered at 24- and 31-h intervals. Behavioural Brain Research, 205(1), pp.102–114.: https://pubmed.ncbi.nlm.nih.gov/19595707/
------------------------------------------------------------

ID: 60 | (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol
FDA: Approved
Описание: Potential chronodisruptor like other opioids. Young, A.M., Thompson, T., Jensen, M.A. and Muchow, L.R., 1979. Effects of response-contingent clock stimuli on behavior maintained by intravenous codeine in the rhesus monkey. Pharmacology Biochemistry and Behavior, 11(1), pp.43-49. Warfield, A.E., P...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284371
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Механизмы: opioid receptors binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry)
Статьи: Young, A.M., Thompson, T., Jensen, M.A. and Muchow, L.R., 1979. Effects of response-contingent clock stimuli on behavior maintained by intravenous codeine in the rhesus monkey. Pharmacology Biochemistry and Behavior, 11(1), pp.43–49.: https://pubmed.ncbi.nlm.nih.gov/115015/, Warfield, A.E., Prather, J.F. and Todd, W.D., 2021. Systems and circuits linking chronic pain and circadian rhythms. Frontiers in Neuroscience, 15, p.705173.: https://pubmed.ncbi.nlm.nih.gov/34276301/
------------------------------------------------------------

ID: 61 | 6-(dimethylamino)-4,4-diphenylheptan-3-one
FDA: Approved
Описание: Methadone acts by binding to the μ-opioid receptor, but also has some affinity for the NMDA receptor, an ionotropic glutamate receptor. Methadone is metabolized by CYP3A4, CYP2B6, CYP2D6, and is a substrate, or in this case target, for the P-glycoprotein efflux protein. 10-day administration and ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4095
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Механизмы: Mu opioid receptor binding, Kappa opioid receptor binding, delta opioid receptor binding, opioid receptors binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry), NMDA receptor (https://www.rcsb.org/structure/4pe5), iGluRs (https://www.rcsb.org/structure/5l1f)
Статьи: Pačesová, D., Spišská, V., Novotný, J. and Bendová, Z., 2023. Methadone administered to rat dams during pregnancy and lactation affects the circadian rhythms of their pups. Journal of Neuroscience Research, 101(11), pp.1737–1756.: https://pubmed.ncbi.nlm.nih.gov/37551165/#:~:text=Methadone%20administered%20to%20rat%20dams,circadian%20rhythms%20of%20their%20pups, Pačesová, D., Novotný, J. and Bendová, Z., 2016. The effect of chronic morphine or methadone exposure and withdrawal on clock gene expression in the rat suprachiasmatic nucleus and AA-NAT activity in the pineal gland. Physiological Research, 65(3), pp.517–525.: https://pubmed.ncbi.nlm.nih.gov/27070740/
------------------------------------------------------------

ID: 62 | Tramadol
FDA: Approved
Описание: A potential chronodisruptor like other opioids. Melatonin is responsible for regulating the sleep-wake cycle and circadian rhythms in mammals. Tramadol, a synthetic opioid analgesic, is used to manage moderate to severe pain but has a high potential for abuse and dependence. Studies have shown t...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/33741
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Mu opioid receptor binding, Kappa opioid receptor binding, delta opioid receptor binding, opioid receptors binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
Статьи: Hakami, A.Y., Alghamdi, B.S. and Alshehri, F.S., 2024. Exploring the potential use of melatonin as a modulator of tramadol-induced rewarding effects in rats. Frontiers in Pharmacology, 15, p.1373746.: https://pubmed.ncbi.nlm.nih.gov/38738177/, Liu, X.P. and Song, J.G., 2001. [Chronopharmacology of tramadol in mice]. Yao Xue Xue Bao (Acta Pharmaceutica Sinica), 36(8), pp.561–564.: https://pubmed.ncbi.nlm.nih.gov/12579929/
------------------------------------------------------------

ID: 63 | Buprenorphine
FDA: Approved
Описание: Buprenorphine, an opioid used for pain relief and opioid addiction treatment, can have significant effects on the circadian clock and sleep patterns. Here are some key points regarding its impact: Effects on Sleep and Circadian Rhythm • Sleep Disruption: Buprenorphine significantly disrupts sleep...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/644073
KEGG: NULL
Классы: Chronodisruptor
Механизмы: opioid receptors binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
Статьи: Pjrek, E., Frey, R., Naderi-Heiden, A., Strnad, A., Kowarik, A., Kasper, S. and Winkler, D., 2012. Actigraphic measurements in opioid detoxification with methadone or buprenorphine. Journal of Clinical Psychopharmacology, 32(1), pp.75–82: https://pubmed.ncbi.nlm.nih.gov/22198453/, Gauthier, E.A., Guzick, S.E., Brummett, C.M., Baghdoyan, H.A. and Lydic, R., 2011. Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat. Anesthesiology, 115(4), pp.743–753.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3197808/
------------------------------------------------------------

ID: 64 | (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
FDA: Approved
Описание: The effect of morphine on circadial wheel-running rhythms of C57BL/6j mice was examined. Mice received morphine (25 mg kg−1, i.p.) or saline at eight different circadian phases in constant dark. Morphine injections in the middle of the inactive period induced significant advance phase shifts, whe...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5288826
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Механизмы: Unknown, opioid receptors binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
Статьи: Smyth, C., FitzGerald, R. and Waddington, J.L., 1995. Morphine phase-shifts circadian rhythms in mice: role of behavioural activation. Neuroreport, 7(1), pp.209–212.: https://journals.lww.com/neuroreport/abstract/1995/12290/morphine_phase_shifts_circadian_rhythms_in_mice_.50.aspx
------------------------------------------------------------

ID: 65 | [(4R,4aR,7S,7aR,12bS)-9-acetyloxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate
FDA: Not approved
Описание: Heroin self-administration during the light cycle reverses the rat sleep–wake cycle. Reversal does not depend on the amount of drug taken. Wake and NREM sleep patterns recover immediately in abstinence. REM sleep patterns remain reversed into early abstinence (3–6 days). Coffey, A.A., Guan, Z., ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5462328
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Механизмы: opioid receptors binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
Статьи: Coffey, A.A., Guan, Z., Grigson, P.S. and Fang, J., 2016. Reversal of the sleep-wake cycle by heroin self-administration in rats. Brain Research Bulletin, 123, pp.33–46.: https://pubmed.ncbi.nlm.nih.gov/26431774/
------------------------------------------------------------

ID: 66 | 1-phenylpropan-2-amine
FDA: Approved
Описание: In the striatum, acute injection of d-amphetamine did not alter Per1, Per2 and Reverse erythroblastosis virus α (Rev-erbα) expressions. Chronic administration shifted the phase of Per1 and Per2 expressions from a nocturnal to diurnal pattern and advance shifted the peak of Rev-erbα in d-amphetami...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3007
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Core clock modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406)
Статьи: Wongchitrat, P., Mukda, S., Phansuwan-Pujito, P. and Govitrapong, P., 2013. Effect of amphetamine on the clock gene expression in rat striatum. Neuroscience Letters, 542, pp.126–130.: https://pubmed.ncbi.nlm.nih.gov/23518151/, Khazaie, H., Ahmadi, H.R., Kiani, A. and Ghadami, M.R., 2019. Circadian melatonin profile in opium and amphetamine dependent patients: A preliminary study. Neurobiology of Sleep and Circadian Rhythms, 7, p.100046.: https://pubmed.ncbi.nlm.nih.gov/31463419/
------------------------------------------------------------

ID: 67 | methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
FDA: Not approved
Описание: Cocaine administration to mice disrupts nocturnal photic phase resetting of the suprachiasmatic (SCN) circadian clock, whereas administration during the day induces non-photic phase shifts. Importantly, the same effects are seen when cocaine is applied to the SCN in vitro, where it blocks photic-...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/446220
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: inhibition of photic phase shifts in mice (SCN-dependent)
Механизмы: Unknown, Dopamine receptor binding, Core clock modulation
Цели: SEROTONIN TRANSPORTER (https://www.rcsb.org/structure/6AWN), PPAR gamma (https://www.rcsb.org/structure/2p4y), D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Wang, D.Q., Wang, X.L., Wang, C.Y., Wang, Y., Li, S.X. and Liu, K.Z., 2019. Effects of chronic cocaine exposure on the circadian rhythmic expression of the clock genes in reward-related brain areas in rats. Behavioural Brain Research, 363, pp.61–69.: https://pubmed.ncbi.nlm.nih.gov/30682435/, Prosser, R.A., Stowie, A., Amicarelli, M., Nackenoff, A.G., Blakely, R.D. and Glass, J.D., 2014. Cocaine modulates mammalian circadian clock timing by decreasing serotonin transport in the SCN. Neuroscience, 275, pp.184–193: https://pubmed.ncbi.nlm.nih.gov/24950119/
------------------------------------------------------------

ID: 68 | Propofol
FDA: Approved
Описание: Chronodisruptor. When administered around (±2 h) the daily rest/activity transition point, a 30-min propofol anesthesia induced a 1-h phase advance in the free-running rest-activity rhythm, while anesthesia had no significant resetting effect at other times of the day. Challet, E., Gourmelen, S....
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4943
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Эффекты: Phase advance
Механизмы: GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Challet, E., Gourmelen, S., Pevet, P., Oberling, P. and Pain, L., 2007. Reciprocal relationships between general (propofol) anesthesia and circadian time in rats. Neuropsychopharmacology, 32(3), pp.728–735.: https://pubmed.ncbi.nlm.nih.gov/16641940/, Bienert, A., Kusza, K., Wawrzyniak, K., Grześkowiak, E., Kokot, Z.J., Matysiak, J., Grabowski, T., Wolc, A., Wiczling, P. and Regulski, M., 2010. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients. Journal of Pharmacokinetics and Pharmacodynamics, 37, pp.289–304.: https://link.springer.com/article/10.1007/s10928-010-9161-5, Touitou, Y., Mauvieux, B., Reinberg, A. and Dispersyn, G., 2016. Disruption of the circadian period of body temperature by the anesthetic propofol. Chronobiology International, 33(9), pp.1247–1254.: https://pubmed.ncbi.nlm.nih.gov/27463411/
------------------------------------------------------------

ID: 69 | 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
FDA: Approved
Описание: Ketamine modulates CLOCK:BMAL1-mediated transcriptional activation when these regulators are ectopically expressed in NG108-15 neuronal cells. Bellet, M.M., Vawter, M.P., Bunney, B.G., Bunney, W.E. and Sassone-Corsi, P., 2011. Ketamine influences CLOCK: BMAL1 function leading to altered circadia...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3821
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Modulation of circadian gene expression and CLOCK:BMAL1 transcriptional activity in neuronal cells and rats
Механизмы: Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Bellet, M.M., Vawter, M.P., Bunney, B.G., Bunney, W.E. and Sassone-Corsi, P., 2011. Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One, 6(8), p.e23982.: https://pubmed.ncbi.nlm.nih.gov/21887357/, Zhuo, C., Tian, H., Li, G., Chen, M., Jiang, D., Lin, X., Xu, Y. and Wang, W., 2019. Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment-resistant depression: a protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans. Brain and Behavior, 9(11), p.e01423: https://pubmed.ncbi.nlm.nih.gov/31617335/, Mihara, T., Kikuchi, T., Kamiya, Y., Koga, M., Uchimoto, K., Kurahashi, K. and Goto, T., 2012. Day or night administration of ketamine and pentobarbital differentially affect circadian rhythms of pineal melatonin secretion and locomotor activity in rats. Anesthesia & Analgesia, 115(4), pp.805–813.: https://pubmed.ncbi.nlm.nih.gov/22886841/
------------------------------------------------------------

ID: 70 | Glycopyrrolate
FDA: Approved
Описание: Glycopyrrolate affects melatonin synthsis. Melatonin secretion evaluated from the saliva samples was significantly diminished during the first postoperative evening as compared with that during the preoperative evening (P<0.001). There was also a significant decline of 26% (P<0.05) in postoperati...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11693
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Affects melatonin synthesis
Цели: Muscarinic acetilcholine receptror M1 (https://pubchem.ncbi.nlm.nih.gov/protein/P11229)
Статьи: Kärkelä, J., Vakkuri, O., Kaukinen, S., Huang, W.Q. and Pasanen, M., 2002. The influence of anaesthesia and surgery on the circadian rhythm of melatonin. Acta Anaesthesiologica Scandinavica, 46(1), pp.30–36.: https://pubmed.ncbi.nlm.nih.gov/11903069/, Christensen, K.C., Stadil, F., Malmström, J. and Rehfeld, J.F., 1978. The effect of beta-adrenergic and cholinergic blockade on the circadian rhythm of gastrins in serum. Scandinavian Journal of Gastroenterology, 13(3), pp.263–272.: https://pubmed.ncbi.nlm.nih.gov/39327/
------------------------------------------------------------

ID: 71 | methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
FDA: Approved
Описание: Remifentanil inhibited rapid eye movement sleep (14.1 +/- 7.2% to 3.9 +/- 6.9%). The amount of slow wave sleep decreased from 6.8 +/- 7.6% to 3.2 +/- 6.1%, but this decrease was not statistically significant. Remifentanil did not decrease melatonin concentration. Melatonin administration did not ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/60815
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: REM sleep suppression in humans
Механизмы: Unknown, Mu opioid receptor binding, Kappa opioid receptor binding, delta opioid receptor binding
Цели: Mu opioid receptor (https://www.uniprot.org/uniprotkb/P35372/entry), OPRK1 (https://www.uniprot.org/uniprotkb/P48039/entry), OPRD1 (https://www.uniprot.org/uniprotkb/P41143/entry)
Статьи: Bonafide, C.P., Aucutt-Walter, N., Divittore, N., King, T., Bixler, E.O. and Cronin, A.J., 2008. Remifentanil inhibits rapid eye movement sleep but not the nocturnal melatonin surge in humans. Anesthesiology, 108(4), pp.627–633.: https://pubmed.ncbi.nlm.nih.gov/18362594/, Wenk, M., Pöpping, D.M., Chapman, G., Grenda, H. and Ledowski, T., 2013. Long-term quality of sleep after remifentanil-based anaesthesia: a randomized controlled trial. British Journal of Anaesthesia, 110(2), pp.250–257: https://pubmed.ncbi.nlm.nih.gov/23166147/
------------------------------------------------------------

ID: 72 | Sevoflurane
FDA: Approved
Описание: Expression of the genes encoding Per2, Dbp, Arc, Egr1, Krox20 and NGFI-B was suppressed during inhalation of sevoflurane for 2 h and 6 h. Although the suppression tended to be alleviated after awakening from anesthesia, the expression levels after a recovery period of 24 h remained significantly ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5206
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Механизмы: Unknown, Core clock modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7)
Статьи: Sugimura, S., Imai, R., Katoh, T., Makino, H., Hokamura, K., Kurita, T., Suzuki, Y., Aoki, Y., Kimura, T., Umemura, K. and Nakajima, Y., 2024. Effects of volatile anesthetics on circadian rhythm in mice: a comparative study of sevoflurane, desflurane, and isoflurane. Journal of Anesthesia, 38(1), pp.10–18.: https://pubmed.ncbi.nlm.nih.gov/37741919/, Kobayashi, K., Takemori, K. and Sakamoto, A., 2007. Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Brain Research, 1185, pp.1–7.: https://pubmed.ncbi.nlm.nih.gov/17942082/
------------------------------------------------------------

ID: 73 | Desflurane
FDA: Not approved
Описание: Effects are like those observed in sevoflurane, the closest alike compound. Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Kobayashi, K., Takemori, K. and Sakamoto, A., 2007. Circadian gene expression is suppressed during sevofl...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/42113
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor, Potential chronodisruptor
Механизмы: Core clock modulation
Цели: CRY1-PER2 complex (https://www.rcsb.org/structure/6of7)
Статьи: Sugimura, S., Imai, R., Katoh, T., Makino, H., Hokamura, K., Kurita, T., Suzuki, Y., Aoki, Y., Kimura, T., Umemura, K. and Nakajima, Y., 2024. Effects of volatile anesthetics on circadian rhythm in mice: a comparative study of sevoflurane, desflurane, and isoflurane. Journal of Anesthesia, 38(1), pp.10–18.: https://pubmed.ncbi.nlm.nih.gov/37741919/, Anzai, M., Iijima, N., Higo, S., Takumi, K., Matsuo, I., Mori, K., Ohe, Y., Kadota, K., Akimoto, T., Sakamoto, A. and Ozawa, H., 2013. Direct and specific effect of sevoflurane anesthesia on rat Per2 expression in the suprachiasmatic nucleus. PLoS One, 8(3), p.e59454.: https://pubmed.ncbi.nlm.nih.gov/23555676/
------------------------------------------------------------

ID: 74 | Isoflurane
FDA: Approved
Описание: Supressor of core clock. Kobayashi, K., Takemori, K. and Sakamoto, A., 2007. Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Brain research, 1185, pp.1-7. Wren-Dail, M.A., Dauchy, R.T., Blask, D.E., Hill, S.M., Ooms, T.G., Dupepe...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3763
KEGG: NULL
Классы: circadian rhythm modulator, Chronodisruptor
Механизмы: Core clock suppression, Core clock modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7)
Статьи: Kobayashi, K., Takemori, K. and Sakamoto, A., 2007. Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Brain Research, 1185, pp.1–7.: https://pubmed.ncbi.nlm.nih.gov/17942082/, Wren-Dail, M.A., Dauchy, R.T., Blask, D.E., Hill, S.M., Ooms, T.G., Dupepe, L.M. and Bohm, R.P. Jr., 2017. Effect of Isoflurane Anesthesia on Circadian Metabolism and Physiology in Rats. Comparative Medicine, 67(2), pp.138–146.: https://pubmed.ncbi.nlm.nih.gov/28381314/
------------------------------------------------------------

ID: 75 | Hyoscyamine
FDA: Approved
Описание: Affects adenylate cyclase type 1, which catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. Mediates responses to increased cellular Ca(2+)/calmodulin levels (By similarity). May be involved in regulatory processes in the central nervous system. May play a r...
PubChem: NULL
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Adenylate cyclase binding activity affects circadian clock
Цели: ADCY1 (https://www.uniprot.org/uniprotkb/Q08828/entry)
Статьи: Pérez-Llorca, M. and Müller, M., 2024. Unlocking nature’s rhythms: insights into secondary metabolite modulation by the circadian clock. International Journal of Molecular Sciences, 25(13), p.7308.: https://www.mdpi.com/1422-0067/25/13/7308, Nilsen, N.G., Gilson, S.J., Pedersen, H.R., Hagen, L.A., Wildsoet, C.F. and Baraas, R.C., 2024. The effect of topical 1% atropine on ocular dimensions and diurnal rhythms of the human eye. Vision Research, 214, p.108341.: https://pubmed.ncbi.nlm.nih.gov/38065032/
------------------------------------------------------------

ID: 76 | SRT2183
FDA: Not approved
Описание: SRT2183 is a synthetic chronobiotic compound and a direct activator of SIRT1. It modulates circadian rhythms by enhancing SIRT1 deacetylase activity, leading to suppression of CLOCK:BMAL1-mediated transcription. This results in decreased expression and amplitude of key circadian genes such as Per...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/24180126#section=Chemical-Gene-Co-Occurrences-in-Literature
KEGG: NULL
Классы: chronobiotic
Эффекты: RT2183, a SIRT1 activator, affects circadian rhythms by reducing the expression of circadian genes, achieved by decreasing the hidstone acetylation
Механизмы: SIRT1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), SIRT1 (https://pmc.ncbi.nlm.nih.gov/articles/PMC8650132/)
Статьи: Bellet, M.M., Nakahata, Y., Boudjelal, M., Watts, E., Mossakowska, D.E., Edwards, K.A., Cervantes, M., Astarita, G., Loh, C., Ellis, J.L. and Vlasuk, G.P., 2013. Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1. Proceedings of the National Academy of Sciences, 110(9), pp.3333-3338.: https://www.pnas.org/doi/10.1073/pnas.1214266110, Sultan, A., Ali, R., Sultan, T., Ali, S., Khan, N.J. and Parganiha, A., 2021. Circadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 Mpro for pharmacological interventions in COVID-19 pandemic. Chronobiology International, 38(7), pp.971–985.: https://pubmed.ncbi.nlm.nih.gov/33820462/
------------------------------------------------------------

ID: 77 | SRT 1720 Hydrochloride
FDA: Not approved
Описание: SRT1720 Hydrochloride is a potent synthetic activator of SIRT1, functioning as a chronobiotic by modulating circadian rhythms. It acts through deacetylation of core circadian transcription factors, specifically inhibiting CLOCK:BMAL1-driven transcription. Its administration leads to decreased exp...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/25232708
KEGG: NULL
Классы: chronobiotic
Эффекты: Studies using SRT1720 have demonstrated that it can alter the expression of genes involved in the circadian clock.
Механизмы: Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), SIRT1 (https://pmc.ncbi.nlm.nih.gov/articles/PMC8650132/)
Статьи: Bellet, M.M., Nakahata, Y., Boudjelal, M., Watts, E., Mossakowska, D.E., Edwards, K.A., Cervantes, M., Astarita, G., Loh, C., Ellis, J.L., Vlasuk, G.P. and Sassone-Corsi, P., 2013. Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1. Proceedings of the National Academy of Sciences of the United States of America, 110(9), pp.3333–3338.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3587185/, Yao, H., Sundar, I.K., Huang, Y., Gerloff, J., Sellix, M.T., Sime, P.J. and Rahman, I., 2015. Disruption of sirtuin 1–mediated control of circadian molecular clock and inflammation in chronic obstructive pulmonary disease. American journal of respiratory cell and molecular biology, 53(6), pp.782-792.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4742939/#:~:text=SRT1720%20Attenuated%20LPS%2DInduced%20Reduction,partly%20due%20to%20SIRT1%20reduction.
------------------------------------------------------------

ID: 78 | Camptothecin
FDA: Not approved
Описание: Camptothecin is a naturally occurring pyranoindolizinoquinoline alkaloid, originally isolated from the Chinese tree Camptotheca acuminata. Known primarily as a potent DNA Topoisomerase I inhibitor with strong antineoplastic activity, camptothecin also exerts an effect on circadian rhythms by modu...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/24360#section=InChI
KEGG: NULL
Классы: Potential chronodisruptor
Эффекты: lengthening of the circadian period, as Bmal1 is involved in determining the length of the clock's oscillation.
Механизмы: Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Raju, U., Koumenis, C., Nunez-Regueiro, M. and Eskin, A., 1991. Alteration of the phase and period of a circadian oscillator by a reversible transcription inhibitor. Science, 253(5020), pp.673-675.: https://pubmed.ncbi.nlm.nih.gov/1871602/
------------------------------------------------------------

ID: 79 | Harmine
FDA: Not approved
Описание: Harmine is a naturally occurring β-carboline alkaloid, traditionally isolated from Peganum harmala (Syrian rue) and found in other plants like Banisteriopsis caapi. Known for its monoamine oxidase inhibiting (MAOI) activity and potential psychoactive effects, harmine also modulates circadian rhyt...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5280953
KEGG: NULL
Классы: chronobiotic
Эффекты: lengthen the circadian period, meaning the time it takes for the clock to complete one cycle, Specifically, it can increase the stability of PER2 protein, a key player in the molecular clock, and enhance the function of RORα, another protein in
Механизмы: Bmal1
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Onishi, Y., Oishi, K., Kawano, Y. and Yamazaki, Y., 2012. The harmala alkaloid harmine is a modulator of circadian Bmal1 transcription. Bioscience Reports, 32(1), pp.45-52.: https://portlandpress.com/bioscirep/article-abstract/32/1/45/55977/The-harmala-alkaloid-harmine-is-a-modulator-of?redirectedFrom=fulltext, Kondoh, D., Yamamoto, S., Tomita, T., Miyazaki, K., Itoh, N., Yasumoto, Y., Oike, H., Doi, R. and Oishi, K., 2014. Harmine lengthens circadian period of the mammalian molecular clock in the suprachiasmatic nucleus. Biological and Pharmaceutical Bulletin, 37(8), pp.1422-1427.: https://www.jstage.jst.go.jp/article/bpb/37/8/37_b14-00229/_article/-char/en
------------------------------------------------------------

ID: 80 | Prasterone (DHEA)
FDA: Approved
Описание: Prasterone (commonly known as dehydroepiandrosterone or DHEA) is an endogenous steroid hormone produced predominantly by the adrenal glands in humans and is available as an over-the-counter dietary supplement in some regions. Acting as a prohormone for testosterone and estradiol, it exerts divers...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5881#section=Crystal-Structures
KEGG: NULL
Классы: chronobiotic
Эффекты: Recent reports, however, have shown that high doses of DHEA (e.g., 100 μM) lengthen circadian period and decrease amplitude
Механизмы: modulation of nuclear receptor signaling pathways
Цели: NMDA receptor (https://www.rcsb.org/structure/5IPQ)
Статьи: Tamai, T. K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M., Nishiwaki-Ohkawa, T., Sato, A., & Yoshimura, T. (2018). Identification of circadian clock modulators from existing drugs. EMBO Molecular Medicine, 10(5), e8724.: https://pubmed.ncbi.nlm.nih.gov/29666146/, Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724, Rey, G., Valekunja, U.K., Feeney, K.A., Wulund, L., Milev, N.B., Stangherlin, A., Ansel-Bollepalli, L., Velagapudi, V., O’Neill, J.S. and Reddy, A.B., 2016. The pentose phosphate pathway regulates the circadian clock. Cell metabolism, 24(3), pp.462-473.: https://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30375-8, Putker, M., Crosby, P., Feeney, K.A., Hoyle, N.P., Costa, A.S., Gaude, E., Frezza, C. and O'Neill, J.S., 2018. Mammalian circadian period, but not phase and amplitude, is robust against redox and metabolic perturbations. Antioxidants & Redox Signaling, 28(7), pp.507-520.: https://www.liebertpub.com/doi/abs/10.1089/ars.2016.6911
------------------------------------------------------------

ID: 81 | T0901317
FDA: Not approved
Описание: T0901317 is a potent synthetic agonist of the liver X receptors LXRα and LXRβ. LXRs are nuclear receptors that regulate the transcription of genes involved in cholesterol homeostasis, lipid metabolism, and inflammatory responses. By activating these receptors, T0901317 alters metabolic pathways a...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/447912
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Circadian modulation via nuclear receptor pathways (LXRα/β) in mammalian cells
Механизмы: LXRα, LXRβ
Цели: Liver X receptors (https://pmc.ncbi.nlm.nih.gov/articles/PMC5419308/)
Статьи: Ribeiro, R.F., Cavadas, C. and Silva, M.M.C., 2021. Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases. Drug Discovery Today, 26(7), pp.1620-1641.: https://www.sciencedirect.com/science/article/abs/pii/S1359644621001525#b0265, Ribeiro, R. F. N., Cavadas, C., & Silva, M. M. C. (2021). Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases. Drug Discovery Today, 26(7), 1620–1641.: https://pubmed.ncbi.nlm.nih.gov/33781946/, Gbaguidi, G.F. and Agellon, L.B., 2004. The inhibition of the human cholesterol 7α‐hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor α and peroxisome proliferator‐activated receptor α heterodimer. Nucleic acids research, 32(3), pp.1113-1121.: https://academic.oup.com/nar/article-abstract/32/3/1113/2904513, Feillet, C., Guérin, S., Lonchampt, M., Dacquet, C., Gustafsson, J.Å., Delaunay, F. and Teboul, M., 2016. Sexual Dimorphism in Circadian Physiology Is Altered in LXR α Deficient Mice. PLoS One, 11(3), p.e0150665.: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150665#pone.0150665.ref061
------------------------------------------------------------

ID: 82 | SR  1078
FDA: Not approved
Описание: SR 1078 is a synthetic agonist of the retinoic acid receptor-related orphan receptors RORα and RORγ, key regulators of genes involved in circadian rhythm and metabolic processes. By binding to these nuclear receptors, SR 1078 influences the expression of various circadian and metabolic target gen...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/17980288
KEGG: NULL
Классы: Chronomodulator
Эффекты: It affects circadian rhythms by activating RORα/γ, which in turn regulates the transcription of target genes, including the core clock component BMAL1
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Wang, Y., Kumar, N., Nuhant, P., Cameron, M.D., Istrate, M.A., Roush, W.R., Griffin, P.R. and Burris, T.P., 2010. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ. ACS chemical biology, 5(11), pp.1029-1034.: https://pubmed.ncbi.nlm.nih.gov/20735016/, Wang, Y., Kumar, N., Nuhant, P., Cameron, M. D., Istrate, M. A., Roush, W. R., Griffin, P. R., & Burris, T. P. (2010). Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ. ACS Chemical Biology, 5(11), 1029–1034: https://pubmed.ncbi.nlm.nih.gov/20735016/
------------------------------------------------------------

ID: 83 | SR3335 (ML-176)
FDA: Not approved
Описание: SR 3335 is a synthetic compound acting as an inverse agonist of RORα, a nuclear receptor critically involved in controlling circadian and metabolic genes. By inhibiting RORα activity, SR 3335 modulates the expression of various clock‐controlled genes, making it a valuable tool both for probing ci...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2360837
KEGG: NULL
Классы: Chronomodulator
Эффекты: leading to a decrease in the expression of core clock genes, which are essential for maintaining circadian rhythms. This can affect various aspects of
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Kumar, N., Kojetin, D.J., Solt, L.A., Kumar, K.G., Nuhant, P., Duckett, D.R., Cameron, M.D., Butler, A.A., Roush, W.R., Griffin, P.R. and Burris, T.P., 2011. Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist. ACS chemical biology, 6(3), pp.218-222.: https://pubmed.ncbi.nlm.nih.gov/21090593/
------------------------------------------------------------

ID: 84 | SR1001
FDA: Not approved
Описание: SR1001 is a synthetic molecule acting as an inverse agonist of both RORα and RORγ. By blocking the transcriptional activities of these nuclear receptors, SR1001 reduces expression of genes governed by RORα/γ, thereby modulating multiple circadian and immune/metabolic processes. It has been studie...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/44241473
KEGG: NULL
Классы: Chronomodulator
Эффекты: resets the molecular circadian clock in eosinophils
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Ribeiro, R.F., Cavadas, C. and Silva, M.M.C., 2021. Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases. Drug Discovery Today, 26(7), pp.1620-1641.: https://pubmed.ncbi.nlm.nih.gov/33781946/, Teppan, J., Bärnthaler, T., Farzi, A., Durrington, H., Gioan-Tavernier, G., Platt, H., Wolf, P., Heinemann, A. and Böhm, E., 2025. The molecular circadian clock of eosinophils: A potential therapeutic target for asthma. American Journal of Physiology-Cell Physiology, 328(5), pp.C1394-C1408.: https://pubmed.ncbi.nlm.nih.gov/40131242/
------------------------------------------------------------

ID: 85 | SR2211
FDA: Not approved
Описание: SR2211 is a synthetic small molecule acting primarily as an inverse agonist of RORγt (the thymus-specific isoform of RORγ). By inhibiting RORγt’s transcriptional activity, SR2211 suppresses genes under RORγt control, impacting T-helper 17 (Th17) cell differentiation and function (and thereby infl...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/51035449
KEGG: NULL
Классы: Chronomodulator
Эффекты: SR2211 acts as an inverse agonist of RORγ, meaning it blocks the activity of the receptor. This can have implications for circadian rhythms, as RORγ's
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Kumar, N., Lyda, B., Chang, M.R., Lauer, J.L., Solt, L.A., Burris, T.P., Kamenecka, T.M. and Griffin, P.R., 2012. Identification of SR2211: a potent synthetic RORγ-selective modulator. ACS chemical biology, 7(4), pp.672-677.: https://europepmc.org/article/pmc/3331898
------------------------------------------------------------

ID: 86 | SR1555
FDA: Not approved
Описание: SR1555 is a synthetic small molecule acting as a modulator of ROR nuclear receptors. By targeting these transcription factors (especially RORγ), SR1555 influences the expression of ROR-controlled genes affecting circadian rhythms, immune/inflammatory responses, and metabolic homeostasis. It is co...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/71470549
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Suppresses TH17 cells and Stimulates T Regulatory Cells, It reduces food intake, fat mass, and improves insulin sensitivity in obese diabetic mice, indicating potential as an anti-diabetic and anti-obesity
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Solt, L.A., Kumar, N., He, Y., Kamenecka, T.M., Griffin, P.R. and Burris, T.P., 2012. Identification of a selective RORγ ligand that suppresses TH17 cells and stimulates T regulatory cells. ACS chemical biology, 7(9), pp.1515-1519.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3448878/#:~:text=We%20report%20here%20the%20identification,of%20therapeutics%20targeting%20autoimmune%20diseases., Xiang, K., Xu, Z., Hu, Y.Q., He, Y.S., Wu, G.C., Li, T.Y., Wang, X.R., Ding, L.H., Zhang, Q., Tao, S.S. and Ye, D.Q., 2021. Circadian clock genes as promising therapeutic targets for autoimmune diseases. Autoimmunity Reviews, 20(8), p.102866.: https://pubmed.ncbi.nlm.nih.gov/34118460/, Chang, M.R., He, Y., Khan, T.M., Kuruvilla, D.S., Garcia-Ordonez, R., Corzo, C.A., Unger, T.J., White, D.W., Khan, S., Lin, L. and Cameron, M.D., 2015. Antiobesity effect of a small molecule repressor of RORγ. Molecular Pharmacology, 88(1), pp.48-56.: https://europepmc.org/article/pmc/pmc4468634
------------------------------------------------------------

ID: 87 | ML209
FDA: Not approved
Описание: ML 209 is a synthetic small‐molecule antagonist of RORγt, discovered through a cell-based high-throughput screen targeting RORγt transcriptional activity. It potently blocks RORγt function at submicromolar concentrations, suppressing Th17 (interleukin 17–producing T-helper) cell differentiation. ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/53385590
KEGG: NULL
Классы: Chronomodulator
Эффекты: inhibited the transcriptional activity of RORγt
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Huang, W., Wang, H., Johnson, R.L., Huang, R., Englund, E.E., Huh, J. and Littman, D.R., 2013. Identification of potent and selective RORγ antagonists. Probe Reports from the NIH Molecular Libraries Program [Internet].: https://www.ncbi.nlm.nih.gov/books/NBK133441/
------------------------------------------------------------

ID: 88 | TMP778
FDA: Not approved
Описание: TMP778 is a small-molecule inverse agonist that potently and selectively binds the ligand-binding domain of RORγt, blocking this nuclear receptor’s ability to promote transcription of Th17-associated genes (e.g., IL-17A, IL-17F, IL-22). In contrast to many broad-spectrum immunosuppressants, TMP77...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/71247311
KEGG: NULL
Классы: Chronomodulator
Эффекты: Modulation of circadian gene expression via RORγt inhibition in mice/human immune cells
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Lyu, C., Bing, S.J., Wandu, W.S., Xu, B., Shi, G., Hinshaw, S.J., Lobera, M., Caspi, R.R., Lu, L., Yang, J. and Gery, I., 2018. TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations. European journal of immunology, 48(11), pp.1810-1816.: https://pmc.ncbi.nlm.nih.gov/articles/PMC6392427/, Venken, K., Jacques, P., Mortier, C., Labadia, M.E., Decruy, T., Coudenys, J., Hoyt, K., Wayne, A.L., Hughes, R., Turner, M. and Van Gassen, S., 2019. RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients. Nature communications, 10(1), p.9.: https://www.nature.com/articles/s41467-018-07911-6
------------------------------------------------------------

ID: 89 | GSK805
FDA: Not approved
Описание: GSK805 is a potent, orally active small molecule that acts primarily as an inverse agonist of RORγt. By binding to the RORγ ligand-binding domain, GSK805 inhibits Th17 cell differentiation and suppresses IL-17 production in both in vitro and in vivo models. Its oral bioavailability and effectiven...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/71285927
KEGG: NULL
Классы: Chronomodulator, Chronodisruptor
Эффекты: Disrupts cellular circadian system
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA)
Статьи: Borrmann, H., Ulkar, G., Kliszczak, A.E., Ismed, D., Schilling, M., Magri, A., Harris, J.M., Balfe, P., Vasudevan, S., Borrow, P. and Zhuang, X., 2023. Molecular components of the circadian clock regulate HIV-1 replication. Iscience, 26(7).: https://pmc.ncbi.nlm.nih.gov/articles/PMC10391662/
------------------------------------------------------------

ID: 90 | KL101
FDA: Not approved
Описание: KL101 is a small-molecule modulator that selectively stabilizes CRY1, a key component of the circadian clock. Unlike KL001, which stabilizes both CRY1 and CRY2, KL101 is highly selective for CRY1 and requires its C-terminal region for its effects. By enhancing CRY1 stability, KL101 lengthens the ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4626654#section=2D-Structure
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Selective stabilizer of CRY1
Цели: CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407)
Статьи: Miller, S., Son, Y.L., Aikawa, Y., Makino, E., Nagai, Y., Srivastava, A., Oshima, T., Sugiyama, A., Hara, A., Abe, K. and Hirata, K., 2020. Isoform-selective regulation of mammalian cryptochromes. Nature chemical biology, 16(6), pp.676-685.: https://www.nature.com/articles/s41589-020-0505-1
------------------------------------------------------------

ID: 91 | KL201
FDA: Not approved
Описание: KL201 is a thienopyrimidine-based small molecule that selectively stabilizes CRY1, a key component of the circadian clock, while showing minimal effects on CRY2. KL201 achieves its effects by interfering with FBXL3, a subunit of the E3 ubiquitin ligase complex that targets CRY1 for degradation. B...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/1330855#section=2D-Structure
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: lengthen circadian rhtyhms
Механизмы: Selective stabilizer of CRY1
Цели: CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407)
Статьи: Crane, B.R., 2020. Winding down: Selectively drugging a promiscuous pocket in cryptochrome slows circadian rhythms. Cell chemical biology, 27(9), pp.1109-1111.: https://pmc.ncbi.nlm.nih.gov/articles/PMC8042606/
------------------------------------------------------------

ID: 92 | TH301
FDA: Not approved
Описание: TH301 is a thienopyrazole-based small molecule that selectively stabilizes CRY2, a key component of the mammalian circadian clock. Unlike KL201 and KL101 (which target CRY1), TH301 acts specifically on CRY2, preventing its degradation and influencing circadian rhythm regulation. This isoform sele...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4653191#section=2D-Structure
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Selectively stabilizes CRY2
Цели: CRY1-PER2 complex (https://www.rcsb.org/structure/6of7)
Статьи: Miller, S., Son, Y.L., Aikawa, Y., Makino, E., Nagai, Y., Srivastava, A., Oshima, T., Sugiyama, A., Hara, A., Abe, K. and Hirata, K., 2020. Isoform-selective regulation of mammalian cryptochromes. Nature chemical biology, 16(6), pp.676-685.: https://www.nature.com/articles/s41589-020-0505-1
------------------------------------------------------------

ID: 93 | PF-670462
FDA: Not approved
Описание: PF-670462 (commonly referred to as PF-670462 dihydrochloride) is a selective CK1δ inhibitor with modest activity against CK1ε at higher doses. By inhibiting CK1δ-mediated phosphorylation of PER proteins, PF-670462 stabilizes nuclear PER, prolongs negative feedback in the molecular clock, and leng...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/51049607#section=2D-Structure
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Period lengthening and phase delay in rodents and SCN slices
Механизмы: Inhibits CK1δ
Цели: CK1δ (https://en.wikipedia.org/wiki/CSNK1D)
Статьи: Meng, Q.J., Maywood, E.S., Bechtold, D.A., Lu, W.Q., Li, J., Gibbs, J.E., Dupré, S.M., Chesham, J.E., Rajamohan, F., Knafels, J. and Sneed, B., 2010. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proceedings of the National Academy of Sciences, 107(34), pp.15240-15245.: https://www.pnas.org/doi/10.1073/pnas.1005101107
------------------------------------------------------------

ID: 94 | M47
FDA: Not approved
Описание: M47 was discovered via structure-based virtual screening for compounds that bind the “FAD-binding” pocket of CRY1. Experimental analyses show that it selectively decreases CRY1 half-life (via increased polyubiquitination and proteasomal degradation) while sparing CRY2. By reducing nuclear CRY1, M...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/23601714
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Period lengthening in human cells (U2OS)
Механизмы: Binds CRY1 FAD-binding
Цели: CRY1 (https://www.rcsb.org/structure/4ct0)
Статьи: Gul, S., Akyel, Y.K., Gul, Z.M., Isin, S., Ozcan, O., Korkmaz, T., Selvi, S., Danis, I., Ipek, O.S., Aygenli, F. and Taskin, A.C., 2022. Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice. Nature Communications, 13(1), p.6742.: https://pubmed.ncbi.nlm.nih.gov/36347873/
------------------------------------------------------------

ID: 95 | SR8278
FDA: Not approved
Описание: SR8278 is a synthetic small molecule discovered as an antagonist of REV-ERB. By inhibiting REV-ERB’s repressive function on BMAL1 transcription, SR8278 upregulates clock-control gene (CCG) expression and enhances CLOCK–BMAL1–driven transcription. It has been applied in various studies to probe th...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/53393127#section=2D-Structure
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Amplitude enhancement and phase shift in human cells
Механизмы: Antagonist of Rev-Erb nuclear receptors, de-repressing BMAL1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Kojetin, D., Wang, Y., Kamenecka, T.M. and Burris, T.P., 2011. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS chemical biology, 6(2), pp.131-134.: https://pubs.acs.org/doi/abs/10.1021/cb1002575, Anabtawi, N., Cvammen, W. and Kemp, M.G., 2021. Pharmacological inhibition of cryptochrome and REV-ERB promotes DNA repair and cell cycle arrest in cisplatin-treated human cells. Scientific Reports, 11(1), p.17997.: https://www.nature.com/articles/s41598-021-97603-x
------------------------------------------------------------

ID: 96 | Methohexital
FDA: Approved
Описание: While specific circadian effects of methohexital are not well-documented, its use as an anesthetic can indirectly affect circadian rhythms by altering sleep patterns. Methohexital is known for its rapid onset and short duration of action, which might minimize long-term disruptions to the circadia...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9034
KEGG: NULL
Классы: Potential chronodisruptor
Механизмы: Unknown, Muscarinic receptor binding, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Song, Y., Liu, Y., Yuan, Y., Jia, X., Zhang, W., Wang, G., Jia, Y., Wang, X., Liu, L., Li, W. and Li, X., 2021. Effects of general versus subarachnoid anaesthesia on circadian melatonin rhythm and postoperative delirium in elderly patients undergoing hip fracture surgery: a prospective cohort clinical trial. EBioMedicine, 70.: https://pmc.ncbi.nlm.nih.gov/articles/PMC8318871
------------------------------------------------------------

ID: 97 | Geldanamycin
FDA: Not approved
Описание: Geldanamycin is a 1,4-benzoquinone ansamycin antitumor antibiotic that inhibits the function of Hsp90 (Heat Shock Protein 90) by binding to the unusual ADP/ATP-binding pocket of the protein. HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5288382
KEGG: https://www.kegg.jp/entry/C11222
Классы: circadian rhythm modulator
Эффекты: heat shock protein 90 binding affinity affectin circadian clock (indirect effects
Механизмы: HSP90 binding (in Arabidopsis)
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Davis, M.A. and Carbott, D.E., 1999. Herbimycin A and geldanamycin inhibit okadaic acid-induced apoptosis and p38 activation in NRK-52E renal epithelial cells. Toxicology and applied pharmacology, 161(1), pp.59-74.: https://www.sciencedirect.com/science/article/abs/pii/S0041008X99987653
------------------------------------------------------------

ID: 98 | Herbimycin
FDA: Approved
Описание: Herbimycin A (PLANT CHRONOBIOTIC)_, a benzoquinone ansamycin antibiotic, has been identified as a modulator of cellular circadian rhythms through its dual inhibitory effects on Src family kinases and heat shock protein 90 (Hsp90). This compound disrupts the molecular clock machinery by interferin...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5311102
KEGG: https://www.genome.jp/dbget-bin/www_bget?C11225
Классы: Potential modulator of circdain rhtyhms
Механизмы: Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Davis, M.A. and Carbott, D.E., 1999. Herbimycin A and geldanamycin inhibit okadaic acid-induced apoptosis and p38 activation in NRK-52E renal epithelial cells. Toxicology and applied pharmacology, 161(1), pp.59-74.: https://www.sciencedirect.com/science/article/abs/pii/S0041008X99987653, Zhang, Z., Xue, N., Bian, C., Yan, R., Jin, L., Chen, X. and Yu, X., 2016. C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity. Bioorganic & Medicinal Chemistry Letters, 26(17), pp.4287-4291.: https://pubmed.ncbi.nlm.nih.gov/27476419/
------------------------------------------------------------

ID: 99 | Rifaximin
FDA: Approved
Описание: Rifaximin has been shown to have protective effects against disruptions in circadian rhythms, particularly in relation to cognitive impairment and gut health. Research indicates that rifaximin can mitigate the negative impacts of circadian rhythm disruption (CRD) by preventing gut barrier damage ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6436173
KEGG: https://www.kegg.jp/entry/D02554
Классы: Chronomodulator, chronobiotic, circadian rhythm modulator
Эффекты: protective effects against cognitive impairment caused by circadian rhythm disruption
Механизмы: protect
Цели: Microbiota (https://pubmed.ncbi.nlm.nih.gov/36189686/)
Статьи: Meng, D., Yang, M., Hu, L., Liu, T., Zhang, H., Sun, X., Wang, X., Chen, Y.U., Jin, Y.U. and Liu, R., 2022. Rifaximin protects against circadian rhythm disruption–induced cognitive impairment through preventing gut barrier damage and neuroinflammation. Journal of neurochemistry, 163(5), pp.406-418.: https://pubmed.ncbi.nlm.nih.gov/36189686/
------------------------------------------------------------

ID: 100 | Lincomycin
FDA: not approved
Описание: Lincomycin, an antibiotic that inhibits protein synthesis in chloroplasts, has been shown to affect circadian rhythms, particularly in plants. Research indicates that lincomycin has a dose-dependent effect on the amplitude of circadian rhythms related to photosynthesis in species like *Marchantia...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3000540
KEGG: https://www.kegg.jp/entry/D00223
Классы: circadian rhythm modulator
Эффекты: alone caused a long circadian period. However, the degree of lengthening was less than with Fe deficiency alone
Механизмы: Unknown
Цели: Fe deficiency (https://pubmed.ncbi.nlm.nih.gov/23307650/)
Статьи: Chen, Y.Y., Wang, Y., Shin, L.J., Wu, J.F., Shanmugam, V., Tsednee, M., Lo, J.C., Chen, C.C., Wu, S.H. and Yeh, K.C., 2013. Iron is involved in the maintenance of circadian period length in Arabidopsis. Plant physiology, 161(3), pp.1409-1420.: https://academic.oup.com/plphys/article/161/3/1409/6110716?login=false
------------------------------------------------------------

ID: 101 | Clarithromycin
FDA: Approved
Описание: Clarithromycin, a macrolide antibiotic, can have circadian effects, impacting sleep and alertness. It has been shown to reduce sleepiness in some individuals, particularly those with hypersomnolence related to GABA-A receptors, possibly by altering gastrointestinal microbiota. This improvement co...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/84029
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Improvement in daytime sleepiness in patients with GABA-related hypersomnia
Механизмы: Unknown
Цели: Microbiota (https://pubmed.ncbi.nlm.nih.gov/36189686/)
Статьи: Trotti, L.M., Saini, P., Freeman, A.A., Bliwise, D.L., García, P.S., Jenkins, A. and Rye, D.B., 2014. Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: clinical experience. Journal of psychopharmacology, 28(7), pp.697-702.: https://journals.sagepub.com/doi/10.1177/0269881113515062
------------------------------------------------------------

ID: 102 | Sulfamethoxazole
FDA: Approved
Описание: Sulfamethoxazole (SMZ or SMX) is an antibiotic. It is used for bacterial infections such as urinary tract infections, bronchitis, and prostatitis and is effective against both gram negative and positive bacteria such as Escherichia coli and Listeria monocytogenes. Antibiotics have recently gained...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5329
KEGG: https://www.genome.jp/dbget-bin/www_bget?dr:D00447
Классы: Chronodisruptor
Эффекты: Circadian phase shift and dysrhythmia in eclosion rhythm in Drosophila melanogaster
Механизмы: Core clock suppression
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Yu, Z., Shen, J., Li, Z., Yao, J., Li, W., Xue, L., Vandenberg, L.N. and Yin, D., 2020. Obesogenic effect of sulfamethoxazole on Drosophila melanogaster with simultaneous disturbances on eclosion rhythm, glucolipid metabolism, and microbiota. Environmental Science & Technology, 54(9), pp.5667-5675.: https://pubs.acs.org/doi/abs/10.1021/acs.est.9b07889
------------------------------------------------------------

ID: 103 | Sulfanilamide
FDA: not approved
Описание: PLANT CHRONOBIOTIC. Sulfanilamide, an inhibitor of folate biosynthesis, delays flowering by repressing the expression of florigen FLOWERING LOCUS T (FT) in Arabidopsis thaliana. Transcriptome deep sequencing and quantitative polymerase chain reaction analyses showed that the expression of the cir...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5333
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Regulates Flowering Time through Expression of the Circadian Clock Gene LUX
Механизмы: Affects flowering rhythms (LUX)
Цели: LUX (GENE) (https://pubmed.ncbi.nlm.nih.gov/21236673/)
Статьи: Hirohata, A., Yamatsuta, Y., Ogawa, K., Kubota, A., Suzuki, T., Shimizu, H., Kanesaka, Y., Takahashi, N. and Endo, M., 2022. Sulfanilamide regulates flowering time through expression of the circadian clock gene LUX. Plant and Cell Physiology, 63(5), pp.649-657.: https://academic.oup.com/pcp/article/63/5/649/6541824
------------------------------------------------------------

ID: 104 | Sulfasalazine
FDA: Approved
Описание: Regulation of BCRP expression by REV-ERBα was assessed using Rev-erbα-/- mice and AML12 and CT26 cells. Pharmacokinetic analysis was performed with Rev-erbα-/- and wild-type mice after sulfasalazine administration. it was found that the expression levels of BCRP mRNA and protein were downregulat...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5339
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: circadian clock mediated antitumor effect
Механизмы: Core clock suppression
Цели: REV-ERBα (https://www.rcsb.org/structure/4n73)
Статьи: Okazaki, F., Matsunaga, N., Hamamura, K., Suzuki, K., Nakao, T., Okazaki, H., Kutsukake, M., Fukumori, S., Tsuji, Y. and To, H., 2017. Administering xCT inhibitors based on circadian clock improves antitumor effects. Cancer research, 77(23), pp.6603-6613.: https://pubmed.ncbi.nlm.nih.gov/29038345/
------------------------------------------------------------

ID: 105 | Doxycycline
FDA: Approved
Описание: Early doxycycline treatment improves memory in fatal familial insomnia mice. Doxycycline restores normal circadian motor rhythmicity. Doxycycline reduces microglial activation in the hippocampus. Doxycycline does not reduce mutant prion protein aggregation or protease resistance. Doxycycline does...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/54671203
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: rescues recognition memory and circadian motor rhythmicity but does not prevent terminal disease in fatal familial insomnia mice, restores normal circadian rhythms, may cause daytime sleepiness
Механизмы: Central clock rescue via microbial community alteration
Цели: Unknown (https://www.sciencedirect.com/science/article/pii/S0969996121002047)
Статьи: Lavigna, G., Masone, A., Bouybayoune, I., Bertani, I., Lucchetti, J., Gobbi, M., Porcu, L., Zordan, S., Rigamonti, M., Imeri, L. and Restelli, E., 2021. Doxycycline rescues recognition memory and circadian motor rhythmicity but does not prevent terminal disease in fatal familial insomnia mice. Neurobiology of Disease, 158, p.105455.: https://pubmed.ncbi.nlm.nih.gov/34358614/
------------------------------------------------------------

ID: 106 | Rifampin
FDA: Approved
Описание: Rifampicin lengthened the circadian period under darkness in plants. Salicylic acid (SA) increased oscillatory robustness and shortened the period. The latter was attenuated by sucrose addition and was also gated, taking place during the first 3 h of the subjective day. Furthermore, the effect of...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/135398735
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Rifampicin lengthened the circadian period under darkness in plants.
Механизмы: Lenghthen the circadian period
Цели: organellar transcription (https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00429/full)
Статьи: Philippou, K., Davis, A.M., Davis, S.J. and Sánchez-Villarreal, A., 2020. Chemical perturbation of chloroplast-related processes affects circadian rhythms of gene expression in Arabidopsis: salicylic acid application can entrain the clock. Frontiers in physiology, 11, p.429.: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00429/full
------------------------------------------------------------

ID: 107 | Chloramphenicol
FDA: Approved
Описание: Chloramphenicol, an inhibitor of mitochondrial protein synthesis, shortened the period length of the circadian rhythm in the Timex strain of Neurospora crassa by 2 hours. Both the l(+) threo and d(−) threo optical isomers had the same effect on the period of the rhythm, whereas only the d(−) thre...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5959
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: shortened the period length of the circadian rhythm by 2 hours
Механизмы: Chloramphenicol can inhibit both bacterial and mitochondrial protein synthesis
Цели: Mitochondrial translation machine (https://academic.oup.com/plphys/article/58/4/592/6075206)
Статьи: Feldman, J.F. and Dunlap, J.C., 1983. Neurospora crassa: a unique system for studying circadian rhythms. In Photochemical and Photobiological Reviews: Volume 7 (pp. 319-368). Boston, MA: Springer US.: https://link.springer.com/chapter/10.1007/978-1-4684-4505-3_7
------------------------------------------------------------

ID: 108 | Metronidazole
FDA: NULL
Описание: Metronidazole, an antibiotic, can influence circadian rhythms by affecting skeletal muscle metabolism and disrupting pineal gland function. It can lead to skeletal muscle atrophy and alter the expression of genes involved in the muscle's circadian clock and metabolism. Additionally, metronidazole...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4173
KEGG: NULL
Классы: circadian rhythm modulator, Potential chronodisruptor
Эффекты: Circadian disruption in skeletal muscle and pineal gland (in animals)
Механизмы: Melatonin synthesis alteration
Цели: Microbiota (https://pubmed.ncbi.nlm.nih.gov/36189686/)
Статьи: Manickam, R., Oh, H.Y.P., Tan, C.K., Paramalingam, E. and Wahli, W., 2018. Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism. International journal of molecular sciences, 19(8), p.2418.: https://pmc.ncbi.nlm.nih.gov/articles/PMC6121908/#sec1-ijms-19-02418
------------------------------------------------------------

ID: 109 | Aripiprazole
FDA: Approved
Описание: Many patients with psychiatric conditions, such as bipolar disorder and major depressive disorder, frequently experience disruptions in their sleep–wake cycles. Several case studies and clinical trials have shown that the administration of aripiprazole, a commonly prescribed antipsychotic drug, a...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/60795
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Disrupts cellular synchrony in suprachiasmatic nucleus
Механизмы: Dopamine receptor binding
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Li, R., Masuda, K., Ono, D., Kanbayashi, T., Hirano, A. and Sakurai, T., 2023. Aripiprazole disrupts cellular synchrony in the suprachiasmatic nucleus and enhances entrainment to environmental light–dark cycles in mice. Frontiers in Neuroscience, 17, p.1201137.: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1201137/full
------------------------------------------------------------

ID: 110 | Quetiapine
FDA: Approved
Описание: Quetiapine has been shown to improve sleep quality and duration in both healthy volunteers and patients with bipolar depression. It increases sleep efficiency and can delay the final wake time. Circadian Rhythm: While quetiapine does not significantly delay the circadian rhythm like lithium, it c...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5002
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: improves sleep in insomnia
Механизмы: Bmal1, Core clock modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Caruso, V., Geoffroy, P.A., Alfì, G., Miniati, M., Riemann, D., Gemignani, A. and Palagini, L., 2024. Effects of Mood Stabilizers on Sleep and Circadian Rhythms: A Systematic Review. Current Sleep Medicine Reports, 10(3), pp.329-357.: https://link.springer.com/article/10.1007/s40675-024-00298-5, Endicott, J., Paulsson, B., Gustafsson, U., Schiöler, H. and Hassan, M., 2008. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep. Journal of affective disorders, 111(2-3), pp.306-319.: https://pubmed.ncbi.nlm.nih.gov/18774180/
------------------------------------------------------------

ID: 111 | Haloperidol
FDA: Approved
Описание: Circadian changes in behavioral responses to haloperidol were evaluated in rats under normal and altered lighting cycles. There was a 5.5-fold change in ED50 between the maximum (4 PM) and minimum (4 AM) cataleptic response to the drug under normal lighting (lights on 7 AM-7 PM). The rhythm was p...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3559
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: affect expression of PER1 and CRY1 genes in human glioblastoma cell line
Механизмы: CRY gene expression modulation, PER gene exspression modulation
Цели: mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407)
Статьи: Mokros, Ł., Karbownik, M.S., Nowakowska-Domagała, K., Szemraj, J., Wieteska, Ł., Woźniak, K., Witusik, A., Antczak, A. and Pietras, T., 2016. Haloperidol, but not olanzapine, may affect expression of PER1 and CRY1 genes in human glioblastoma cell line. Biological Rhythm Research, 47(6), pp.865-871.: https://www.tandfonline.com/doi/full/10.1080/09291016.2016.1202379
------------------------------------------------------------

ID: 112 | Asenapine
FDA: Approved
Описание: Asenapine, an atypical antipsychotic used primarily for treating schizophrenia and bipolar disorder, has a complex interaction with circadian rhythms. While there is no direct evidence that asenapine significantly alters circadian rhythms, its effects on serotonin receptors, particularly the 5-HT...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3036780
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Induces resless legs syndrome
Механизмы: 5-HT7 binding
Цели: 5-HT7 (https://www.rcsb.org/structure/7XTC)
Статьи: Delcourte, S., Abrial, E., Etiévant, A., Rovera, R., Arnt, J., Didriksen, M. and Haddjeri, N., 2017. Asenapine modulates mood‐related behaviors and 5‐HT 1A/7 receptors‐mediated neurotransmission. CNS Neuroscience & Therapeutics, 23(6), pp.518-525.: https://pmc.ncbi.nlm.nih.gov/articles/PMC6492759/, Colita, C.I., Hermann, D.M., Filfan, M., Colita, D., Doepnner, T.R., Tica, O., Glavan, D. and Popa-Wagner, A., 2024. Optimizing Chronotherapy in Psychiatric Care: The Impact of Circadian Rhythms on Medication Timing and Efficacy. Clocks & Sleep, 6(4), pp.635-655.: https://pmc.ncbi.nlm.nih.gov/articles/PMC11586979/, McCall, W.V., Riley, M.A., Hodges, C., McCloud, L., Phillips, M. and Rosenquist, P.B., 2014. Asenapine-induced restless legs syndrome: differentiation from akathisia. Journal of Clinical Sleep Medicine, 10(12), pp.1341-1342.: https://jcsm.aasm.org/doi/10.5664/jcsm.4296
------------------------------------------------------------

ID: 113 | Benperidol
FDA: Approved
Описание: D2 receptor antagonists, such as benperidol and droperidol, increase wakefulness as well as rest in Zebrafish. Altenhofen, S. and Bonan, C.D., 2022. Zebrafish as a Tool in the Study of Sleep and Memory-related Disorders. Current neuropharmacology, 20(3), pp.540-549.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/16363
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Dopamine receptor agonist, Dopamine receptor binding
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Altenhofen, S. and Bonan, C.D., 2022. Zebrafish as a Tool in the Study of Sleep and Memory-related Disorders. Current neuropharmacology, 20(3), pp.540-549.: https://benthamscience.com/public/article/116642
------------------------------------------------------------

ID: 114 | Cariprazine
FDA: Approved
Описание: Cariprazine (0.3 mg/kg i.p.) reduced the time spent in rapid eye movement (REM) sleep and increased REM latency. This dose of cariprazine decreased the gamma (40–80 Hz) band frequency oscillations and increased the theta (4–9 Hz) and alpha (9–15 Hz) frequencies during the wake periods but not dur...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11154555
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Dopamine receptor binding
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Nyitrai, G., et al. 2021. Cariprazine modulates sleep architecture in rats. Journal of Psychopharmacology, 35(3), pp.303-310.: https://journals.sagepub.com/doi/10.1177/0269881120981378
------------------------------------------------------------

ID: 115 | Chlorpromazine
FDA: Approved
Описание: Chlorpromazine, a phenothiazine antipsychotic, has been studied for its effects on circadian rhythms, although its primary use is not related to circadian rhythm regulation. It is known to modulate the circadian rhythm of contrast sensitivity by influencing the rhythmic expression of NPAS2 in ret...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2726
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Unknown
Цели: NPAS2 (https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPAS2)
Статьи: Nagayama, H., Takagi, A., Sakurai, Y., Nishiwaki, K. and Takahashi, R., 1978. Chronopharmacological study of neuroleptics: II. Circadian susceptibility rhythm to chlorpromazine. Psychopharmacology, 58, pp.49-53.: https://pubmed.ncbi.nlm.nih.gov/97719/
------------------------------------------------------------

ID: 116 | Zuclopentixol
FDA: Approved
Описание: Antipsychotics, particularly atypical ones, have been shown to dampen the morning cortisol peak and flatten the body temperature curve, which are important components of the circadian rhythm. Melatonin: There is limited evidence that antipsychotics significantly affect melatonin levels. While zu...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5311507
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Unknown
Цели: Unknown (https://link.springer.com/content/pdf/10.1007/978-3-319-56015-1_421-1.pdf)
Статьи: Herberger, S., Ruether, E. and Hajak, G., 2021. Somnologics: Medicines for the Treatment of Sleep Disorders. In NeuroPsychopharmacotherapy (pp. 1-39). Cham: Springer International Publishing.: https://link.springer.com/referenceworkentry/10.1007/978-3-319-56015-1_421-1
------------------------------------------------------------

ID: 117 | Clozapine
FDA: Approved
Описание: Clozapine, an atypical antipsychotic, has been observed to affect circadian rhythms, particularly in patients with psychiatric disorders such as schizophrenia and Alzheimer's disease. Clozapine has been shown to improve the rest-activity cycle in patients, which is often disrupted in psychiatric ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/135398737
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: restores normal circadian rhythms
Механизмы: 5-HT7 binding
Цели: 5-HT7 (https://www.rcsb.org/structure/7XTC)
Статьи: Wirz-Justice, A., Werth, E., Savaskan, E., Knoblauch, V., Gasio, P.F. and Müller-Spahn, F., 2000. Haloperidol disrupts, clozapine reinstates the circadian rest–activity cycle in a patient with early-onset Alzheimer disease. Alzheimer Disease & Associated Disorders, 14(4), pp.212-215.: https://journals.lww.com/alzheimerjournal/abstract/2000/10000/haloperidol_disrupts,_clozapine_reinstates_the.5.aspx
------------------------------------------------------------

ID: 118 | Flupentixol
FDA: Approved
Описание: Typical antipsychotics like flupentixol have been associated with disruptions in daily rhythms, including irregular sleep-wake cycles. This is evident in case series and case reports where patients treated with flupentixol or similar drugs experienced disturbances in their rest-activity patterns,...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5281881
KEGG: NULL
Классы: Potential chronodisruptor
Эффекты: Circadian disruption in humans (rest-activity rhythm disturbance with flupentixol)
Механизмы: Unknown, 5-HT7 binding
Цели: Unknown (https://link.springer.com/content/pdf/10.1007/978-3-319-56015-1_421-1.pdf)
Статьи: Dagan, Y. and Borodkin, K., 2005. Behavioral and psychiatric consequences of sleep-wake schedule disorders. Dialogues in clinical neuroscience, 7(4), pp.357-365.: https://www.tandfonline.com/doi/full/10.31887/DCNS.2005.7.4/ydagan, Bad News for Antipsychotics and Circadian Rhythms: https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/3338-bad-news-for-antipsychotics-and-circadian-rhythms-60-sec-psych-
------------------------------------------------------------

ID: 119 | Risperidon
FDA: Approved
Описание: Risperidone, an atypical antipsychotic, has been shown to affect circadian rhythms in both animal models and humans. Here are some key points regarding its impact. Risperidone alters the expression of circadian genes such as Per1, Per2, Cry1, Cry2, Bmal1, and Rev-erbα in tissues like the liver an...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/44402564
KEGG: NULL
Классы: chronobiotic
Механизмы: CRY gene expression modulation, BMAL1 expression modulation, PER gene exspression modulation, Core clock modulation
Цели: CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407), REV-ERBα (https://www.rcsb.org/structure/4n73), mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0)
Статьи: Zapata, R.C., Silver, A., Yoon, D., Chaudry, B., Libster, A., McCarthy, M.J. and Osborn, O., 2022. Adverse effects of antipsychotic drugs on metabolism depend on drug dosing and feeding times. medRxiv, pp.2022-02.: https://www.medrxiv.org/content/10.1101/2022.02.23.22271365.abstract, Cherukalady, R., Kumar, D., Basu, P. and Singaravel, M., 2017. Risperidone resets the circadian clock in mice. Biological Rhythm Research, 48(4), pp.583-591.: https://www.tandfonline.com/doi/abs/10.1080/09291016.2017.1287820
------------------------------------------------------------

ID: 120 | Sulpiride
FDA: Approved
Описание: Sulpiride, an antipsychotic drug, primarily acts as a selective antagonist of the dopamine D2 receptor. Research indicates that sulpiride can affect circadian rhythms, particularly in relation to metabolic outcomes. Here are some key points about how sulpiride impacts circadian rhythms. Sulpiride...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5355
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Modulates insulin release rhtyhms
Механизмы: Dopamine receptor binding
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Wei, H., Zapata, R.C., Lopez-Valencia, M., Aslanoglou, D., Farino, Z.J., Benner, V., Osborn, O., Freyberg, Z. and McCarthy, M.J., 2020. Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms. Psychoneuroendocrinology, 113, p.104551.: https://www.sciencedirect.com/science/article/abs/pii/S0306453019312922
------------------------------------------------------------

ID: 121 | Fluphenazine decanoate
FDA: Approved
Описание: Antipsychotics like fluphenazine decanoate may perturb circadian gene expression in tissues such as the liver and gonadal white adipose tissue (gWAT), as observed in studies with risperidone. These changes could disrupt metabolic hormones and inflammatory pathways, though direct evidence for flup...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3388
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Binding to rat brainα- andβ-adrenergic, muscarinic cholinergic, dopamine and opiate receptors
Цели: Unknown (https://link.springer.com/content/pdf/10.1007/978-3-319-56015-1_421-1.pdf)
Статьи: Naber, D., Wirz-Justice, A. and Kafka, M.S., 1982. Chronic fluphenazine treatment modifies circadian rhythms of neurotransmitter receptor binding in rat brain. Journal of Neural Transmission, 55, pp.277-288.: https://link.springer.com/article/10.1007/BF01243449
------------------------------------------------------------

ID: 122 | Lurasidone
FDA: Approved
Описание: Studies in animal models have demonstrated that lurasidone can reverse the abnormalities in CLOCK genes (such as Per1, Per2, and Cry2) caused by chronic stress in the prefrontal cortex. This normalization is associated with improved depression-like behaviors in rats12. Serotonin Receptor Antagoni...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/213046
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Clock gene normalization and potential phase shift in rats
Механизмы: Core clock modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406)
Статьи: Krystal, A.D. and Zammit, G., 2016. The sleep effects of lurasidone: a placebo‐controlled cross‐over study using a 4‐h phase‐advance model of transient insomnia. Human Psychopharmacology: Clinical and Experimental, 31(3), pp.206-216.: https://onlinelibrary.wiley.com/doi/abs/10.1002/hup.2533?casa_token=D1QiuVEEzzwAAAAA:XBpsffY_W5zuUdpts41nWNqx-s9XH7WfHFTTOurXrjroBOyQFFvYJ-OedVaBcayEnxvDGl7MKbGhMwvi, Calabrese, F., Savino, E., Papp, M., Molteni, R. and Riva, M.A., 2016. Chronic mild stress-induced alterations of clock gene expression in rat prefrontal cortex: modulatory effects of prolonged lurasidone treatment. Pharmacological research, 104, pp.140-150.: https://www.sciencedirect.com/science/article/pii/S1043661815300864
------------------------------------------------------------

ID: 123 | Olanzapine
FDA: Approved
Описание: Olanzapine alters the temporal relationship between serum prolactin and cortisol rhythms in healthy individuals, shifting their daily acrophase (peak timing)4. While cortisol rhythms in schizophrenia patients remain relatively intact compared to healthy controls1, olanzapine-induced prolactin ele...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/135398745
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Unknown, Disruption of circadian clock
Цели: Unknown (https://link.springer.com/content/pdf/10.1007/978-3-319-56015-1_421-1.pdf)
Статьи: Romo‐Nava, F., Buijs, F.N., Valdés‐Tovar, M., Benítez‐King, G., Basualdo, M., Perusquía, M., Heinze, G., Escobar, C. and Buijs, R.M., 2017. Olanzapine‐induced early cardiovascular effects are mediated by the biological clock and prevented by melatonin. Journal of Pineal Research, 62(4), p.e12402.: https://onlinelibrary.wiley.com/doi/full/10.1111/jpi.12402?casa_token=qj5Il6Iqz4EAAAAA%3AsXE22eVIh0so2TCQSfCsP7qwVi-dvhpkcn0wLlOOOCrmKTPsikGPubFm2SaNegDemAjM-1IRSG9iQxhs, Vidarsdottir, S., Roelfsema, F., Frolich, M. and Pijl, H., 2009. Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men. Psychoneuroendocrinology, 34(5), pp.705-712.: https://www.sciencedirect.com/science/article/abs/pii/S030645300800320X
------------------------------------------------------------

ID: 124 | Pimozidine
FDA: Approved
Описание: When GBL was given intra-peritoneally during the light phase of the lighting cycle the onset of inactivity occurred rapidly (4m), while when GBL was given during the dark phase of the cycle the onset was delayed (16m). Duration of the inactive phase also varied with time of administration. GBL wa...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/16362
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Phase-dependent modulation of activity amplitude and onset (in rodents)
Механизмы: Dopamine receptor binding
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Davies, J.A., 1979. The Influence of Dopaminergic Mechanism on 24-Hour Temperature and Activity Rhythms in Rodents. In Neuro-Psychopharmacology (pp. 611-620). Pergamon.: https://www.sciencedirect.com/science/article/pii/B9780080230894500715
------------------------------------------------------------

ID: 125 | Promazine
FDA: Approved
Описание: Circadian Disruption: Antipsychotics can impact circadian rhythms indirectly by affecting neurotransmitter systems that regulate sleep and wakefulness. For example, serotonin and dopamine play roles in modulating circadian rhythms. Sleep-Wake Cycle: Some antipsychotics, like chlorpromazine (a rel...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4926
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, Chronodisruptor
Эффекты: Circadian rhythm disruption in humans
Механизмы: Hypnotic effect, Sleep promotion
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Nagayama, H., Takagi, A., Sakurai, Y., Nishiwaki, K. and Takahashi, R., 1978. Chronopharmacological study of neuroleptics: II. Circadian susceptibility rhythm to chlorpromazine. Psychopharmacology, 58, pp.49-53.: https://pubmed.ncbi.nlm.nih.gov/97719/
------------------------------------------------------------

ID: 126 | Trifluoperazine
FDA: Approved
Описание: Trifluoperazine has been shown to cause phase shifts in circadian rhythms. In Neurospora, it effectively shifts the phase of the conidiation rhythm, leading to a maximum phase delay at certain concentrations, such as 30 μM24. This indicates that TFP can influence the timing of biological processe...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5566
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Phase shift in fungi (Neurospora)
Механизмы: Calmodulin binding (Neurospora)
Цели: Calmodulin (https://www.rcsb.org/structure/3cln)
Статьи: Suzuki, S., Katagiri, S. and Nakashima, H., 1996. Mutants with altered sensitivity to a calmodulin antagonist affect the circadian clock in Neurospora crassa. Genetics, 143(3), pp.1175-1180.: https://pmc.ncbi.nlm.nih.gov/articles/PMC1207388/
------------------------------------------------------------

ID: 127 | Eszopiclone
FDA: Approved
Описание: A sedative-hypnotic used in the treatment of insomnia, improving both the latency phase and the maintenance phase of sleep. Krystal, A.D., Walsh, J.K., Laska, E., Caron, J., Amato, D.A., Wessel, T.C. and Roth, T., 2003. Sustained efficacy of eszopiclone over 6 months of nightly treatment: result...
PubChem: NULL
KEGG: NULL
Классы: hypnotic
Эффекты: helps with sleep, it doesn't necessarily reset or re-establish the body's internal clock
Механизмы: Sleep promotion
Цели: Unknown (https://link.springer.com/content/pdf/10.1007/978-3-319-56015-1_421-1.pdf)
Статьи: Krystal, A.D., Walsh, J.K., Laska, E., Caron, J., Amato, D.A., Wessel, T.C. and Roth, T., 2003. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep, 26(7), pp.793-799.: https://pubmed.ncbi.nlm.nih.gov/14655910/
------------------------------------------------------------

ID: 128 | Zolpidem
FDA: Approved
Описание: The abrupt and frequent changes in a rotating work-shift schedule can lead to dysregulation of the circadian sleep/wake cycle. Keuroghlian, A.S., Barry, A.S. and Weiss, R.D., 2012. Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work. ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5732
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, hypnotic
Механизмы: GABAergic system influence, Hypnotic effect
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Copinschi, G., Akseki, E., Moreno-Reyes, R., Leproult, R., L'Hermite-Balériaux, M., Caufriez, A., Vertongen, F. and Cauter, E.V., 1995. Effects of Bedtime Administration of Zolpidem on Orcadian and Sleep-Related Hormonal Profiles in Normal Women. Sleep, 18(6), pp.417-424.: https://academic.oup.com/sleep/article-abstract/18/6/417/2749661?redirectedFrom=fulltext, Keuroghlian, A.S., Barry, A.S. and Weiss, R.D., 2012. Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions, 21(6), p.576.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3744365/, Keating, G.M., 2005. Zolpidem: a review of its use in the management of insomnia. CNS Drugs, 19(1), pp.65-89.: https://pubmed.ncbi.nlm.nih.gov/15651908/
------------------------------------------------------------

ID: 129 | Droperidol
FDA: Approved
Описание: A butyrophenone derivative and dopamine antagonist used to prevent and treat postoperative nausea and vomiting. Cugini, P., Delogu, G., Casula, M.A., Gatta, L., Cascioli, C. and Di Palma, L., 1991. Anaesthesia‐induced dissociation between the circadian rhythms of blood pressure and heart rate. B...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3168
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, hypnotic
Механизмы: Dopamine receptor binding, Dopamine receptor antagonist, Dopamine receptor binding
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS)
Статьи: Cugini, P., Delogu, G., Casula, M.A., Gatta, L., Cascioli, C. and Di Palma, L., 1991. Anaesthesia‐induced dissociation between the circadian rhythms of blood pressure and heart rate. Biological Rhythm Research, 22(4), pp.333-340.: https://www.tandfonline.com/doi/abs/10.1080/09291019109360118
------------------------------------------------------------

ID: 130 | Buspirone
FDA: Approved
Описание: Buspirone, a serotonin 1A receptor partial agonist, is known to affect circadian rhythms. Here are some key points regarding its impact: Buspirone attenuates phase advances to late subjective night light pulses in hamsters and wild-type mice. This suggests that it can modify how the circadian sys...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2477
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: Phase advance and reduced amplitude in mice and hamsters
Механизмы: Serotoninergic signaling
Цели: 5-HT1A (https://www.rcsb.org/structure/7e2y)
Статьи: Smith, V.M., Iannatonne, S., Achal, S., Jeffers, R.T. and Antle, M.C., 2014. The serotonergic anxiolytic buspirone attenuates circadian responses to light. European Journal of Neuroscience, 40(10), pp.3512-3525.: https://pubmed.ncbi.nlm.nih.gov/25195769/
------------------------------------------------------------

ID: 131 | Hydroxyzine
FDA: Approved
Описание: Histamine H1 Blocker Hydroxyzine Improves Sleep in Patients With Cirrhosis and Minimal Hepatic Encephalopathy. Subjective improvement in sleep was observed in 40% of hydroxyzine-treated patients but in none receiving placebo (P < 0.04). Objectively, 65% of hydroxyzine-treated patients versus 25% ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3658
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Механизмы: Histamine 1 blocker
Цели: Histamine 1 receptor (https://www.rcsb.org/structure/3RZE)
Статьи: Spahr, L., Coeytaux, A., Giostra, E., Hadengue, A. and Annoni, J.M., 2007. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. Official journal of the American College of Gastroenterology| ACG, 102(4), pp.744-753.: https://journals.lww.com/ajg/abstract/2007/04000/histamine_h1_blocker_hydroxyzine_improves_sleep_in.9.aspx
------------------------------------------------------------

ID: 132 | Lemborexant
FDA: Approved
Описание: Lemborexant is a novel dual orexin receptor antagonist approved for the treatment of insomnia in adults, particularly those experiencing difficulties in sleep onset and/or sleep maintenance. Unlike traditional hypnotics that work by enhancing sleep drive via GABA and melatonin receptors, lemborex...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/56944144
KEGG: NULL
Классы: Chronomodulator
Механизмы: Orexin Receptor Antagonism
Цели: Orexin Receptors OX1R and OX2R (https://www.sciencedirect.com/topics/medicine-and-dentistry/orexin-receptor)
Статьи: https://pubmed.ncbi.nlm.nih.gov/33336219/: https://pubmed.ncbi.nlm.nih.gov/33336219/
------------------------------------------------------------

ID: 133 | Dexmedetomidine
FDA: Approved
Описание: An alpha-2 agonist used for sedation during various procedures, positively affects sleep quality. In the D6H group, the whole expression of seven genes was changed significantly compared with the N group. In the P6H group, all gene expressions except for Tef (thyrotroph embryonic factor) were c...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5311068
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: Altered expression of clock genes in mice
Механизмы: Core clock modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7)
Статьи: Huang, X., Lin, D., Sun, Y., Wu, A. and Wei, C., 2021. Effect of dexmedetomidine on postoperative sleep quality: a systematic review. Drug design, development and therapy, pp.2161-2170.: https://www.dovepress.com/effect-of-dexmedetomidine-on-postoperative-sleep-quality-a-systematic--peer-reviewed-fulltext-article-DDDT
------------------------------------------------------------

ID: 134 | Daridorexant
FDA: Approved
Описание: Daridorexant is an FDA- and EU-approved dual orexin receptor antagonist specifically developed for the treatment of insomnia. It shortens the latency to persistent sleep and reduces wake time after sleep onset, improving both subjective and objective sleep parameters and, at higher doses (50 mg),...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/91801202
KEGG: NULL
Классы: Chronomodulator
Механизмы: Orexin Receptor Antagonism
Цели: Orexin Receptors OX1R and OX2R (https://www.sciencedirect.com/topics/medicine-and-dentistry/orexin-receptor)
Статьи: Amodeo, L.R., Wills, D.N., Benedict, J. and Ehlers, C.L., 2025. Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence. Alcohol, 124, pp.35-46.: https://pubmed.ncbi.nlm.nih.gov/39870333/#:~:text=Both%20daridorexant%20doses%20led%20to,duration%20and%20inactive%20fragmentation%20ratio.
------------------------------------------------------------

ID: 135 | Zaleplon
FDA: Approved
Описание: Zaleplon has been shown to increase nocturnal melatonin secretion in humans without affecting daytime melatonin levels. This increase in melatonin can influence the circadian rhythm, as melatonin plays a crucial role in regulating sleep-wake cycles. Circadian Rhythm Influence: While zaleplon's di...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5719
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: Affects melatonin synthsis, increases melatonin synthesis
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Morera, A.L., Abreu-Gonzalez, P. and Henry, M., 2009. Zaleplon increases nocturnal melatonin secretion in humans. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33(6), pp.1013-1016.: https://www.sciencedirect.com/science/article/abs/pii/S0278584609001638
------------------------------------------------------------

ID: 136 | Filorexant
FDA: Not approved
Описание: Filorexant (MK-6096) is an investigational dual orexin receptor antagonist that was clinically studied for insomnia and other potential indications, such as migraine prophylaxis and major depressive disorder. By reducing orexin-mediated arousal signaling, filorexant promotes sleep and alters slee...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/25128145
KEGG: NULL
Классы: Chronomodulator
Механизмы: Orexin Receptor Antagonism
Цели: Orexin Receptors OX1R and OX2R (https://www.sciencedirect.com/topics/medicine-and-dentistry/orexin-receptor)
Статьи: Hoyer, D., Dürst, T., Fendt, M., Jacobson, L.H., Betschart, C., Hintermann, S., Behnke, D., Cotesta, S., Laue, G., Ofner, S. and Legangneux, E., 2013. Distinct effects of IPSU and suvorexant on mouse sleep architecture. Frontiers in neuroscience, 7, p.235.: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2013.00235/full
------------------------------------------------------------

ID: 137 | Promethazine
FDA: Approved
Описание: Promethazine, a phenothiazine derivative, acts as an anti-emetic, sedative, and hypnotic. It is primarily used for its antihistamine properties, which help in treating allergic reactions, inducing sedation, and reducing pain23. Promethazine can influence circadian rhythms indirectly by affecting ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4927
KEGG: NULL
Классы: hypnotic, Chronodisruptor, Sedative drug
Механизмы: Histamine 1 blocker
Цели: Histamine 1 receptor (https://www.rcsb.org/structure/3RZE)
Статьи: Masse, M., Henry, H., Cuvelier, E., Pinçon, C., Pavy, M., Beeuwsaert, A., Barthélémy, C., Cuny, D., Gautier, S., Kambia, N. and Lefebvre, J.M., 2022, January. Sleep medication in older adults: identifying the need for support by a community pharmacist. In Healthcare (Vol. 10, No. 1, p. 147). MDPI.: https://pubmed.ncbi.nlm.nih.gov/35052310/, Cantisani, C., Ricci, S., Grieco, T., Paolino, G., Faina, V., Silvestri, E. and Calvieri, S., 2013. Topical promethazine side effects: our experience and review of the literature. BioMed research international, 2013(1), p.151509.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3852816/
------------------------------------------------------------

ID: 138 | Adenosine
FDA: Approved
Описание: Adenosine, a ubiquitous nucleoside, plays a critical role in modulating circadian rhythms, the endogenous ~24-hour cycles that regulate physiological and behavioral processes in organisms. Emerging research highlights adenosine as a key mediator linking metabolic state with circadian timing, prim...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/60961
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Phase shift modulation and period regulation via adenosine receptor signaling (in mice and mammals)
Механизмы: Activation of Adenosine Receptors
Цели: Adenosine A1, A2A, A2B, and A3 Receptors (https://www.sciencedirect.com/topics/neuroscience/adenosine-receptor)
Статьи: Jagannath, A., Varga, N., Dallmann, R., Rando, G., Gosselin, P., Ebrahimjee, F., Taylor, L., Mosneagu, D., Stefaniak, J., Walsh, S. and Palumaa, T., 2021. Adenosine integrates light and sleep signalling for the regulation of circadian timing in mice. Nature communications, 12(1), p.2113.: https://www.nature.com/articles/s41467-021-22179-z#:~:text=Adenosine%20encodes%20sleep%20history%20and%20this%20signal,regulate%20the%20clock%20genes%20Per1%20and%20Per2.
------------------------------------------------------------

ID: 139 | Zopiclone
FDA: Approved
Описание: A nonbenzodiazepine hypnotic used for the short-term management of insomnia. Zopiclone has been shown to accelerate the readjustment of the rest/activity rhythm after a westward flight, helping to normalize the phase relationship between sleep and the temperature rhythm. This effect is primarily ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5735
KEGG: NULL
Классы: hypnotic, chronobiotic, circadian rhythm modulator
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Masse, M., Henry, H., Cuvelier, E., Pinçon, C., Pavy, M., Beeuwsaert, A., Barthélémy, C., Cuny, D., Gautier, S., Kambia, N. and Lefebvre, J.M., 2022, January. Sleep medication in older adults: identifying the need for support by a community pharmacist. In Healthcare (Vol. 10, No. 1, p. 147). MDPI.: https://pubmed.ncbi.nlm.nih.gov/35052310/
------------------------------------------------------------

ID: 140 | BAY 60-6583
FDA: Not approved
Описание: BAY 60-6583 is a selective adenosine A₂B receptor (ADORA2B) agonist. Adenosine receptors are G-protein-coupled receptors (GPCRs) that modulate intracellular cyclic AMP (cAMP) levels, especially in hypoxic or ischemic tissues. Hinz, S., Lacher, S.K., Seibt, B.F. and Müller, C.E., 2014. BAY60-6583...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11717831
KEGG: NULL
Классы: Chronomodulator
Механизмы: A2B receptor agonist.
Цели: ADORA2B (https://en.wikipedia.org/wiki/Adenosine_A2B_receptor)
Статьи: Hinz, S., Lacher, S.K., Seibt, B.F. and Müller, C.E., 2014. BAY60-6583 acts as a partial agonist at adenosine A2B receptors. The Journal of pharmacology and experimental therapeutics, 349(3), pp.427-436.: https://www.sciencedirect.com/science/article/pii/S0022356524186867
------------------------------------------------------------

ID: 141 | Chloral hydrate
FDA: Not approved
Описание: A mild hypnotic used for experimental purposes that was previously used for the treatment of insomnia. A study found that the success rate of chloral hydrate sedation was higher in the afternoon compared to the morning, suggesting that circadian rhythms may influence its efficacy. This indicates...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2707
KEGG: NULL
Классы: hypnotic, circadian rhythm modulator
Механизмы: GABAergic system influence
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Ashrafi, M.R., Mohammadi, M., Tafarroji, J., Shabanian, R., Salamati, P. and Zamani, G.R., 2010. Melatonin versus chloral hydrate for recording sleep EEG. european journal of paediatric neurology, 14(3), pp.235-238.: https://www.sciencedirect.com/science/article/pii/S1090379809001111
------------------------------------------------------------

ID: 142 | Butisol (butabarbital)
FDA: Approved
Описание: Butabarbital, known by the brand name Butisol, is a barbiturate with a fast onset and short duration of action. It acts by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) in the brain, leading to sedation and sleep induction. While barbiturates like butabarbital can help induce...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2479
KEGG: NULL
Классы: hypnotic
Эффекты: Indirect circadian disruption via altered sleep–wake timing (in humans)
Механизмы: GABAergic system influence
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Prinz, P.N., Vitiello, M.V., Raskind, M.A. and Thorpy, M.J., 1990. Sleep disorders and aging. New England Journal of Medicine, 323(8), pp.520-526.: https://www.nejm.org/doi/abs/10.1056/NEJM199008233230805
------------------------------------------------------------

ID: 143 | Doral (quazepam)
FDA: Approved
Описание: Doral, also known as quazepam, is a benzodiazepine used primarily for the short-term treatment of insomnia, particularly for sleep-maintenance insomnia. While quazepam is effective in promoting sleep by enhancing the effects of the neurotransmitter GABA, its impact on circadian rhythms is not exp...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4999
KEGG: NULL
Классы: hypnotic
Механизмы: GABAergic system influence
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Hilbert, J.M., Chung, M., Maier, G., Gural, R., Symchowicz, S. and Zampaglione, N., 1984. Effect of sleep on quazepam kinetics. Clinical Pharmacology & Therapeutics, 36(1), pp.99-104.: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1038/clpt.1984.146?casa_token=KKF3ysdqITMAAAAA:pD7a0Nf9UolDjgTQwlFu1zcM83EYd90kkALauwqRZUcKgDtzd6hc5Dn6kcqzeJaL-fWtmLCuHhQpfS6Z
------------------------------------------------------------

ID: 144 | Estazolam
FDA: Approved
Описание: Estazolam, a benzodiazepine derivative, is primarily used for the short-term management of insomnia. While there is no direct evidence that estazolam specifically affects the circadian clock, benzodiazepines in general can influence the body's natural rhythms due to their effects on sleep and wak...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3261
KEGG: NULL
Классы: hypnotic
Эффекты: sleep modulation in humans
Механизмы: GABAergic system influence
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Vogel, G.W. and Morris, D., 1992. The effects of estazolam on sleep, performance, and memory: a long‐term sleep laboratory study of elderly insomniacs. The Journal of Clinical Pharmacology, 32(7), pp.647-651.: https://accp1.onlinelibrary.wiley.com/doi/abs/10.1002/j.1552-4604.1992.tb05776.x?casa_token=6B3qnViTGeIAAAAA:x5buso9R3HWdiI5_myhafaZrTUg8tNiaqTkTlunvjJPahl1_R44MXw8Q8uF0w265H_wDiLRUvlyIj8PR
------------------------------------------------------------

ID: 145 | Fluconazole
FDA: Approved
Описание: Fluconazole is a well-known triazole antifungal agent widely used in treating both superficial and systemic mycoses, especially infections caused by Candida albicans. It exerts a mainly fungistatic effect by disrupting the conversion of lanosterol into ergosterol, an essential component of the fu...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3365
KEGG: NULL
Классы: Chronomodulator
Эффекты: Discrupts temporal organization in Candida albicans
Механизмы: Inhibits the fungal enzyme lanosterol 14-α-demethylase (CYP51)
Цели: Lanosterol 14-α-demethylase (fungal CYP51) (https://en.wikipedia.org/wiki/Lanosterol_14_alpha-demethylase)
Статьи: Nikolenko, M.V., TKh, T. and Paromova, Y.I., 2015. EFFECT OF FLUCONAZOLE ON TEMPORAL ORGANIZATION OF BIOLOGICAL PROPERTIES OF CANDIDA ALBICANS. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, (4), pp.30-35.: https://europepmc.org/article/med/26470415
------------------------------------------------------------

ID: 146 | Flurazepam
FDA: Approved
Описание: Treatments in parallel groups were administered before shifted sleeps. Sleep disturbance was greatest in the last quarter of shifted nights (6.5 to 8.5 hours after medication). Subjects taking placebo showed significant sleep loss on shifted nights and increased sleepiness the next day. Triazolam...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3393
KEGG: NULL
Классы: hypnotic
Механизмы: GABAergic system influence
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Seidel, W.F., Cohen, S.A., Bliwise, N.G., Roth, T. and Dement, W.C., 1986. Dose‐related effects of triazolam and flurazepam on a circadian rhythm insomnia. Clinical Pharmacology & Therapeutics, 40(3), pp.314-320.: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1038/clpt.1986.182, Crowley, T.J. and Hydinger-Macdonald, M., 1979. Bedtime flurazepam and the human circadian rhythm of spontaneous motility. Psychopharmacology, 62, pp.157-161.: https://link.springer.com/article/10.1007/BF00427130
------------------------------------------------------------

ID: 147 | Halcion (triazolam)
FDA: Approved
Описание: Seidel, W.F., Cohen, S.A., Bliwise, N.G., Roth, T. and Dement, W.C., 1986. Dose‐related effects of triazolam and flurazepam on a circadian rhythm insomnia. Clinical Pharmacology & Therapeutics, 40(3), pp.314-320. Turek, F.W. and Losee-Olson, S.H., 1987. Dose response curve for the phase-shifting ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5556
KEGG: NULL
Классы: hypnotic, circadian rhythm modulator
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Seidel, W.F., Cohen, S.A., Bliwise, N.G., Roth, T. and Dement, W.C., 1986. Dose‐related effects of triazolam and flurazepam on a circadian rhythm insomnia. Clinical Pharmacology & Therapeutics, 40(3), pp.314-320.: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1038/clpt.1986.182, Turek, F.W. and Losee-Olson, S.H., 1987. Dose response curve for the phase-shifting effect of triazolam on the mammalian circadian clock. Life sciences, 40(11), pp.1033-1038.: https://pubmed.ncbi.nlm.nih.gov/3821371/
------------------------------------------------------------

ID: 148 | Restoril (temazepam)
FDA: Approved
Описание: Temazepam has been shown to help induce sleep during periods of circadian rhythm desynchronization, such as during transmeridian flights. It aids in resetting the sleep-wake cycle to align with the new time zone, which can help mitigate jet lag symptoms. Studies indicate that temazepam improves s...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5391
KEGG: NULL
Классы: hypnotic
Эффекты: Sleep induction and jet lag symptom relief in humans
Механизмы: GABAergic system influence
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Heel, C., Brogden, R.N., Speight, T.M. and Avery, G.S., 1981. Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs, 21, pp.321-340.: https://europepmc.org/article/med/6112127
------------------------------------------------------------

ID: 149 | Seconal (secobarbital)
FDA: NULL
Описание: Secobarbital is a member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by prop-2-en-1-yl and pentan-2-yl groups. It has a role as an anaesthesia adjuvant, a GABA modulator and a sedative. It is functionally related to a barbituric acid. ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5193
KEGG: NULL
Классы: hypnotic
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Brunet, R., Caza, N. and Cyr, A., 1996. Food intake and circadian rhythms of activity of red-winged blackbirds (Agelaius phoeniceus). A time-course study on the effects of alpha-chloralose and secobarbital. Biological Rhythm Research, 27(2), pp.227-240.: https://www.collectionscanada.gc.ca/obj/s4/f2/dsk3/ftp04/nq26376.pdf
------------------------------------------------------------

ID: 150 | Silenor (doxepin)
FDA: Approved
Описание: Six studies were on doxepin 1–6 mg/d, two on doxepin 25–300 mg/d, and one on ramelteon 8 mg and doxepin 3 mg combined. All low-dose studies were industry-sponsored. We found that low-dose doxepin had a small to medium effect size against placebo for sleep maintenance and sleep duration but not fo...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6419921
KEGG: NULL
Классы: hypnotic
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Yeung, W.F., Chung, K.F., Yung, K.P. and Ng, T.H.Y., 2015. Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep medicine reviews, 19, pp.75-83.: https://pubmed.ncbi.nlm.nih.gov/25047681/
------------------------------------------------------------

ID: 151 | Benadryl (diphenhydramine)
FDA: Approved
Описание: Histamine, which diphenhydramine antagonizes, plays a role in modulating circadian rhythms through pathways involving nuclear factors like NF-κB2. However, diphenhydramine's effect on histamine receptors does not directly imply an impact on the circadian clock itself. Indirect Effects: While diph...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3100
KEGG: NULL
Классы: hypnotic, circadian rhythm modulator
Эффекты: NREM sleep promotion in humans
Механизмы: Histamine 1 blocker
Цели: Histamine 1 receptor (https://www.rcsb.org/structure/3RZE)
Статьи: Wang, Y.Q., Takata, Y., Li, R., Zhang, Z., Zhang, M.Q., Urade, Y., Qu, W.M. and Huang, Z.L., 2015. Doxepin and diphenhydramine increased non-rapid eye movement sleep through blockade of histamine H1 receptors. Pharmacology Biochemistry and Behavior, 129, pp.56-64.: https://pubmed.ncbi.nlm.nih.gov/25498564/, Morioka, E., Kanda, Y., Koizumi, H., Miyamoto, T. and Ikeda, M., 2018. Histamine regulates molecular clock oscillations in human retinal pigment epithelial cells via H1 receptors. Frontiers in endocrinology, 9, p.108.: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2018.00108/full
------------------------------------------------------------

ID: 152 | Unisom (doxylamine)
FDA: Approved
Описание: Doxylamine is a medication used to manage and treat nausea and vomiting of pregnancy (NVP), allergic rhinitis, and insomnia. It is in the first-generation histamine receptor H1 antagonist class of medications. In the USA, it is available as an over-the-counter medication. Ward, L.G., Bourjeily, ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11224
KEGG: NULL
Классы: hypnotic
Эффекты: effects on the circadian rhythm, also known as the body's natural sleep-wake cycle, are primarily related to its drowsiness and sedation properties
Механизмы: Histamine 1 blocker
Цели: Histamine 1 receptor (https://www.rcsb.org/structure/3RZE)
Статьи: Ward, L.G., Bourjeily, G., Guthrie, K., Salmoirago-Blotcher, E., Sharp, M., Desmarattes, A. and Bublitz, M., 2024. Sleep Quality in High-Risk Pregnancies: Mixed Methods Results from a Randomized Controlled Trial of a Mindfulness Training Intervention. Journal of Integrative and Complementary Medicine, 30(10), pp.953-960.: https://pubmed.ncbi.nlm.nih.gov/38629887/
------------------------------------------------------------

ID: 153 | Lormetazepam
FDA: Not approved
Описание: Lormetazepam is a benzodiazepine used primarily for its hypnotic effects, particularly in treating insomnia. While it has been studied for its effects on sleep architecture, such as reducing REM sleep and increasing sleep spindles and K-complexes, there is limited direct evidence regarding its im...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/13314
KEGG: https://www.kegg.jp/entry/D01657
Классы: hypnotic
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: https://pubmed.ncbi.nlm.nih.gov/35052310/: https://pubmed.ncbi.nlm.nih.gov/35052310/
------------------------------------------------------------

ID: 154 | Nitrazepam
FDA: Not approved
Описание: Nitrazepam, a long-acting benzodiazepine, is primarily prescribed for the treatment of insomnia and certain seizure disorders. While its sedative and anxiolytic properties are well-documented, its influence on circadian rhythms—the endogenous ~24-hour cycles regulating sleep-wake patterns, hormon...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4506
KEGG: https://www.kegg.jp/entry/D00531
Классы: hypnotic, circadian rhythm modulator
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: Turek, F.W. and Van Reeth, O., 1989. Use of benzodiazepines to manipulate the circadian clock regulating behavioral and endocrine rhythms. Hormone Research in Paediatrics, 31(1-2), pp.59-65.: https://karger.com/hrp/article-abstract/31/1-2/59/365242/Use-of-Benzodiazepines-to-Manipulate-the-Circadian
------------------------------------------------------------

ID: 155 | Loprazolam
FDA: Not approved
Описание: There is limited specific information available on how loprazolam affects circadian rhythms. However, benzodiazepines, the class of drugs to which loprazolam belongs, can influence sleep patterns and potentially impact circadian rhythms indirectly. Some benzodiazepines, like triazolam, have been ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4506
KEGG: https://www.kegg.jp/entry/D07326
Классы: hypnotic, circadian rhythm modulator
Механизмы: GABAergic system influence, GABA A receptor binding
Цели: GABAA receptors (https://www.rcsb.org/structure/6d6t)
Статьи: De Crescenzo, F., D'Alò, G.L., Ostinelli, E.G., Ciabattini, M., Di Franco, V., Watanabe, N., Kurtulmus, A., Tomlinson, A., Mitrova, Z., Foti, F. and Del Giovane, C., 2022. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. The Lancet, 400(10347), pp.170-184.: https://www.thelancet.com/article/S0140-6736(22)00878-9/fulltext
------------------------------------------------------------

ID: 156 | DEQUALINIUM CHLORIDE
FDA: Approved
Описание: Dequalinium chloride is an organic chloride salt derived from dequalinium, a quaternary ammonium compound. It acts as an antiseptic, antifungal, antibacterial, and antineoplastic agent. It is commonly used in wound dressings, mouth infections, and vaginal tablets for bacterial vaginosis. Dequalin...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/10649
KEGG: https://www.kegg.jp/entry/D01575
Классы: circadian rhythm modulator
Эффекты: Modulation of circadian gene expression in human U2OS cells
Механизмы: BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 157 | Berberine Chloride
FDA: Not approved
Описание: GASTROINTESTINAL drug. Binds Baculoviral IAP repeat-containing protein 5. Tamai et al. 2018. detected activity on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Ka...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/12456
KEGG: https://www.kegg.jp/entry/D01147
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Rev-erb expression modulation, NLRP3 inflammasome binding
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), NLRP3 inflammasome (https://www.uniprot.org/uniprotkb/Q96P20/entry), REV-ERBα (https://www.rcsb.org/structure/4n73), Rev-erb expression (https://www.ncbi.nlm.nih.gov/gene/217166)
Статьи: Ye, C., Zhang, Y., Lin, S., Chen, Y., Wang, Z., Feng, H., Fang, G. and Quan, S., 2023. Berberine ameliorates metabolic-associated fatty liver disease mediated metabolism disorder and redox homeostasis by upregulating clock genes: Clock and Bmal1 expressions. Molecules, 28(4), p.1874.: https://www.mdpi.com/1420-3049/28/4/1874, Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724, Zhou, Z., Lin, Y., Gao, L., Yang, Z., Wang, S. and Wu, B., 2020. Circadian pharmacological effects of berberine on chronic colitis in mice: role of the clock component Rev-erbα. Biochemical pharmacology, 172, p.113773.: https://pubmed.ncbi.nlm.nih.gov/31866303/
------------------------------------------------------------

ID: 158 | Protoporphyrin IX
FDA: NULL
Описание: ANTI-CANCER, IMMUNOSUPPRESSIVES agent. Binds Ferritin light chain. Tamai detected activity on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, ...
PubChem: NULL
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 159 | Nadifloxacin
FDA: Approved
Описание: DISINFECTANT, ANTISEPTIC. DNA gyrase subunit A*, B* binding is observed. Tamai et al detected activity of Nadifloxacin on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4410
KEGG: https://www.kegg.jp/entry/D01147
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724, Jacob, H., Curtis, A.M. and Kearney, C.J., 2020. Therapeutics on the clock: circadian medicine in the treatment of chronic inflammatory diseases. Biochemical pharmacology, 182, p.114254.: https://pubmed.ncbi.nlm.nih.gov/33010213/
------------------------------------------------------------

ID: 160 | Metergoline
FDA: Approved
Описание: Tamai et al detected activity of Metergoline on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and N...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/28693
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, BMAL1 expression modulation, de-repressing BMAL1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 161 | Cyproterone
FDA: Approved
Описание: Cyproterone is a synthetic steroidal antiandrogen that was studied in the 1960s and 1970s but was never introduced for medical use. It is a precursor to cyproterone acetate (CPA), which is widely used as a medication. Cyproterone acts as a potent antiandrogen, though it has about three-fold lower...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284537
KEGG: https://www.kegg.jp/entry/D07766
Классы: circadian rhythm modulator
Эффекты: Circadian gene modulation in human U2OS cells
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 162 | Clorgyline hydrochloride
FDA: Approved
Описание: CENTRAL NERVOUS SYSTEM drug affects Monoamine oxidase A. Tamai detected activity of Clorgyline hydrochloride on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadof...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/28767
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Monoamine oxidase A binding, de-repressing BMAL1, BMAL1 expression modulation, Bmal1
Цели: Monoamine oxidase A (https://www.rcsb.org/structure/2z5x), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 163 | Nitroxoline
FDA: Approved
Описание: Nitroxoline is a urinary antibacterial agent used primarily to treat urinary tract infections (UTIs). It is effective against both gram-positive and gram-negative bacteria, as well as mycoplasmas and certain fungi like Candida spp. Nitroxoline works by chelating metallic ions essential for microb...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/19910
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 164 | Artenimol (DHA, Dihydroartemisinin)
FDA: Approved
Описание: Artenimol, also known as dihydroartemisinin (DHA), is an artemisinin derivative used as an antimalarial agent. It is the active metabolite of all artemisinin compounds and is effective against uncomplicated Plasmodium falciparum infections. Artenimol works by producing free radicals that damage t...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3000518#section=Names-and-Identifiers
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, "Peptidyl-prolyl cis-trans isomerase A  Peroxiredoxin-1  60S ribosomal protein L10, L14, L18, L23a, L35, L4  40S ribosomal prote
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 165 | Hydroxyprogesterone
FDA: Approved
Описание: Tamai detected activity of Hydroxyprogesterone on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxyprogesterone
KEGG: https://www.kegg.jp/entry/D08053
Классы: circadian rhythm modulator
Механизмы: Glyceraldehyde-3-phosphate dehydrogenase
Цели: Glyceraldehyde-3-phosphate dehydrogenase (https://www.rcsb.org/structure/2PKQ), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 166 | Rapamycin (Sirolimus)
FDA: Approved
Описание: Rapamycin, also known as sirolimus, is a macrolide compound produced by the bacterium Streptomyces hygroscopicus. It is primarily used as an immunosuppressant to prevent organ transplant rejection and in drug-eluting stents to inhibit restenosis. Rapamycin acts by inhibiting the mammalian target ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284616
KEGG: https://www.kegg.jp/entry/D00753
Классы: circadian rhythm modulator
Эффекты: Period lengthening in human cells
Механизмы: mTOR signaling inhibition, BMAL1 expression modulation, BMAL1 expression modulation, de-repressing BMAL1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 167 | SERTACONAZOLE
FDA: Approved
Описание: Tamai detected activity of SERTACONAZOLE on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishi...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/65863
KEGG: https://www.kegg.jp/entry/D06883
Классы: circadian rhythm modulator
Механизмы: Myosin-9 binding, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 168 | BLEOMYCIN SULFATE
FDA: Approved
Описание: ANTI-CANCER, IMMUNOSUPPRESSIVE drug. Protein disulfide-isomerase binding. Tamai detected activity of BLEOMYCIN on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Ka...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5360373
KEGG: https://www.kegg.jp/entry/D02177
Классы: circadian rhythm modulator, Potential chronodisruptor
Эффекты: Circadian rhythm disruption
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation, by an immediate-early induction of Dec1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1), Dec1 gene expression (https://pmc.ncbi.nlm.nih.gov/articles/PMC2423136/)
Статьи: Chen, S.J., Yu, F., Feng, X., Li, Q., Jiang, Y.H., Zhao, L.Q., Cheng, P.P., Wang, M., Song, L.J., Liang, L.M. and He, X.L., 2024. DEC1 is involved in circadian rhythm disruption-exacerbated pulmonary fibrosis. Cell Communication and Signaling, 22(1), p.245.: https://pubmed.ncbi.nlm.nih.gov/38671456/, Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 169 | Erlotinib
FDA: Approved
Описание: Erlotinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that is used in the treatment of non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is typically marketed under the trade name Tarceva. Erlotinib binds to the epidermal growth...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/176870
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: potential period alteration via EGFR/JAK2 inhibition
Механизмы: inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase
Цели: JAK2 (https://www.rcsb.org/structure/7F7W), EGFR (https://www.rcsb.org/structure/1IVO), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 170 | Felodipine
FDA: Approved
Описание: CARDIOVASCULAR DRUG. Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, f...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3333
KEGG: https://www.kegg.jp/entry/D00319
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, 1,4-dihydropyridine calcium channel blocker, BMAL1 expression modulation, Bmal1
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 171 | Bromocriptine
FDA: Approved
Описание: CENTRAL NERVOUS SYSTEM DRUG. "D1A, D1B, D2, D3, D4 dopamine receptor, 5-hydroxytryptamine receptor 1A, 1B, 1D, 2A, 2B, 2C, 7 Alpha-1A, 1B, 1D, 2A, 2B, 2C adrenergic receptor binding activity. Tamai detected activity of BROMOCRIPTINE on circadian gene expression using a human osteosarcoma U2OS c...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/31101
KEGG: https://www.kegg.jp/entry/D03165
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, Dopamine receptor binding, Dopamine receptor agonist, BMAL1 expression modulation, Dopamine receptor binding, Bmal1
Цели: D2R (dopamine receptor) (https://www.rcsb.org/structure/8IRS), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 172 | Acitretin
FDA: Approved
Описание: DERMATOLOGICAL DRUG. An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. Tamai detected activity of Acitretin on circadian gene expression using a human osteosarcoma U2OS c...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5284513
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 173 | CALCITRIOL
FDA: Approved
Описание: VITAMIN. Calcitriol is an active metabolite of vitamin D with 3 hydroxyl (OH) groups and is commonly referred to as 1,25-dihydroxycholecalciferol, or 1alpha,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D3. It is produced in the body after series of conversion steps of 7-dehydrocholesterol from ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5280453
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Circadian gene modulation
Механизмы: BMAL1 expression modulation, Bmal1, Vitamin D3 receptor,  Homeobox protein Hox-A10,  Vitamin D-binding protein, BMAL1 expression modulation
Цели: Vitamin D binding protein (https://www.rcsb.org/structure/1KW2), Vitamin D3 receptor (https://www.rcsb.org/structure/1DB1), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 174 | KETOCONAZOLE
FDA: Approved
Описание: DISINFECTANT, ANTISEPTIC. Binding Androgen receptor, 17-hydroxylase, Steroid 21-hydroxylase, 11-hydroxylase, Cytochrome P450 19A1, Potassium voltage-gated channel subfamily H member 2, Nuclear receptor subfamily 2, 3. Tamai detected activity of KETOCONAZOLE on circadian gene expression usin...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/456201
KEGG: https://www.kegg.jp/entry/D00351
Классы: circadian rhythm modulator
Эффекты: Circadian modulator activity
Механизмы: BMAL1 expression modulation, BMAL1 expression modulation, Binding Androgen receptor,  17-hydroxylase,  Steroid 21-hydroxylase,  11-hydroxylase,  Cytochrome P450 19A1,  Potassium voltage-
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 175 | DAUNORUBICIN HCL
FDA: Approved
Описание: ANTI-CANCER drug, IMMUNOSUPPRESSANT. Tamai et al. 2018 detected activity of DAUNORUBICIN on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/62770
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, DNA  DNA topoisomerase 2-alpha, beta binding, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
------------------------------------------------------------

ID: 176 | Bexarotene
FDA: Approved
Описание: ANTI-CANCER drug, IMMUNOSUPPRESSANT. Tamai et al. 2018 detected activity of bexarotene on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/82146
KEGG: https://www.kegg.jp/entry/D03106
Классы: circadian rhythm modulator
Эффекты: Circadian modulation detected in Bmal1-reporter assay
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 177 | CLOFARABINE
FDA: Approved
Описание: Clofarabine is a purine nucleoside analogue consisting of a 6-amino-2-chloropurin-9-yl group attached to the 1beta position of 2'-deoxy-2'-fluoro-D-arabinofuranose. It is metabolized intracellularly to the active 5'-triphosphate metabolite, which inhibits DNA synthesisis and so stops the growth o...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/119182
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 178 | VINBLASTINE SULFATE
FDA: Approved
Описание: Methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxy...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5388983
KEGG: https://www.kegg.jp/entry/D01068
Классы: circadian rhythm modulator
Эффекты: Circadian modulation via Bmal1 activation (U2OS cells)
Механизмы: Tubulin alpha-1A, beta, delta, gamma-1, epsilon chain  Transcription factor AP-1 binding, BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 179 | CHLORAMBUCIL
FDA: Approved
Описание: ANTI-CANCER, IMMUNOSUPPRESSIVE drug. Chlorambucil is a monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leuk...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2708
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 180 | MITOXANTRONE HCL
FDA: Approved
Описание: ANTI-CANCER, IMMUNOSUPPRESSIVE drug, targeting DNA and DNA topoisomerase 2-alpha. Tamai detected activity of MITOXANTRONE on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock reporter Bmal1‐dLuc. Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishigu...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/51082
KEGG: https://www.kegg.jp/entry/D02166
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 181 | Paclitaxel (TAXOL)
FDA: Approved
Описание: Paclitaxel injections delayed voluntary wheel running activity onset in a light-dark cycle (LD) and lengthened the free-running period of locomotion in constant darkness (DD), indicating an effect on inherent suprachiasmatic nucleus (SCN) pacemaker activity. Paclitaxel attenuated clock gene rhyth...
PubChem: https://www.chemspider.com/Chemical-Structure.10368587.html
KEGG: https://www.kegg.jp/entry/D00491
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Sullivan, K.A., Grant, C.V., Jordan, K.R., Obrietan, K. and Pyter, L.M., 2022. Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice. Brain, behavior, and immunity, 99, pp.106-118.: https://pmc.ncbi.nlm.nih.gov/articles/PMC8671246/
------------------------------------------------------------

ID: 182 | NEFAZODONE HCL
FDA: Approved
Описание: Nefazodone Hydrochloride is a synthetic derivative of phenylpiperazine and chemically unrelated to selective serotonin reuptake inhibitors, tricyclics, tetracyclics, or monoamine oxidase inhibitors (MAOI), antidepressant Nefazadone Hydrochloride antagonizes central 5-HT2 receptors and inhibits re...
PubChem: https://www.chemspider.com/Chemical-Structure.49584.html
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Nefazodone decreased both sleep latency and stage 1 sleep and increased sleep efficiency.
Механизмы: BMAL1 expression modulation, BMAL1 expression modulation, de-repressing BMAL1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 183 | Oxiconazole Nitrate
FDA: Approved
Описание: Oxiconazole Nitrate is the nitrate salt form of oxiconazole, a broad spectrum imidazole derivative with antifungal activity. Although the exact mechanism of action has yet to be fully elucidated, oxiconazole, like other azole antifungals, most likely inhibits the cytochrome P450-dependent demethy...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9556529
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 184 | PROGESTERONE
FDA: Approved
Описание: Progesterone is a C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species. It has a role as a contraceptive ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5994
KEGG: https://www.kegg.jp/entry/D00066
Классы: circadian rhythm modulator
Эффекты: Progesterone regulates the expression of clock genes like PER1, which is crucial for circadian timing.
Механизмы: BMAL1 expression modulation, Bmal1, Progesterone receptor,  Estrogen receptor alpha, Mineralocorticoid receptor, Steroid 17-alpha-hydroxylase/17,20 lyase  Kappa-typ, BMAL1 expression modulation
Цели: Progesterone receptor (https://www.uniprot.org/uniprotkb/P06401/entry), Estrogen receptor alpha (https://www.rcsb.org/structure/4J24), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 185 | Nelfinavir mesylate
FDA: Approved
Описание: Nelfinavir mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of nelfinavir and methanesulfonic acid. It is used for treatment of HIV and also exhibits some anticancer properties. It has a role as a HIV protease inhibitor and an antineoplastic agent. It contains a nelf...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/64142
KEGG: https://www.kegg.jp/entry/D00899
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, BMAL1 expression modulation, HIV-1 protease binding, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 186 | Adefovir Dipivoxil
FDA: Approved
Описание: Adefovir pivoxil is an organic phosphonate that is the dipivoxil ester of adefovir. A prodrug for adefovir, an HIV-1 reverse transcriptase inhibitor, adefovir pivoxil is used to treat chronic hepatitis B viral infection. It has a role as a prodrug, an antiviral drug, a DNA synthesis inhibitor, a ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/60871
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, BMAL1 expression modulation, DNA polymerase/reverse transcriptase (HBV-D) binding, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 187 | ARSENIC TRIOXIDE
FDA: NULL
Описание: ANTI-CANCER, IMMUNOSUPPRESSIVE Inhibitor of nuclear factor kappa-B kinase subunit beta, Thioredoxin reductase 1, cytoplasmic, Transcription factor AP-1, G1/S-specific cyclin-D1 , Mitogen-activated protein kinase 1, 3, RAC-alpha serine/threonine-protein kinase, Cyclin-dependent kinase inhibito...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/14888
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, BMAL1 expression modulation, "Inhibitor of nuclear factor kappa-B kinase subunit beta  Thioredoxin reductase 1, cytoplasmic  Transcription factor AP-1  G1/S-, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 188 | CIDOFOVIR
FDA: Not approved
Описание: Cidofovir is an injectable antiviral medication employed in the treatment of cytomegalovirus (CMV) retinitis in patients diagnosed with AIDS. It suppresses CMV replication through selective inhibition of viral DNA synthesis. It was manufactured by Gilead and initially approved by the FDA in 1996,...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/60613
KEGG: https://www.kegg.jp/entry/D10547
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 189 | CINACALCET HCL
FDA: Approved
Описание: Cinacalcet Hydrochloride is the orally bioavailable hydrochloride salt of the calcimimetic cinacalcet. Cinacalcet increases the sensitivity of calcium-sensing receptors on chief cells in the parathyroid gland to extracellular calcium, thereby reducing parathyroid hormone (PTH) secretion. A reduct...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/156418
KEGG: https://www.kegg.jp/entry/D03505
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, BMAL1 expression modulation, calcimimetic and a P450 inhibitor, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 190 | Cladribine
FDA: Approved
Описание: Cladribine is a purine analogue or a chlorinated derivative of adenine that causes apoptosis of B and T lymphocytes. Cladribine was first approved in the United States in 1993 initially as a treatment for a number of hematological malignancies; currently, it is approved for the treatment of hairy...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/20279#section=2D-Structure
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 191 | Clotrimazole
FDA: Approved
Описание: Clotrimazole is a member of the class of imidazoles that is 1H-imidazole in which the hydrogen attached to a nitrogen is replaced by a monochlorotrityl group. It has a role as an antiinfective agent, an environmental contaminant and a xenobiotic. It is a member of imidazoles, a member of monochlo...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2812#section=2D-Structure
KEGG: https://www.kegg.jp/entry/D00282
Классы: circadian rhythm modulator
Механизмы: Intermediate conductance calcium-activated potassium channel, protein 4  Nuclear receptor subfamily 1 group I member 2, 3, BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 192 | Dasatinib
FDA: Approved
Описание: Dasatinib is an orally available multikinase inhibitor indicated for the treatment of Philadelphia chromosome (Ph)-positive leukemias. Ph is a chromosomal abnormality found in patients with chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL), where the ABL tyrosine kinase and ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3062316
KEGG: https://www.kegg.jp/entry/D03658
Классы: circadian rhythm modulator
Эффекты: Period lengthening in human U2OS cells
Механизмы: "Tyrosine-protein kinase ABL1, Lck, Yes, Fyn, BTK, CSK, Fgr, FRK, Lyn  Proto-oncogene tyrosine-protein kinase Src  Ephrin type-A, BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 193 | Deferasirox
FDA: Approved
Описание: Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions. Tamai detected activity of Deferasirox on circadian gene expression using a human osteosarcoma U2OS cell line stably expressing the clock repor...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/214348
KEGG: https://www.kegg.jp/entry/D03669
Классы: circadian rhythm modulator
Эффекты: Period lengthening in human U2OS cells
Механизмы: BMAL1 expression modulation, Bmal1, BMAL1 expression modulation
Цели: Fe (https://pubchem.ncbi.nlm.nih.gov/compound/23925), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 194 | AA92593
FDA: Not approved
Описание: AA92593 is a piperidine-based sulfonamide first identified through a small-molecule screening campaign for inhibitors of melanopsin-mediated Ca²⁺ mobilization. Together with similar molecules (collectively termed “opsinamides”), AA92593 demonstrates the capacity to displace retinal from melanopsi...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/847007
KEGG: NULL
Классы: Chronomodulator
Эффекты: Inhibition of light-induced phase shifts via melanopsin antagonism
Механизмы: Competitive blockade of melanopsin’s retinal-binding site
Цели: Melanopsin (Opn4) (https://en.wikipedia.org/wiki/Melanopsin)
Статьи: Obayashi, K., Zou, R., Kawaguchi, T., Mori, T. and Tsukamoto, H., 2025. Molecular basis underlying the specificity of an antagonist AA92593 for mammalian melanopsins. Journal of Biological Chemistry, 301(5), p.108461.: https://pubmed.ncbi.nlm.nih.gov/40154611/, Bertolesi, G.E., Debnath, N., Malik, H.R., Man, L.L. and McFarlane, S., 2022. Type II opsins in the eye, the pineal complex and the skin of Xenopus laevis: Using changes in skin pigmentation as a readout of visual and circadian activity. Frontiers in Neuroanatomy, 15, p.784478.: https://www.frontiersin.org/journals/neuroanatomy/articles/10.3389/fnana.2021.784478/full
------------------------------------------------------------

ID: 195 | AA41612
FDA: Not approved
Описание: AA41612 is a dichlorophenyl sulfonamide identified through high-throughput screening for inhibitors of melanopsin-mediated Ca²⁺ signaling. Along with AA92593 and other “opsinamides,” AA41612 competes with cis-retinal or 9-cis retinal for binding to melanopsin, thus preventing photoactivation in c...
PubChem: NULL
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: AA41612 alters the body's response to light, potentially influencing the timing and duration of circadian rhythms, such as sleep-wake cycles,
Механизмы: Competitive binding at melanopsin’s retinal-binding site, Photoreception inhibition
Цели: Melanopsin (Opn4) (https://en.wikipedia.org/wiki/Melanopsin)
Статьи: Jones, K.A., Hatori, M., Mure, L.S., Bramley, J.R., Artymyshyn, R., Hong, S.P., Marzabadi, M., Zhong, H., Sprouse, J., Zhu, Q. and Hartwick, A.T., 2013. Small-molecule antagonists of melanopsin-mediated phototransduction. Nature chemical biology, 9(10), pp.630-635.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3839535/
------------------------------------------------------------

ID: 196 | SB-202190
FDA: Not approved
Описание: SB-202190 is an imidazole-based compound best known as a selective inhibitor of the α and β isoforms of p38 mitogen-activated protein kinase (MAPK). Because p38 MAPKs are key regulators of inflammatory and stress-related signaling pathways, SB-202190 is widely employed in cell biology to dissect ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5169
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Period lengthening in Aplysia.
Механизмы: Inhibits p38 MAPK α/β isoforms
Цели: p38 MAP kinase (https://en.wikipedia.org/wiki/P38_mitogen-activated_protein_kinases)
Статьи: Sankrithi, N. and Eskin, A., 1999. Effects of Cyclin‐Dependent Kinase Inhibitors on Transcription and Ocular Circadian Rhythm of Aplysia. Journal of neurochemistry, 72(2), pp.605-613.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4412876/, Hirota, T., Lewis, W.G., Liu, A.C., Lee, J.W., Schultz, P.G. and Kay, S.A., 2008. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3β. Proceedings of the National Academy of Sciences, 105(52), pp.20746-20751.: https://www.pnas.org/doi/abs/10.1073/pnas.0811410106, Shanware, N.P., Williams, L.M., Bowler, M.J. and Tibbetts, R.S., 2009. Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190. BMB reports, 42(3), p.142.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4412876/
------------------------------------------------------------

ID: 197 | Laduviglusib (CHIR-99021)
FDA: Not approved
Описание: CHIR-99021 (also called laduviglusib) is regarded as one of the most potent and specific GSK-3 inhibitors. It has found utility in stem cell biology (promoting self-renewal of embryonic stem cells) and in circadian biology, where inhibiting GSK-3 shortens the circadian period in mammalian cells. ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9956119
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Highly selective, ATP-competitive inhibition of GSK-3 (both α and β isoforms)
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3)
Статьи: Hirota, T., Lewis, W.G., Liu, A.C., Lee, J.W., Schultz, P.G. and Kay, S.A., 2008. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3β. Proceedings of the National Academy of Sciences, 105(52), pp.20746-20751.: https://www.pnas.org/doi/abs/10.1073/pnas.0811410106
------------------------------------------------------------

ID: 198 | DROSPIRENONE
FDA: Approved
Описание: Drospirenone is a synthetic progestin commonly found in the popular oral contraceptive, Yaz in combination with [Ethinyl estradiol]. Most recently, it was approved by both Health Canada and the FDA in combination with [Estetrol] as an oral contraceptive therapy. Aside from its contraceptive effec...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/68873
KEGG: https://www.kegg.jp/entry/D03917
Классы: circadian rhythm modulator
Механизмы: Mineral corticoid receptor binding, BMAL1 expression modulation, de-repressing BMAL1, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 199 | EPIRUBICIN HCL
FDA: Approved
Описание: Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This a...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/65348
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, DNA  DNA topoisomerase 2-alpha, beta binding, targeting DNA and DNA topoisomerase 2-alpha., BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 200 | EVEROLIMUS
FDA: Approved
Описание: ANTI-CANCER, IMMUNOSUPPRESSIVE drug. Everolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mT...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6442177
KEGG: https://www.kegg.jp/entry/D02714
Классы: circadian rhythm modulator
Эффекты: Circadian modulation in human cells
Механизмы: Serine/threonine-protein kinase mTOR, BMAL1 expression modulation, de-repressing BMAL1, mTOR signaling inhibition, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 201 | Irinotecan Hydrochloride
FDA: Approved
Описание: Irinotecan HCl is the hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic alkaloid extracted from Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzym...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/74990
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: inhibits topoisomerase I, BMAL1 expression modulation, de-repressing BMAL1, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Topoisomerase I (https://www.rcsb.org/structure/1T8I), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 202 | ISOTRETINOIN (13-CIS-RETINOIC ACID)
FDA: Approved
Описание: DERMATOLOGICAL drug affecting retinoic acid receptor alpha. Isotretinoin can cause developmental toxicity according to an independent committee of scientific and health experts. Tamai detected activity of ISOTRETINOIN on circadian gene expression using a human osteosarcoma U2OS cell line stably ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5282379
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Binding retinoic acid receptor alpha, de-repressing BMAL1, BMAL1 expression modulation, Bmal1
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Retinoic acid receptor alpha (https://www.rcsb.org/structure/7B88), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 203 | MECLIZINE DIHYDROCHLORIDE
FDA: Approved
Описание: Meclizine Hydrochloride is the hydrochloride salt form of meclizine, a synthetic piperazine with anti-emetic, sedative and histamine H1 antagonistic properties. Meclizine hydrochloride blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries,...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/64713
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, Histamine H1 receptor,  Nuclear receptor subfamily 1 group I member 3, Histamine 1 blocker, BMAL1 expression modulation, Bmal1
Цели: Histamine 1 receptor (https://www.rcsb.org/structure/3RZE), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 204 | NEBIVOLOL HCL
FDA: Approved
Описание: NEBIVOLOL HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for hypertension and stroke. Tamai detected activity of NEBIVOLOL HYDROCHLORIDE on circadian gene expression using a human osteosar...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9933004
KEGG: https://www.kegg.jp/entry/D05127
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, Beta-1, 2 adrenergic receptor binding, BMAL1 expression modulation, Bmal1
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), Beta 1,2 adrenergic receptor (https://www.rcsb.org/structure/2YCY)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 205 | NILOTINIB
FDA: Approved
Описание: Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). A Phase I clinical trial in 2006 showed that this drug was relatively safe and offered significant therapeutic benefits in cases of CML which were fo...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/644241
KEGG: https://www.kegg.jp/entry/D08953
Классы: circadian rhythm modulator
Эффекты: Circadian gene expression modulation in human cells (U2OS)
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, "Tyrosine-protein kinase ABL1  Mast/stem cell growth factor receptor binding, BMAL1 expression modulation, Bmal1
Цели: Tyrosine proteine kinase ABL1 (https://www.uniprot.org/uniprotkb/P00519/entry), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 206 | PAZOPANIB HCL
FDA: Approved
Описание: Pazopanib Hydrochloride is the hydrochloride salt of a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor r...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11525740
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Circadian modulation in human U2OS cells
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, Vascular endothelial growth factor receptor 1, 2, 3, Platelet-derived growth factor receptor alpha, beta, Mast/stem cell growth factor receptor Kit, Fibroblast growth factor receptor 3, Tyrosine-protein kinase ITK/TSK, Fibroblast growth factor 1, SH2B adapter protein 3, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 207 | PIMECROLIMUS
FDA: Approved
Описание: Pimecrolimus is an immunomodulating agent that was first marketed by Novartis under the trade name Elidel. It is now promoted in Canada by Galderma since early 2007. It is currently available as a topic cream used in the treatment of atopic dermatitis (eczema). Pimecrolimus is a Calcineurin Inhib...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6509979
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Calcineurin Inhibitor Immunosuppressant, BMAL1 expression modulation, BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 208 | PODOFILOX
FDA: Approved
Описание: Podophyllotoxin is an organic heterotetracyclic compound that has a furonaphthodioxole skeleton bearing a 3,4,5-trimethoxyphenyl substituent. It is found in the roots and rhizomes of Podophyllum species and is used for the topical treatment of genital warts. It has a role as an antineoplastic age...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/10607
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, DNA  DNA topoisomerase 2-alpha, beta binding, Tubulin alpha-4A, beta chain binding, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 209 | Rabeprazole Sodium
FDA: Approved
Описание: Rabeprazole Sodium is the sodium salt of the prodrug rabeprazole, a substituted benzimidazole proton pump inhibitor, with potential anti-ulcer activity. After protonation, accumulation, and transformation to the active sulfenamide within the acidic environment of gastric parietal cells, rabeprazo...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/14720269
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, Potassium-transporting ATPase alpha chain 1 binding activity, BMAL1 expression modulation, Bmal1
Цели: H+ K+ ATPase (https://www.rcsb.org/structure/3IXZ), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 210 | Tazarotene
FDA: Approved
Описание: Tazarotene, commonly marketed as Tazorac®, Avage®, and Zorac®, is member of the acetylenic class of retinoids. It is a prodrug that is found in topical formulations used in the treatment of various conditons, such as psoriasis, acne, and sun damaged skin (photodamage). Tamai detected activity of ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5381
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, de-repressing BMAL1, BMAL1 expression modulation
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Retinoic acid receptor alpha (https://www.rcsb.org/structure/7B88), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 211 | THIOTEPA
FDA: Not approved
Описание: Tris(1-aziridinyl)phosphine Sulfide (Thiotepa) can cause cancer according to an independent committee of scientific and health experts. California Office of Environmental Health Hazard Assessment (OEHHA) Tris(aziridinyl)phosphine sulfide is an odorless white crystalline solid. (NTP, 1992) Thiotep...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5453
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, DNA alkylation, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 212 | TRETINOIN
FDA: Approved
Описание: DERMATOLOGICAL drug affecting Retinoic acid receptor RXR-alpha, beta, gamma, Retinoic acid receptor alpha, beta, gamma, Retinal dehydrogenase 1, Retinoic acid-induced protein 3, Nuclear receptor subfamily 0 group B member 1, Retinal dehydrogenase 2, Retinoic acid receptor responder protein 1...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/444795
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Circadian modulation in human U2OS cells
Механизмы: BMAL1 expression modulation, Binding retinoic acid receptor alpha, de-repressing BMAL1, Retinoic acid receptor RXR-alpha, beta, gamma binding, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tamai, T.K., Nakane, Y., Ota, W., Kobayashi, A., Ishiguro, M., Kadofusa, N., Ikegami, K., Yagita, K., Shigeyoshi, Y., Sudo, M. and Nishiwaki‐Ohkawa, T., 2018. Identification of circadian clock modulators from existing drugs. EMBO molecular medicine, 10(5), p.e8724.: https://www.embopress.org/action/oidcStart?redirectUri=%2Fdoi%2Fabs%2F10.15252%2Femmm.201708724
------------------------------------------------------------

ID: 213 | Irbesartan
FDA: Approved
Описание: Irbesartan is an angiotensin receptor blocker (ARB) indicated to treat hypertension or diabetic nephropathy. It can also be used as part of a combination product with [hydrochlorothiazide] for patients not well controlled or not expected to be well controlled on monotherapy. Unlike angiotensin co...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3749
KEGG: https://www.kegg.jp/entry/D00523
Классы: circadian rhythm modulator
Механизмы: Angiotensin receptor binding, PER3
Цели: PER3 (https://www.ncbi.nlm.nih.gov/gene/8863), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406)
Статьи: Zhao, et al., 2024. Irbesartan ameliorates diabetic kidney injury in db/db mice by restoring circadian rhythm and cell cycle. Journal of translational internal medicine, 12(2), pp.157-169.: https://pmc.ncbi.nlm.nih.gov/articles/PMC11117442/
------------------------------------------------------------

ID: 214 | KL001
FDA: Not approved
Описание: KL001 is a small molecule identified as a modulator of the circadian clock through its specific interaction with cryptochrome proteins (CRY1 and CRY2). It stabilizes these proteins by preventing their ubiquitin-dependent degradation, thereby lengthening the circadian period. KL001 achieves this b...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/kl001
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Механизмы: Selective stabilizer of CRY1, Selectively stabilizes CRY2, Binds CRY1 FAD-binding
Цели: CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0)
Статьи: Hirota, T., Lee, J.W., St. John, P.C., Sawa, M., Iwaisako, K., Noguchi, T., Pongsawakul, P.Y., Sonntag, T., Welsh, D.K., Brenner, D.A. and Doyle III, F.J., 2012. Identification of small molecule activators of cryptochrome. Science, 337(6098), pp.1094-1097: https://pubmed.ncbi.nlm.nih.gov/22798407/, Iida, M., Nakane, Y., Yoshimura, T. and Hirota, T., 2022. Effects of cryptochrome-modulating compounds on circadian behavioural rhythms in zebrafish. Journal of Biochemistry, 171(5), pp.501-507.: https://pubmed.ncbi.nlm.nih.gov/34528676/
------------------------------------------------------------

ID: 215 | KS15
FDA: Not approved
Описание: KS15 can functionally inhibit the effects of CRY1/2 in the molecular circadian clockwork. In conclusion, the present study describes the first novel chemical inhibitor of CRY1/2 that inhibits the repressive function of CRY1/2, thereby activating CLOCK-BMAL1-evoked E-box-mediated transcription. C...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/25114872
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: decreased the amplitude of circadian rhythm significantly while having no effect on the period, CRY1/2 inhibition
Механизмы: Binds CRY1 FAD-binding, CRY1/2 inhibitor, Activation of CLOCK/Bmal1 mediated transcription
Цели: CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY2 (https://www.rcsb.org/structure/7V8Y), CRY1 (https://www.rcsb.org/structure/4ct0)
Статьи: Solovev, I.A., Shaposhnikov, M.V. and Moskalev, A.A., 2021. Chronobiotics KL001 and KS15 extend lifespan and modify circadian rhythms of Drosophila melanogaster. Clocks & Sleep, 3(3), pp.429-441.: https://www.mdpi.com/2624-5175/3/3/30, Chun, S.K., Jang, J., Chung, S., Yun, H., Kim, N.J., Jung, J.W., Son, G.H., Suh, Y.G. and Kim, K., 2014. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. ACS chemical biology, 9(3), pp.703-710.: https://pubmed.ncbi.nlm.nih.gov/24387302/, 전승국, 2014. Development of circadian clock modulator and its application (Doctoral dissertation, 서울대학교 대학원).: https://s-space.snu.ac.kr/handle/10371/121386, Jang, J., Chung, S., Choi, Y., Lim, H.Y., Son, Y., Chun, S.K., Son, G.H., Kim, K., Suh, Y.G. and Jung, J.W., 2018. The cryptochrome inhibitor KS15 enhances E-box-mediated transcription by disrupting the feedback action of a circadian transcription-repressor complex. Life sciences, 200, pp.49-55.: https://pubmed.ncbi.nlm.nih.gov/29534992/
------------------------------------------------------------

ID: 216 | Azakenpaullone
FDA: Not approved
Описание: 1-Azakenpaullone (sometimes referred to as 1-AKP or simply “azakenpaullone”) is a brominated derivative in the paullone family, showing potent inhibition of GSK-3. In circadian studies, GSK-3 blockade by 1-azakenpaullone and related molecules has been linked to period shortening of mammalian cell...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6538897#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Dual inhibitor of Cyclin-dependent kinases (CDK) and Glycogen Synthase Kinase-3 (GSK-3)
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3)
Статьи: He, B. and Chen, Z., 2016. Molecular targets for small-molecule modulators of circadian clocks. Current drug metabolism, 17(5), pp.503-512.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4825319/
------------------------------------------------------------

ID: 217 | CLK8
FDA: Not approved
Описание: CLK8 emerged from a structure-based virtual screen designed to identify small molecules that disrupt the CLOCK–BMAL1 interface. Experimental validation in cell-based assays indicated that CLK8 decreases CLOCK–BMAL1 binding, thereby diminishing CLOCK nuclear entry. This selective inhibition leads ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4869040
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Механизмы: Interferes with CLOCK–BMAL1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Doruk, Y.U., Yarparvar, D., Akyel, Y.K., Gul, S., Taskin, A.C., Yilmaz, F., Baris, I., Ozturk, N., Türkay, M., Ozturk, N. and Okyar, A., 2020. A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude. Journal of Biological Chemistry, 295(11), pp.3518-3531.: https://pubmed.ncbi.nlm.nih.gov/32019867/
------------------------------------------------------------

ID: 218 | 5,8-Quinoxalinedione
FDA: Not approved
Описание: 5,8-Quinoxalinedione was identified via a screening approach to find chemical inhibitors of the BMAL1–CLOCK transcriptional complex. This small molecule impairs the ability of BMAL1/CLOCK to bind E-box sequences, a central step in the circadian positive feedback loop. By decreasing E-box occupanc...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11355645#section=2D-Structure
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Transcriptional inhibition of BMAL1–CLOCK complex in human cells
Механизмы: Targets BMAL1–CLOCK DNA-binding activity
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Hosoya, Y., Nojo, W., Kii, I., Suzuki, T., Imanishi, M. and Ohkanda, J., 2020. Identification of synthetic inhibitors for the DNA binding of intrinsically disordered circadian clock transcription factors. Chemical Communications, 56(76), pp.11203-11206.: https://pubmed.ncbi.nlm.nih.gov/32969426/
------------------------------------------------------------

ID: 219 | Protoheme
FDA: Not approved
Описание: Protoheme (also called heme b or ferroprotoporphyrin IX) is the most abundant heme type in animal cells. It integrates an iron(II)/(III) center into a protoporphyrin IX ring. This arrangement underpins oxygen transport (hemoglobin, myoglobin), electron transfer (respiratory chain cytochromes), an...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/26945#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Serves as a cofactor in various hemoproteins (e.g., hemoglobin, cytochromes) and can modulate transcription factors (e.g., REV-E
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Freeman, S.L., Kwon, H., Portolano, N., Parkin, G., Venkatraman Girija, U., Basran, J., Fielding, A.J., Fairall, L., Svistunenko, D.A., Moody, P.C. and Schwabe, J.W., 2019. Heme binding to human CLOCK affects interactions with the E-box. Proceedings of the National Academy of Sciences, 116(40), pp.19911-19916.: https://pmc.ncbi.nlm.nih.gov/articles/PMC6778266/
------------------------------------------------------------

ID: 220 | LH-846
FDA: Not approved
Описание: LH-846 emerged from a high-throughput cell-based screen for compounds that alter circadian rhythms. It prominently lengthens the cellular circadian period (by approximately 10 hours) in U2OS reporter cells. Mechanistically, LH-846 blocks phosphorylation of the PER1 protein by CKIδ, hindering PER1...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/851474#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Period lengthening in human cells (U2OS)
Механизмы: Inhibits casein kinase 1 delta (CKIδ) activity
Цели: CK1δ (https://en.wikipedia.org/wiki/CSNK1D)
Статьи: Ray, S., Lach, R., Heesom, K.J., Valekunja, U.K., Encheva, V., Snijders, A.P. and Reddy, A.B., 2019. Phenotypic proteomic profiling identifies a landscape of targets for circadian clock–modulating compounds. Life Science Alliance, 2(6).: https://pubmed.ncbi.nlm.nih.gov/31792063/, Lee, J.W., Hirota, T., Peters, E.C., Garcia, M., Gonzalez, R., Cho, C.Y., Wu, X., Schultz, P.G. and Kay, S.A., 2011. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angewandte Chemie (International ed. in English), 50(45), p.10608.: https://pubmed.ncbi.nlm.nih.gov/21954091/
------------------------------------------------------------

ID: 221 | naphthalene
FDA: none
Описание: Chronotoxicant. Naphthalene, methylnaphthalenes appears as a black liquid with the odor of coal tar. Negligibly soluble in water. Slightly denser than water. Vapors, fumes or direct contact may irritate the eyes. Direct skin contact may produce severe burns. Inhalation may produce mucous irritati...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/931
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Core clock suppression, BMAL1 expression modulation, Bmal1, Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 222 | anthracene
FDA: none
Описание: Chronodisruptor from food, a solid polycyclic aromatic hydrocarbon (PAH) consisting of three benzene rings derived from coal-tar, is the simplest tricyclic aromatic hydrocarbon. It is on the EPA's priority pollutant list. It is primarily used as an intermediate in the production of dyes, smoke sc...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/8418
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Core clock suppression, aryl hydrocarbon receptor (AhR) binding, Disruption of circadian clock, Interferes with CLOCK–BMAL1
Цели: CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 223 | Benz[a]anthracene
FDA: NULL
Описание: Benz[a]anthracene is a crystalline, aromatic hydrocarbon consisting of four fused benzene rings, produced by incomplete combustion of organic matter. Benz(a)anthracene is primarily found in gasoline and diesel exhaust, tobacco and cigarette smoke, coal tar and coal tar pitch, coal combustion emis...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5954
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Interferes with CLOCK–BMAL1, aryl hydrocarbon receptor (AhR) binding, Disruption of circadian clock
Цели: CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406)
------------------------------------------------------------

ID: 224 | Dibenzopyrene
FDA: none
Описание: Dibenzo (a,l) pyrene is a yellowish-reddish, carcinogenic aromatic hydrocarbon consisting of six fused rings and produced by the incomplete combustion of organic matter. Dibenzo[a,e]pyrene is primarily found in coal gasification products, cigarette smoke and fossil fuels. This substance is used o...
PubChem: https://pubchem.ncbi.nlm.nih.gov/#query=Dibenzopyrene
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Interferes with CLOCK–BMAL1, Disruption of circadian clock, Core clock suppression, Targets BMAL1–CLOCK DNA-binding activity, aryl hydrocarbon receptor (AhR) binding
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 225 | Benzo[k]fluoranthene
FDA: none
Описание: Benzo[k]fluoranthene is a pale yellow aromatic hydrocarbon consisting of five fused rings and is produced by the incomplete combustion of organic matter. Benzo(k)fluoranthene is primarily found in gasoline exhaust, cigarette smoke, coal tar, coal and oil combustion emissions, lubricating oils, us...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9158
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Circadian disruption via core clock gene targeting in animals (PAH exposure model)
Механизмы: Disruption of circadian clock, Interferes with CLOCK–BMAL1, Targets BMAL1–CLOCK DNA-binding activity, Bmal1, aryl hydrocarbon receptor (AhR) binding
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 226 | Chrysene
FDA: none
Описание: Chrysene can cause cancer according to The Environmental Protection Agency (EPA). Chrysene appears as a crystalline solid. Denser than water and insoluble in water. The primary hazard is the threat to the environment. Immediate steps should be taken to limit spread to the environment. Toxic by in...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9171
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Circadian disruption via core clock targeting in mammals
Механизмы: Disruption of circadian clock, Interferes with CLOCK–BMAL1, Targets BMAL1–CLOCK DNA-binding activity, Bmal1, modulation of nuclear receptor signaling pathways
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 227 | Benzo[b]fluoranthene
FDA: NULL
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9153
KEGG: NULL
Классы: Chronodisruptor
Механизмы: Disruption of circadian clock, Interferes with CLOCK–BMAL1, Targets BMAL1–CLOCK DNA-binding activity, Bmal1, aryl hydrocarbon receptor (AhR) binding
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Schmitt, E. E., Barhoumi, R., Metz, R. P., & Porter, W. W. (2017). Circadian Regulation of Benzo[a]Pyrene Metabolism and DNA Adduct Formation in Breast Cells and the Mouse Mammary Gland. Molecular Pharmacology, 91(3), 178–188.: https://pmc.ncbi.nlm.nih.gov/articles/PMC5325081/
------------------------------------------------------------

ID: 228 | Dibenzo[a,h]anthracene
FDA: none
Описание: Dibenz[a,h]anthracene can cause cancer according to an independent committee of scientific and health experts. Disrupts circadian rhtyhms targeting core clock. Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5889
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Circadian disruption via core clock interference (in mammals)
Механизмы: Interferes with CLOCK–BMAL1, aryl hydrocarbon receptor (AhR) binding, Bmal1, Disruption of circadian clock
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 229 | BENZO(ghi)PERYLENE
FDA: NULL
Описание: Disrupts circadian rhtyhms targeting core clock. Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9117
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Circadian rhythm disruption in mammals
Механизмы: Interferes with CLOCK–BMAL1, aryl hydrocarbon receptor (AhR) binding, Disruption of circadian clock
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 230 | Indeno[1,2,3-c,d]pyrene
FDA: none
Описание: Indeno[1,2,3-cd]pyrene can cause cancer according to an independent committee of scientific and health experts. Disrupts circadian rhtyhms targeting core clock. Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9131
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Circadian rhythm disruption in mammals
Механизмы: aryl hydrocarbon receptor (AhR) binding, Disruption of circadian clock
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Koh, Y.C. and Pan, M.H., 2024. Food-Borne Polycyclic Aromatic Hydrocarbons and Circadian Disruption. ACS omega, 9(29), pp.31298-31312.: https://pubs.acs.org/doi/10.1021/acsomega.4c04120
------------------------------------------------------------

ID: 231 | KK-S6
FDA: none
Описание: Poorly studied core clock modulator. KK-S6 works by targeting specific molecular components of the circadian clock. It is believed to interact with key proteins involved in the regulation of circadian rhythms, such as CLOCK, BMAL1, PER, and CRY. By modulating the expression and activity of these ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/171378887
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: BMAL1 expression modulation, Bmal1, Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Huang, S., Jiao, X., Lu, D., Pei, X., Qi, D. and Li, Z., 2020. Recent advances in modulators of circadian rhythms: an update and perspective. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), pp.1267-1286.: https://pmc.ncbi.nlm.nih.gov/articles/PMC7717701/
------------------------------------------------------------

ID: 232 | GSK4112
FDA: none
Описание: GSK4112 is a Small Molecule Chemical Probe for the Cell Biology of the Nuclear Heme Receptor Rev-erbα. Grant, D., Yin, L., Collins, J.L., Parks, D.J., Orband-Miller, L.A., Wisely, G.B., Joshi, S., Lazar, M.A., Willson, T.M. and Zuercher, W.J., 2010. GSK4112, a small molecule chemical probe for ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/50905018#section=Structures
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Antagonist of Rev-Erb nuclear receptors
Цели: REV-ERBα (https://www.rcsb.org/structure/4n73)
Статьи: Grant, D., Yin, L., Collins, J.L., Parks, D.J., Orband-Miller, L.A., Wisely, G.B., Joshi, S., Lazar, M.A., Willson, T.M. and Zuercher, W.J., 2010. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. ACS chemical biology, 5(10), pp.925-932.: https://pubmed.ncbi.nlm.nih.gov/20677822/
------------------------------------------------------------

ID: 233 | SR9009
FDA: not approved
Описание: SR9009 is known as a synthetic agonist for the REV-ERB nuclear receptors, which play a crucial role in regulating the circadian clock. The circadian clock is a biological system that controls various physiological processes, including sleep-wake cycles, metabolism, and hormone secretion. SR9009 h...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/57394020
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Phase stabilization and circadian gene modulation in mice
Механизмы: Agonist REV-ERB alpha
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864), REV-ERBα (https://www.rcsb.org/structure/4n73)
Статьи: Solt, L.A., et al, 2012. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature, 485(7396), pp.62-68.: https://pubmed.ncbi.nlm.nih.gov/22460951/, Yang, M.Y., Lin, H.Y.H., Chen, Y.Y.M., Hu, M.L., Chen, I.Y. and Yang, C.H., 2025. Chronic low-dose REV-ERBs agonist SR9009 mitigates constant light-induced weight gain and insulin resistance via adipogenesis modulation. Biomedical Journal, p.100830.: https://pubmed.ncbi.nlm.nih.gov/39800061/
------------------------------------------------------------

ID: 234 | SR9011
FDA: none
Описание: SR9011 is a research compound developed by Professor Thomas Burris of Scripps as an agonist of the Rev-ErbAα receptor, with a focus on regulating circadian rhythms and metabolic processes5. It is often used in sports and fitness for its potential to enhance metabolic rates, aid in fat loss, and i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/57394021
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Agonist REV-ERB alpha
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864), REV-ERBα (https://www.rcsb.org/structure/4n73), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Solt, L.A., et al, 2012. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature, 485(7396), pp.62-68.: https://pubmed.ncbi.nlm.nih.gov/22460951/
------------------------------------------------------------

ID: 235 | Pterostilbene
FDA: Not approved
Описание: Pterostilbene (PTE) can affect the circadian clock by ameliorating circadian misalignment and mitochondrial dysfunction12. Studies show PTE can restore rhythms of AMP-activated protein kinase (AMPK) phosphorylation activity, silent information regulator 1 (SIRT1) deacetylation activity, and SIRT1...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5281727
KEGG: NULL
Классы: chronobiotic
Механизмы: SIRT1-mediated peroxisome proliferator-activated receptor coactivator 1α (PGC-1α) deacetylation in sleep-restricted mice, BMAL1 expression modulation, de-repressing BMAL1, Core clock modulation, BMAL1 expression modulation, Activation of CLOCK/Bmal1 mediated transcription, Bmal1
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Liu, Y., Lang, H., Zhou, M., Huang, L., Hui, S., Wang, X., Chen, K. and Mi, M., 2020. The preventive effects of pterostilbene on the exercise intolerance and circadian misalignment of mice subjected to sleep restriction. Molecular Nutrition & Food Research, 64(11), p.1900991.: https://onlinelibrary.wiley.com/doi/abs/10.1002/mnfr.201900991, Zhang, J., Chang, M., Wang, X., Zhou, X., Bai, Q., Lang, H., Zhang, Q., Yi, L., Mi, M. and Chen, K., 2024. Pterostilbene targets the molecular oscillator RORγ to restore circadian rhythm oscillation and protect against sleep restriction induced metabolic disorders. Phytomedicine, 125, p.155327.: https://www.sciencedirect.com/science/article/abs/pii/S0944711323006852
------------------------------------------------------------

ID: 236 | BIBO 3304 trifluoroacetate
FDA: none
Описание: BIBO 3304 trifluoroacetate functions as a selective antagonist of the Y1 receptor, which is one of the receptor subtypes for neuropeptide Y (NPY). NPY is a neurotransmitter involved in various physiological processes, including the regulation of circadian rhythms. By blocking the Y1 receptor, BIB...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5311021
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Phase shift via Y1 receptor antagonism in rodents
Механизмы: Neuropeptide Y1 receptor binding
Цели: Neuropeptide Y Y1 receptor (https://www.rcsb.org/structure/7X9A)
Статьи: Cohen, S., Vainer, E., Matar, M.A., Kozlovsky, N., Kaplan, Z., Zohar, J., Mathé, A.A. and Cohen, H., 2015. Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times. Neuropsychopharmacology, 40(3), pp.774-790.: https://pubmed.ncbi.nlm.nih.gov/25241802/
------------------------------------------------------------

ID: 237 | BIBP3226
FDA: Not approved
Описание: BIBP-3226 acts as a competitive antagonist at NPY Y1 receptors, blocking the effects of NPY, a neuropeptide involved in stress responses, appetite regulation, and circadian rhythm modulation. NPY is known to interact with the suprachiasmatic nucleus (SCN), the brain's master circadian clock, and ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5311023
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Механизмы: Neuropeptide Y1 receptor binding
Цели: Neuropeptide Y Y1 receptor (https://www.rcsb.org/structure/7X9A)
Статьи: Sautel, M., Rudolf, K., Wittneben, H., Herzog, H., Martinez, R., Munoz, M., Eberlein, W., Engel, W., Walker, P. and Beck-Sickinger, A.G., 1996. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Molecular pharmacology, 50(2), pp.285-292.: https://pubmed.ncbi.nlm.nih.gov/8700135/
------------------------------------------------------------

ID: 238 | Nobiletin
FDA: Not approved
Описание: Nobiletin, a natural small molecule, has emerged as a modulator of circadian rhythms with therapeutic implications across various biological systems. Its effects on circadian rhythms are mediated through the enhancement of clock machinery, particularly via activation of Retinoid Acid-related Orph...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/72344
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: prolonged period, increased amplitude, and phase modulation
Механизмы: ROR, PER gene exspression modulation, Activation of CLOCK/Bmal1 mediated transcription, Core clock modulation
Цели: RORA (https://www.ncbi.nlm.nih.gov/gene/6095)
Статьи: Ryan, C., Tahara, Y., Haraguchi, A., Lu, Y. and Shibata, S., 2024. Nobiletin stimulates adrenal hormones and modulates the circadian clock in mice. Nutrients, 16(10), p.1491.: https://www.mdpi.com/2072-6643/16/10/1491#:~:text=In%20vitro%20screening%20assays%20have,modulation%20%5B7%2C8%5D., Neba Ambe, G.N., Breda, C., Bhambra, A.S. and Arroo, R.R., 2022. Effect of the citrus flavone nobiletin on circadian rhythms and metabolic syndrome. Molecules, 27(22), p.7727.: https://pmc.ncbi.nlm.nih.gov/articles/PMC9695244/, Lellupitiyage Don, S.S., Robertson, K.L., Lin, H.H., Labriola, C., Harrington, M.E., Taylor, S.R. and Farkas, M.E., 2020. Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner. PLoS One, 15(7), p.e0236315.: https://scholarworks.umass.edu/server/api/core/bitstreams/5bcf403d-add2-4a6b-aacb-47284751548a/content, Martchenko, A., Biancolin, A.D., Martchenko, S.E. and Brubaker, P.L., 2022. Nobiletin ameliorates high fat-induced disruptions in rhythmic glucagon-like peptide-1 secretion. Scientific Reports, 12(1), p.7271.: https://www.nature.com/articles/s41598-022-11223-7, Lellupitiyage Don, S.S., Robertson, K.L., Lin, H.H., Labriola, C., Harrington, M.E., Taylor, S.R. and Farkas, M.E., 2020. Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner. PLoS One, 15(7), p.e0236315.: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236315
------------------------------------------------------------

ID: 239 | Neoruscogenin
FDA: none
Описание: Neoruscogenin, a member of the steroidal sapogenin family, has been identified as a potent and high-affinity agonist for the nuclear receptor RORα (retinoic acid receptor-related orphan receptor alpha). RORα is a critical regulator of the circadian clock, as it modulates the expression of genes i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9910474
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA), NR1F1 (https://www.uniprot.org/uniprotkb/B6ZGS4/entry), RORA (https://www.ncbi.nlm.nih.gov/gene/6095)
Статьи: Helleboid, S., Haug, C., Lamottke, K., Zhou, Y., Wei, J., Daix, S., Cambula, L., Rigou, G., Hum, D.W. and Walczak, R., 2014. The identification of naturally occurring neoruscogenin as a bioavailable, potent, and high-affinity agonist of the nuclear receptor RORα (NR1F1). Journal of biomolecular screening, 19(3), pp.399-406.: https://www.tandfonline.com/doi/full/10.1080/09291016.2018.1498197
------------------------------------------------------------

ID: 240 | Compound 1a
FDA: none
Описание: Zhang, W., Zhang, J., Fang, L., Zhou, L., Wang, S., Xiang, Z., Li, Y., Wisely, B., Zhang, G., An, G. and Wang, Y., 2012. Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor γ (RORγ) by a class of aryl amide compounds. Molecular...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2733079
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: ROR, RORγ binding
Цели: ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Zhang, W., Zhang, J., Fang, L., Zhou, L., Wang, S., Xiang, Z., Li, Y., Wisely, B., Zhang, G., An, G. and Wang, Y., 2012. Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor γ (RORγ) by a class of aryl amide compounds. Molecular pharmacology, 82(4), pp.583-590.: https://pubmed.ncbi.nlm.nih.gov/22700697/, Trebucq, L.L., Cardama, G.A., Lorenzano Menna, P., Golombek, D.A., Chiesa, J.J. and Marpegan, L., 2021. Timing of novel drug 1A-116 to circadian rhythms improves therapeutic effects against glioblastoma. Pharmaceutics, 13(7), p.1091.: https://www.mdpi.com/1999-4923/13/7/1091
------------------------------------------------------------

ID: 241 | Digoxin
FDA: Approved
Описание: 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2724385
KEGG: https://www.kegg.jp/entry/D00298
Классы: circadian rhythm modulator
Механизмы: ROR, RORγ binding
Цели: ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Huh, J.R., Leung, M.W., Huang, P., Ryan, D.A., Krout, M.R., Malapaka, R.R., Chow, J., Manel, N., Ciofani, M., Kim, S.V. and Cuesta, A., 2011. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature, 472(7344), pp.486-490.: https://pubmed.ncbi.nlm.nih.gov/21441909/
------------------------------------------------------------

ID: 242 | Ursolic acid
FDA: Not approved
Описание: Ursolic Acid is a pentacyclic triterpenoid found in various fruits, vegetables and medicinal herbs, with a variety of potential pharmacologic activities including anti-inflammatory, antioxidative, antiviral, serum lipid-lowering, and antineoplastic activities. Upon administration, ursolic acid ma...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/64945
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Modulation of clock gene expression and metabolic rhythm regulation in liver (in mammals)
Механизмы: PTEN, ROCK, p53
Цели: ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Kojetin, D.J. and Burris, T.P., 2014. REV-ERB and ROR nuclear receptors as drug targets. Nature reviews Drug discovery, 13(3), pp.197-216.: https://www.nature.com/articles/nrd4100, Kwon, E.Y., Shin, S.K. and Choi, M.S., 2018. Ursolic acid attenuates hepatic steatosis, fibrosis, and insulin resistance by modulating the circadian rhythm pathway in diet-induced obese mice. Nutrients, 10(11), p.1719.: https://pmc.ncbi.nlm.nih.gov/articles/PMC6266464/, Zahran, E.M., Mohamad, S.A., Elsayed, M.M., Hisham, M., Maher, S.A., Abdelmohsen, U.R., Elrehany, M., Desoukey, S.Y. and Kamel, M.S., 2024. Ursolic acid inhibits NF-κB signaling and attenuates MMP-9/TIMP-1 in progressive osteoarthritis: a network pharmacology-based analysis. RSC advances, 14(26), pp.18296-18310.: https://pubs.rsc.org/en/journals/journalissues/ra#!issueid=ra015022&type=current&issnonline=2046-2069
------------------------------------------------------------

ID: 243 | Vtp-43742
FDA: Not approved
Описание: Vitae Pharmaceuticals against Psoriasis Phase I; 40 healthy subjects and 34 patients with psoriasis Evaluate safety, tolerability, PK, and PD effects of oral VTP-4374. NCT03724292 Phase I/Phase II; 48 healthy adults and 60 patients with psoriasis NCT02555709 Ribeiro, R.F., Cavadas, C. and Sil...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/118282339#section=Information-Sources
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: RORyt/RORc inhibitor
Цели: ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Ribeiro, R.F., Cavadas, C. and Silva, M.M.C., 2021. Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases. Drug Discovery Today, 26(7), pp.1620-1641.: https://www.sciencedirect.com/science/article/abs/pii/S1359644621001525#b0265, Liu, S., Liu, D., Shen, R., Li, D., Hu, Q., Yan, Y., Sun, J., Zhang, F., Wan, H., Dong, P. and Feng, J., 2021. Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis. Scientific Reports, 11(1), p.9132.: https://www.nature.com/articles/s41598-021-88492-1
------------------------------------------------------------

ID: 244 | ARN-6039
FDA: NULL
Описание: ARN-6039 is known as an inverse agonist of RORγ, primarily used for autoimmune demyelinating diseases45. RORγ is not directly mentioned in the context of circadian clock modulation in the provided search results, but RORα is discussed as part of the accessory loop in the circadian clock system, i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/117940165
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Механизмы: ROR
Цели: ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Ribeiro, R.F., Cavadas, C. and Silva, M.M.C., 2021. Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases. Drug Discovery Today, 26(7), pp.1620-1641.: https://www.sciencedirect.com/science/article/abs/pii/S1359644621001525#b0265
------------------------------------------------------------

ID: 245 | AZD-0284e
FDA: NULL
Описание: AZD0284 is a small molecule modulator targeting RORγ, a nuclear receptor involved in circadian rhythm regulation and immune responses. While primarily studied for its immunomodulatory effects, its role in circadian biology emerges through RORγ’s function in the clock system. Mechanism of Action A...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/129205086#section=Information-Sources&fullscreen=true
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Механизмы: ROR, RORγ binding
Цели: ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Ribeiro, R.F., Cavadas, C. and Silva, M.M.C., 2021. Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases. Drug Discovery Today, 26(7), pp.1620-1641.: https://www.sciencedirect.com/science/article/abs/pii/S1359644621001525#b0265
------------------------------------------------------------

ID: 246 | Cintirorgon
FDA: Not approved
Описание: Cintirorgon is an orally bioavailable agonist of retinoic acid-related orphan receptor gamma (RORg), with potential immunomodulatory and antineoplastic activities. Upon oral administration of cintirorgon, this agent selectively binds to the nuclear receptor transcription factor RORg, forming a re...
PubChem: https://pubchem.ncbi.nlm.nih.gov/#query=LYC-55716
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Эффекты: Circadian modulation via RORγ activation in human immune cells
Механизмы: ROR, RORγ binding
Цели: RORB (https://www.ncbi.nlm.nih.gov/gene/6096), ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Mahalingam, D., Wang, J.S., Hamilton, E.P., Sarantopoulos, J., Nemunaitis, J., Weems, G., Carter, L., Hu, X., Schreeder, M. and Wilkins, H.J., 2019. Phase 1 open-label, multicenter study of first-in-class RORγ agonist LYC-55716 (cintirorgon): safety, tolerability, and preliminary evidence of antitumor activity. Clinical Cancer Research, 25(12), pp.3508-3516.: https://aacrjournals.org/clincancerres/article/25/12/3508/81598/Phase-1-Open-Label-Multicenter-Study-of-First-in
------------------------------------------------------------

ID: 247 | Gsk2981278
FDA: none
Описание: GSK-2981278 is under investigation in clinical trial NCT03004846 (A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis). GSK2981278 is a small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication. Amaudrut, J., Argiriadi, M.A., Barth, M., Breinl...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/89875987
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Механизмы: ROR, RORγ binding
Цели: ROR gamma (https://www.rcsb.org/structure/5X8Q)
Статьи: Amaudrut, J., Argiriadi, M.A., Barth, M., Breinlinger, E.C., Bressac, D., Broqua, P., Calderwood, D.J., Chatar, M., Cusack, K.P., Gauld, S.B. and Jacquet, S., 2019. Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters, 29(14), pp.1799-1806.: https://www.sciencedirect.com/science/article/abs/pii/S0960894X19303014
------------------------------------------------------------

ID: 248 | RN-1734
FDA: Not approved
Описание: RN‑1734 is a benzothiazole-derived compound best known as a selective antagonist of the TRPV4 channel. By inhibiting TRPV4, RN‑1734 reduces Ca²⁺ influx, which in turn can alter the activity of signaling cascades that control the expression of AANAT. Since AANAT is pivotal for melatonin production...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3601086
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Affects melatonin synthsis
Механизмы: This inhibition of TRPV4-mediated signaling can affect downstream pathways involved in the regulation of the circadian clock.
Цели: TRPV4 Channel (https://en.wikipedia.org/wiki/TRPV4)
Статьи: Alkozi, H.A., de Lara, M.J.P. and Pintor, J., 2017. Melatonin synthesis in the human ciliary body triggered by TRPV4 activation: Involvement of AANAT phosphorylation. Experimental eye research, 162, pp.1-8.: https://www.sciencedirect.com/science/article/abs/pii/S0014483517300684
------------------------------------------------------------

ID: 249 | HC067047
FDA: Not approved
Описание: HC067047 is a potent and selective antagonist of the transient receptor potential vanilloid 4 (TRPV4) channel. TRPV4 plays a crucial role in mediating Ca²⁺ entry in response to mechanical, osmotic, and thermal stimuli. In the eye, activation of TRPV4 in ciliary body epithelial cells triggers the ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2742550#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: potential circadian entrainment via TRPV4 in eye (mammals)
Механизмы: This inhibition of TRPV4-mediated signaling can affect downstream pathways involved in the regulation of the circadian clock.
Цели: TRPV4 Channel (https://en.wikipedia.org/wiki/TRPV4)
Статьи: Li, W., Xu, Y., Liu, Z., Shi, M., Zhang, Y., Deng, Y., Zhong, X., Chen, L., He, J., Zeng, J. and Luo, M., 2021. TRPV4 inhibitor HC067047 produces antidepressant-like effect in LPS-induced depression mouse model. Neuropharmacology, 201, p.108834.: https://www.sciencedirect.com/science/article/abs/pii/S0028390821003890
------------------------------------------------------------

ID: 250 | Longdaysin
FDA: none
Описание: It significantly lengthens the circadian period by inhibiting three key protein kinases: Casein Kinase I delta (CKIδ), Casein Kinase I alpha (CKIα), and ERK2. These kinases are critical in regulating the phosphorylation and degradation of the circadian clock protein PER1, which plays a central ro...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/49830252
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Inhibits casein kinase 1 delta (CKIδ) activity
Цели: CKI delta (https://www.rcsb.org/structure/1CKI)
Статьи: Hirota, T., Lee, J.W., Lewis, W.G., Zhang, E.E., Breton, G., Liu, X., Garcia, M., Peters, E.C., Etchegaray, J.P., Traver, D. and Schultz, P.G., 2010. High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIα as a clock regulatory kinase. PLoS biology, 8(12), p.e1000559.: https://pubmed.ncbi.nlm.nih.gov/21179498/
------------------------------------------------------------

ID: 251 | BRD1652
FDA: Not approved
Описание: BRD1652 is a chiral pyrrolidine-based compound that exhibits high potency and exceptional selectivity for GSK-3β. Unlike broader inhibitors such as CHIR99021, BRD1652 minimizes off-target kinase inhibition, making it a valuable tool for dissecting GSK-3β’s specific role in circadian regulation. B...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/136237017#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Period shortening in mammalian cells
Механизмы: Selective GSK-3β Inhibition:, Circadian Clock Impact
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3)
Статьи: Wagner, F.F., Bishop, J.A., Gale, J.P., Shi, X., Walk, M., Ketterman, J., Patnaik, D., Barker, D., Walpita, D., Campbell, A.J. and Nguyen, S., 2016. Inhibitors of glycogen synthase kinase 3 with exquisite kinome-wide selectivity and their functional effects. ACS Chemical Biology, 11(7), pp.1952-1963.: https://pubs.acs.org/doi/abs/10.1021/acschembio.6b00306
------------------------------------------------------------

ID: 252 | DK325
FDA: NULL
Описание: DK325 is a photocleavable derivative designed to modulate the circadian clock by controlling the activity of Casein Kinase I (CKI), a key regulator of the circadian rhythm. It is based on longdaysin, a potent CKI inhibitor, but its activity is suppressed until it is exposed to light, allowing for...
PubChem: NULL
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Inhibits CKIδ
Цели: CKI delta (https://www.rcsb.org/structure/1CKI)
------------------------------------------------------------

ID: 253 | PF-4800567
FDA: Not approved
Описание: PF-4800567 is a pyrazolopyrimidine-based compound that selectively inhibits CK1ε. It is used primarily in circadian rhythm studies to dissect the individual roles of CK1 isoforms. Although inhibition of CK1ε has only a slight effect on the circadian period in wild-type cells, it has a pronounced ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/53472153#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: CK1 Inhibition
Цели: CK1δ (https://en.wikipedia.org/wiki/CSNK1D)
------------------------------------------------------------

ID: 254 | DK359
FDA: none
Описание: DK359 is a photocaged derivative of longdaysin, a purine-based inhibitor of CKIα and CKIδ, which are enzymes involved in the regulation of the circadian clock. DK359 is designed to have no effect on the circadian period in the dark, but upon exposure to light, it releases longdaysin, leading to a...
PubChem: NULL
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Inhibits CKIδ, Inhibits casein kinase 1 delta (CKIδ) activity
Цели: CKI delta (https://www.rcsb.org/structure/1CKI)
Статьи: Kolarski, D., Sugiyama, A., Breton, G., Rakers, C., Ono, D., Schulte, A., Tama, F., Itami, K., Szymanski, W., Hirota, T. and Feringa, B.L., 2019. Controlling the circadian clock with high temporal resolution through photodosing. Journal of the American Chemical Society, 141(40), pp.15784-15791.: https://pubs.acs.org/doi/10.1021/jacs.9b05445?src=getftr
------------------------------------------------------------

ID: 255 | CX-4945
FDA: Not approved
Описание: PF‑4800567 is a selective, ATP‑competitive inhibitor of the epsilon isoform of casein kinase 1 (CK1ε). Belonging to the pyrazolopyrimidine family, this compound has been developed as a research tool for dissecting CK1ε‑dependent pathways, particularly in studies of circadian rhythm regulation. S...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/24748573#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Binds to the ATP‑binding site of CK2
Цели: CK1δ (https://en.wikipedia.org/wiki/CSNK1D)
Статьи: Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S.E., Bliesath, J., Omori, M., Huser, N., Ho, C. and Proffitt, C., 2010. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer research, 70(24), pp.10288-10298.: https://aacrjournals.org/cancerres/article/70/24/10288/561243/CX-4945-an-Orally-Bioavailable-Selective-Inhibitor
------------------------------------------------------------

ID: 256 | LH846
FDA: NULL
Описание: A high-throughput cell-based screen identified a benzothiazole analogue, LH846, which induces period lengthening of the circadian rhythm. Affinity chromatography coupled with mass spectrometry and genomic analysis identified protein kinase CKIδ as the biological target of LH846. Lee, J.W., Hirot...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/851474
KEGG: NULL
Классы: circadian rhythm modulator
Механизмы: Inhibits CKIδ, Inhibits casein kinase 1 delta (CKIδ) activity
Цели: CKI delta (https://www.rcsb.org/structure/1CKI)
Статьи: Lee, J.W., Hirota, T., Peters, E.C., Garcia, M., Gonzalez, R., Cho, C.Y., Wu, X., Schultz, P.G. and Kay, S.A., 2011. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angewandte Chemie (International ed. in English), 50(45), p.10608.: https://pubmed.ncbi.nlm.nih.gov/21954091/
------------------------------------------------------------

ID: 257 | 4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide
FDA: none
Описание: Activation of TGF-β/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts. These results indicate that ALK–SMAD3–Dec1 signalling provides an input pathway in the mammalian molecular clock. Activation of activin receptor-like kinase (ALK), triggered by TGF-β, ac...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4521392
KEGG: NULL
Классы: circadian rhythm modulator, Potential chronodisruptor
Эффекты: Phase shift via Dec1 induction in mammalian cells
Механизмы: Activation of activin receptor-like kinase (ALK), by an immediate-early induction of Dec1
Цели: Dec1 gene expression (https://pmc.ncbi.nlm.nih.gov/articles/PMC2423136/)
Статьи: Kon, N., Hirota, T., Kawamoto, T., Kato, Y., Tsubota, T. and Fukada, Y., 2008. Activation of TGF-β/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts. Nature cell biology, 10(12), pp.1463-1469.: https://pubmed.ncbi.nlm.nih.gov/19029909/
------------------------------------------------------------

ID: 258 | Li (Lithium Carbonate)
FDA: Approved
Описание: Lithium is known to affect circadian rhythms across various organisms, including humans and animals. Here's a summary of its effects: Lithium has been shown to lengthen the circadian period in several organisms, including humans, under certain conditions. This effect is observed in both constant ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11125
KEGG: https://www.genome.jp/dbget-bin/www_bget?dr:D00801
Классы: circadian rhythm modulator
Механизмы: inhibits glycogen synthase kinase-3β (GSK-3β)
Цели: CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864), mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), CRY1-PER2 complex (https://www.rcsb.org/structure/6of7), CRY1 (https://www.rcsb.org/structure/4ct0)
Статьи: Rohr, K.E. and McCarthy, M.J., 2022. The impact of lithium on circadian rhythms and implications for bipolar disorder pharmacotherapy. Neuroscience letters, 786, p.136772.: https://pubmed.ncbi.nlm.nih.gov/35798199/
------------------------------------------------------------

ID: 259 | PF670462
FDA: NULL
Описание: PF-670462 is a hydrochloride salt resulting from the formal reaction of 3-[(3-chlorophenoxy)methyl]-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine with 2 mol eq. of hydrogen chloride. It is a selective inhibitor of the delta- and epsilon-isoforms of casein kinase 1 (CK1delta and...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/51049607
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Механизмы: Non-specific kinase inhibitor, Inhibits CK1δ, Inhibits casein kinase 1 delta (CKIδ) activity
Цели: CKI delta (https://www.rcsb.org/structure/1CKI)
Статьи: Wagner, P.M., Fornasier, S.J. and Guido, M.E., 2024. Pharmacological modulation of the cytosolic oscillator affects glioblastoma cell biology. Cellular and Molecular Neurobiology, 44(1), p.51.: https://link.springer.com/article/10.1007/s10571-024-01485-2
------------------------------------------------------------

ID: 260 | 1-Azakenpaullone
FDA: none
Описание: 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase 3β (GSK3β), which plays a role in modulating the circadian clock. GSK3β can phosphorylate key circadian proteins such as CLOCK, PER, REV-ERB, and CRY, influencing their activity and stability. By inhibiting GSK3β, 1-azakenpaull...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6538897
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Period shortening in mammalian cells
Механизмы: Highly selective, ATP-competitive inhibition of GSK-3 (both α and β isoforms), GSK‑3 Inhibition, Selective GSK-3β Inhibition:, inhibits glycogen synthase kinase-3β (GSK-3β)
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3)
Статьи: Miller, S. and Hirota, T., 2020. Pharmacological interventions to circadian clocks and their molecular bases. Journal of molecular biology, 432(12), pp.3498-3514.: https://pubmed.ncbi.nlm.nih.gov/31931005/
------------------------------------------------------------

ID: 261 | Indirubin (Couroupitine B)
FDA: none
Описание: Indirubin derivatives have been shown to alter the circadian period in cell cultures. These compounds can modulate the expression of circadian genes, potentially affecting the timing and amplitude of circadian oscillations. Indirubins are known to inhibit glycogen synthase kinase-3 (GSK-3), an en...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/10177
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: period shortening of the mammalian circadian clock by specific inhibition of GSK-3β
Механизмы: Highly selective, ATP-competitive inhibition of GSK-3 (both α and β isoforms), Selective GSK-3β Inhibition:, inhibits glycogen synthase kinase-3β (GSK-3β), Dual inhibitor of Cyclin-dependent kinases (CDK) and Glycogen Synthase Kinase-3 (GSK-3), GSK‑3 Inhibition
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3)
Статьи: Hirota, T., Lewis, W.G., Liu, A.C., Lee, J.W., Schultz, P.G. and Kay, S.A., 2008. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3β. Proceedings of the National Academy of Sciences, 105(52), pp.20746-20751.: https://www.pnas.org/doi/abs/10.1073/pnas.0811410106
------------------------------------------------------------

ID: 262 | CHIR99021 (Laduviglusib)
FDA: none
Описание: CHIR99021, also known as laduviglusib or CT99021, is a potent and selective inhibitor of glycogen synthase kinase-3 (GSK3), targeting both GSK3α and GSK3β isoforms. It has IC50 values of 10 nM for GSK3α and 6.7 nM for GSK3β, making it highly effective in modulating pathways regulated by these enz...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9956119
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Per2 disruption affected both GBM migration and cell cycle progression., disrupts glioblastoma clock
Механизмы: Highly selective, ATP-competitive inhibition of GSK-3 (both α and β isoforms), GSK‑3 Inhibition, Selective GSK-3β Inhibition:, inhibits glycogen synthase kinase-3β (GSK-3β)
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3)
Статьи: Wagner, P.M., Fornasier, S.J. and Guido, M.E., 2024. Pharmacological modulation of the cytosolic oscillator affects glioblastoma cell biology. Cellular and Molecular Neurobiology, 44(1), p.51.: https://link.springer.com/article/10.1007/s10571-024-01485-2
------------------------------------------------------------

ID: 263 | Bifidobacterium breve CCFM1025
FDA: NULL
Описание: Bifidobacterium breve CCFM1025 has been shown to improve circadian rhythms, particularly in the context of sleep deprivation. Studies indicate that this probiotic strain modulates the gut microbiota, which in turn influences the production of key metabolites involved in regulating sleep function....
PubChem: NULL
KEGG: NULL
Классы: Probiotic
Механизмы: Unknown metabolites
Цели: GUT MICROBIOTA (https://www.sciencedirect.com/science/article/pii/S2213453024001691)
------------------------------------------------------------

ID: 264 | OMNi-BiOTiC® Stress Repair
FDA: Not approved
Описание: The composition of B. bifidum W23, B. lactis W51, B. lactis W52) and lactobacilli (L. acidophilus W22, L. casei W56, L. paracasei W20, L. plantarum W62, L. salivarius W24, L. lactis W19) The gene expression levels of the clock gene CLOCK were significantly altered only in individuals receiving p...
PubChem: NULL
KEGG: NULL
Классы: Probiotic, chronobiotic
Эффекты: restores normal circadian rhythms
Механизмы: Circadian Clock Impact, Core clock modulation, TIMELESS, Activation of CLOCK/Bmal1 mediated transcription, Bmal1
Цели: NPAS2 (https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPAS2), TIMELESS (https://www.ncbi.nlm.nih.gov/gene/8914), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Kreuzer, K., Birkl-Toeglhofer, A.M., Haybaeck, J., Reiter, A., Dalkner, N., Fellendorf, F.T., Maget, A., Platzer, M., Seidl, M., Mendel, L.M. and Lenger, M., 2024. PROVIT-CLOCK: A Potential Influence of Probiotics and Vitamin B7 Add-On Treatment and Metabolites on Clock Gene Expression in Major Depression. Neuropsychobiology, 83(3-4), pp.135-151.: https://karger.com/nps/article/83/3-4/135/907513/PROVIT-CLOCK-A-Potential-Influence-of-Probiotics
------------------------------------------------------------

ID: 265 | Lactobacillus delbrueckii
FDA: none
Описание: Dietary L. delbrueckii affected ileal bacterial composition at the genus level, including Lactobacillus, Enterococcus, Leptotrichia, Pediococcus, Bifidobacte, Cel-lulosilyticum, Desulfomicrobium, Sharpea, Eubacterium, Propionivibrio, and Aerococcus, which were associated with membrane transport, ...
PubChem: NULL
KEGG: NULL
Классы: Probiotic, chronobiotic
Эффекты: restores normal circadian rhythms, improves circadian rhythms in pigs
Механизмы: Unknown metabolites, protect, Circadian Clock Impact
Цели: GUT MICROBIOTA (https://www.sciencedirect.com/science/article/pii/S2213453024001691)
Статьи: Luo, W., Yin, Z., Zhang, M., Huang, X. and Yin, J., 2024. Dietary Lactobacillus delbrueckii Affects Ileal Bacterial Composition and Circadian Rhythms in Pigs. Animals, 14(3), p.412.: https://www.mdpi.com/2076-2615/14/3/412
------------------------------------------------------------

ID: 266 | Urolithin A
FDA: Not approved
Описание: Urolithin A (UA), a kind of intestinal microbial metabolite, was selected in this study. Results showed UA influenced on the expression rhythm of the clock genes BMAL1 and PER2 in intestinal epithelial cells. Furthermore, the study investigated the effects of UA on the expression rhythms of clock...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5488186
KEGG: NULL
Классы: chronobiotic, prebiotic
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, BMAL1 expression modulation, Activation of CLOCK/Bmal1 mediated transcription, Bmal1
Цели: GUT MICROBIOTA (https://www.sciencedirect.com/science/article/pii/S2213453024001691), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Du, Y., Chen, X., Kajiwara, S. and Orihara, K., 2024. Effect of Urolithin A on the Improvement of Circadian Rhythm Dysregulation in Intestinal Barrier Induced by Inflammation. Nutrients, 16(14), p.2263.: https://www.mdpi.com/2072-6643/16/14/2263
------------------------------------------------------------

ID: 267 | Griseofulvin
FDA: Approved
Описание: Griseofulvin, a compound historically used as an antifungal agent, has been shown to influence circadian rhythms in animal models, particularly in mice. Studies indicate that griseofulvin induces impairments in heme biosynthesis, leading to alterations in circadian rhythms. Specifically, mice fed...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/441140
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Эффекты: ~0.3 h shortening of the period of circadian T(b) rhythms in mice kept under conditions of constant darkness (P < 0.01)
Механизмы: Affects heme, Affects heme biosynthesis, Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), Heme (https://www.rcsb.org/structure/1n45)
Статьи: Iwadate, R., Satoh, Y., Watanabe, Y., Kawai, H., Kudo, N., Kawashima, Y., Mashino, T. and Mitsumoto, A., 2012. Impairment of heme biosynthesis induces short circadian period in body temperature rhythms in mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 303(1), pp.R8-R18.: https://pubmed.ncbi.nlm.nih.gov/22552790/
------------------------------------------------------------

ID: 268 | HTL‑6641
FDA: Not approved
Описание: HTL‑6641 is a pyrazolothiadiazinone‑based compound featuring a unique central thiadiazin-3-one 1,1‑dioxide core. It is decorated with a 5,6‑dimethoxypyridin‑3‑yl group and a (2,4,6‑trifluorophenyl)methyl substituent. HTL‑6641 acts as a dual orexin receptor antagonist (DORA) and has been instrumen...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/72707143#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: primarily affect circadian rhythms by promoting sleep, particularly reducing wakefulness after sleep onset and improving sleep maintenance
Механизмы: Dopamine receptor antagonist, Orexin Receptor Antagonism
Цели: orexin receptor subtypes (OX1 and OX2) (https://en.wikipedia.org/wiki/Orexin_receptor#:~:text=There%20are%20two%20variants%2C%20OX,gene%20(HCRTR1%2C%20HCRTR2).&text=Both%20orexin%20receptors%20exhibit%20a,increase%20in%20intracellular%20cal)
Статьи: Christopher, J.A., Aves, S.J., Brown, J., Errey, J.C., Klair, S.S., Langmead, C.J., Mace, O.J., Mould, R., Patel, J.C., Tehan, B.G. and Zhukov, A., 2015. Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties. MedChemComm, 6(5), pp.947-955.: https://pubs.rsc.org/en/content/articlelanding/2015/md/c5md00027k
------------------------------------------------------------

ID: 269 | TU-892 (5-(3,4-dichlorophenyl)-1-phenyl-1,7-dihydro-4H-pyrazolo[3,4-d] pyrimidine-4,6(5H)-dione)
FDA: none
Описание: TU-892 as a period-lengthening molecule. Gene expression analyses showed that TU-892 treatment upregulates CIRCADIAN CLOCK–ASSOCIATED 1 (CCA1) mRNA expression. TU-892 treatment reduced the amount of PRR7 protein, a transcriptional repressor of CCA1. Other PRR proteins including TIMING OF CAB EXPR...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/135444961
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: reduces the levels of PRR7 protein in Arabidopsis
Механизмы: PRR
Цели: CCA1 (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=819296)
Статьи: Uehara, T.N., Takao, S., Matsuo, H., Saito, A.N., Ota, E., Ono, A., Itami, K., Kinoshita, T., Yamashino, T., Yamaguchi, J. and Nakamichi, N., 2023. A Small-Molecule Modulator Affecting the Clock-Associated PSEUDO-RESPONSE REGULATOR 7 Amount. Plant And Cell Physiology, 64(11), pp.1397-1406.: https://pubmed.ncbi.nlm.nih.gov/37705303/
------------------------------------------------------------

ID: 270 | SB203580 (152121-47-6; SB 203580; SB-203580; SB203580; Adezmapimod)
FDA: NULL
Описание: 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole has been reported in Annulohypoxylon truncatum, Eleutherococcus divaricatus, and other organisms with data available. SB203580, a potent p38 MAPK inhibitor, has been shown to affect circadian rhythms. Specifically, in chick...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/176155
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Механизмы: p38 signaling, Core clock modulation
Цели: p38 kinase (https://www.rcsb.org/structure/5uoj)
------------------------------------------------------------

ID: 271 | ACT‑462206
FDA: Not approved.
Описание: ACT‑462206 is a proline sulfonamide-based, brain‑penetrant dual orexin receptor antagonist. It effectively blocks both OX₁ and OX₂ receptors to modulate the sleep–wake cycle. In preclinical studies, ACT‑462206 has shown the ability to decrease wakefulness and enhance sleep quality while preservin...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/40924317#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: Orexin Receptor Blockade
Цели: orexin receptor subtypes (OX1 and OX2) (https://en.wikipedia.org/wiki/Orexin_receptor#:~:text=There%20are%20two%20variants%2C%20OX,gene%20(HCRTR1%2C%20HCRTR2).&text=Both%20orexin%20receptors%20exhibit%20a,increase%20in%20intracellular%20cal)
Статьи: Boss, C., Roch-Brisbare, C., Steiner, M.A., Treiber, A., Dietrich, H., Jenck, F., von Raumer, M., Sifferlen, T., Brotschi, C., Heidmann, B., Williams, J.T., Aissaoui, H., Siegrist, R. and Gatfield, J., 2014. Structure-activity relationship, biological, and pharmacological characterization of the proline sulfonamide ACT-462206: a potent, brain-penetrant dual orexin 1/orexin 2 receptor antagonist. ChemMedChem, 9(11), pp.2486–2496.: https://pubmed.ncbi.nlm.nih.gov/25147058/
------------------------------------------------------------

ID: 272 | GSK1059865
FDA: Not approved
Описание: GSK1059865 is a pyrazolopyrimidine-based small molecule that selectively inhibits the orexin 1 receptor. It is widely used in neuropharmacological research to dissect the specific functions of OX₁ in regulating arousal, stress, and glutamate neurotransmission. Due to its high selectivity, GSK1059...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/44463491#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: sleep-promoting effects
Механизмы: OX₁ Receptor Blockade
Цели: orexin receptor subtypes (OX1 and OX2) (https://en.wikipedia.org/wiki/Orexin_receptor#:~:text=There%20are%20two%20variants%2C%20OX,gene%20(HCRTR1%2C%20HCRTR2).&text=Both%20orexin%20receptors%20exhibit%20a,increase%20in%20intracellular%20cal)
Статьи: Aluisio, L., Fraser, I., Berdyyeva, T., Tryputsen, V., Shireman, B.T., Shoblock, J., Lovenberg, T., Dugovic, C. and Bonaventure, P., 2014. Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex. Frontiers in neuroscience, 8, p.107.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4033200/
------------------------------------------------------------

ID: 273 | SB-334867
FDA: Not approved
Описание: SB‑334867 is a naphthyridine derivative that acts as a selective antagonist of the orexin 1 receptor. It is widely used in neuropharmacological studies to investigate the role of OX₁R in modulating arousal, stress responses, and seizure activity. Preclinical research has demonstrated that SB‑3348...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6604926#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: can attenuate the sleep-promoting effects of the OX2R antagonist
Механизмы: OX₁R Antagonism
Цели: orexin receptor subtypes (OX1 and OX2) (https://en.wikipedia.org/wiki/Orexin_receptor#:~:text=There%20are%20two%20variants%2C%20OX,gene%20(HCRTR1%2C%20HCRTR2).&text=Both%20orexin%20receptors%20exhibit%20a,increase%20in%20intracellular%20cal)
Статьи: Morairty, S.R., Revel, F.G., Malherbe, P., Moreau, J.L., Valladao, D., Wettstein, J.G., Kilduff, T.S. and Borroni, E., 2012. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PloS one, 7(7), p.e39131.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3388080/
------------------------------------------------------------

ID: 274 | SB-408124
FDA: Not approved
Описание: SB‑408124 is an organohalogen quinoline derivative that selectively antagonizes the orexin 1 receptor. Although it exhibits high in vitro affinity for OX₁R—with a Ki in the low nanomolar range—its in vivo utility is compromised by poor brain penetration. SB‑408124 is used in preclinical research ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4331799
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: can attenuate the sleep-promoting effects of the OX2R antagonist
Механизмы: OX₁R Antagonism
Цели: orexin receptor subtypes (OX1 and OX2) (https://en.wikipedia.org/wiki/Orexin_receptor#:~:text=There%20are%20two%20variants%2C%20OX,gene%20(HCRTR1%2C%20HCRTR2).&text=Both%20orexin%20receptors%20exhibit%20a,increase%20in%20intracellular%20cal)
Статьи: Morairty, S.R., Revel, F.G., Malherbe, P., Moreau, J.L., Valladao, D., Wettstein, J.G., Kilduff, T.S. and Borroni, E., 2012. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PloS one, 7(7), p.e39131.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3388080/
------------------------------------------------------------

ID: 275 | TAK‑925 (Danavorexton)
FDA: Not approved
Описание: TAK‑925, also known as Danavorexton, is a non‑peptidic small‑molecule agonist of the OX₂ receptor. It has a molecular formula of C₂₁H₃₂N₂O₅S with a molecular weight of 424.6 g/mol. TAK‑925 binds within the same deep orthosteric pocket used by antagonists but stabilizes the receptor's active confo...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/130310079#section=2D-Structure
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: improve wakefulness in individuals with certain sleep disorders
Механизмы: OX₂R Activation
Цели: orexin receptor subtypes (OX1 and OX2) (https://en.wikipedia.org/wiki/Orexin_receptor#:~:text=There%20are%20two%20variants%2C%20OX,gene%20(HCRTR1%2C%20HCRTR2).&text=Both%20orexin%20receptors%20exhibit%20a,increase%20in%20intracellular%20cal)
Статьи: Yin, J., Kang, Y., McGrath, A.P., Chapman, K., Sjodt, M., Kimura, E., Okabe, A., Koike, T., Miyanohana, Y., Shimizu, Y. and Rallabandi, R., 2022. Molecular mechanism of the wake-promoting agent TAK-925. Nature communications, 13(1), p.2902.: https://pmc.ncbi.nlm.nih.gov/articles/PMC9133036/
------------------------------------------------------------

ID: 276 | Triamcinolone (acetonide)
FDA: Approved
Описание: Both triamcinolone and dexamethasone caused differential activation of genes involved in “Circadian Rhythm Signaling” pathway at both time points tested. Triamcinolone (TAA) uniquely induced significant changes in gene expression in “Calcium Signaling” (1 week) and “Glutamate Receptor Signaling” ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/31307
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: alters the circadian rhythm
Механизмы: Corticosteroid Hormone Receptor Agonist, Core clock modulation, Affects "Circadian rhtyhm signaling", Calcium signaling, Glutamat receptor signaling
Цели: Corticosteroid hormone receptor (https://www.rcsb.org/structure/4P6X)
Статьи: Smit-McBride, Z., Moisseiev, E., Modjtahedi, S.P., Telander, D.G., Hjelmeland, L.M. and Morse, L.S., 2016. Comparison of in vivo gene expression profiling of RPE/choroid following intravitreal injection of dexamethasone and triamcinolone acetonide. Journal of Ophthalmology, 2016(1), p.9856736.: https://pubmed.ncbi.nlm.nih.gov/27429799/
------------------------------------------------------------

ID: 277 | Dexamethasone
FDA: Approved
Описание: In summary, dexamethasone affects circadian rhythms by altering clock gene expression in peripheral tissues, desynchronizing peripheral oscillators from the central clock, and suppressing endogenous cortisol rhythms. These effects can lead to disruptions in sleep, metabolism, and other physiologi...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5743
KEGG: https://www.kegg.jp/entry/D00292
Классы: circadian rhythm modulator, Potential chronodisruptor
Эффекты: Resetting of circadian time in peripheral tissues
Механизмы: Corticosteroid Hormone Receptor Agonist, Glucocorticoid Signaling
Цели: Corticosteroid hormone receptor (https://www.rcsb.org/structure/4P6X)
Статьи: Barnea, M., Madar, Z. and Froy, O., 2013. Dexamethasone induces high-amplitude rhythms in preadipocytes, but hinders circadian expression in differentiated adipocytes. Chronobiology International, 30(6), pp.837-842.: https://cris.huji.ac.il/en/publications/dexamethasone-induces-high-amplitude-rhythms-in-preadipocytes-but, Balsalobre, A., Brown, S.A., Marcacci, L., Tronche, F., Kellendonk, C., Reichardt, H.M., Schutz, G. and Schibler, U., 2000. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science, 289(5488), pp.2344-2347.: https://pubmed.ncbi.nlm.nih.gov/11009419/
------------------------------------------------------------

ID: 278 | Prednisolone
FDA: Approved
Описание: Glucocorticoid Receptor (GR) ligands like prednisone bind GRs in peripheral tissues (e.g., hippocampus, liver), altering circadian gene expression. For example, methylprednisolone upregulates Period1 (Per1) via glucocorticoid response elements (GREs), disrupting rhythmic transcription in hippocam...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5755#section=2D-Structure
KEGG: https://www.kegg.jp/entry/D00472
Классы: Potential modulator of circdain rhtyhms, Chronodisruptor
Эффекты: Disrupts sleep
Механизмы: Corticosteroid Hormone Receptor Agonist, Affects melatonin synthesis, Glucocorticoid Signaling, Melatonin synthesis alteration
Цели: Corticosteroid hormone receptor (https://www.rcsb.org/structure/4P6X)
Статьи: Jiang, Y., Gen, N., Wang, P., Feng, N. and Lu, X., 2022. Prednisolone induces sleep disorders via inhibition of melatonin secretion by the circadian rhythm in zebrafish. Biomedicine & Pharmacotherapy, 147, p.112590.: https://pubmed.ncbi.nlm.nih.gov/35007999/
------------------------------------------------------------

ID: 279 | Aldosterone
FDA: Approved
Описание: Aldosterone influences the expression of clock genes such as Per1, Per2, and Bmal1 in cardiomyoblasts. It induces rhythmic expression of these genes, suggesting a role in modulating circadian rhythms at the cellular level. Aldosterone secretion exhibits a circadian pattern, with peaks often synch...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5839
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Aldosterone influences the expression of clock genes such as Per1, Per2, and Bmal1 in cardiomyoblasts
Механизмы: influences HPA axis, BMAL1 expression modulation, PER gene exspression modulation, BMAL1 expression modulation, Activation of CLOCK/Bmal1 mediated transcription
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), Arntl (gene) (https://www.ncbi.nlm.nih.gov/gene/406), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Tanaka, K., Ashizawa, N., Kawano, H., Sato, O., Seto, S., Nishihara, E., Terazono, H., Isomoto, S., Shinohara, K. and Yano, K., 2007. Aldosterone induces circadian gene expression of clock genes in H9c2 cardiomyoblasts. Heart and vessels, 22, pp.254-260.: https://pubmed.ncbi.nlm.nih.gov/17653520/
------------------------------------------------------------

ID: 280 | Hydrocortisone (Cortisole)
FDA: Approved
Описание: Cortisol exhibits a distinct circadian rhythm, with levels typically peaking in the early morning and reaching their lowest point at the onset of sleep135. This rhythm is essential for synchronizing peripheral clocks throughout the body, ensuring that physiological activities align with the light...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5754
KEGG: https://www.kegg.jp/entry/D00088
Классы: circadian rhythm modulator, Potential chronodisruptor
Механизмы: Glucocorticoid Signaling, Glucocorticoid receptors
Цели: Corticosteroid hormone receptor (https://www.rcsb.org/structure/4P6X)
Статьи: Kanki, M. and Young, M.J., 2021. Corticosteroids and circadian rhythms in the cardiovascular system. Current Opinion in Pharmacology, 57, pp.21-27.: https://www.sciencedirect.com/science/article/abs/pii/S1471489220301053
------------------------------------------------------------

ID: 281 | IIK7
FDA: none
Описание: IIK7, a selective melatonin type 2 (MT2) receptor agonist, affects circadian rhythms by mimicking the phase-shifting effect of melatonin (MLT). Melatonin administration can entrain human circadian rhythms2. Studies show that treatment with IIK7 influences sleep patterns and the bioluminescence rh...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4172142
KEGG: NULL
Классы: chronobiotic
Эффекты: significantly reduced NREM sleep onset latency and transiently increased the time spent in NREM sleep, but did not alter REM sleep latency or the amou, acute sleep-promoting activity
Механизмы: MT2 receptor ligand, Melatonin receptor binding
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Fisher, S.P. and Sugden, D., 2009. Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat. Neuroscience letters, 457(2), pp.93-96.: https://eurekamag.com/research/055/813/055813577.php?srsltid=AfmBOoqmHMLlbqhOCdyfLNz7W6FpJXWX1RDyvR_N-_zc8yu80oprYeL6
------------------------------------------------------------

ID: 282 | UCSF7447
FDA: NULL
Описание: UCSF7447 was found to act as selective inverse agonist of the melatonin receptor 1A (MT1 receptor). It represents a novel chemotype for MT ligands, and was designed using structure-based optimisation of a lead molecule that was identified in a docking screen of 150 million virtual molecules again...
PubChem: NULL
KEGG: NULL
Классы: chronobiotic
Эффекты: phase advance, lengthened the periods of BMAL1 and PER2
Механизмы: MT1 receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Stein, R.M., Kang, H.J., McCorvy, J.D., Glatfelter, G.C., Jones, A.J., Che, T., Slocum, S., Huang, X.P., Savych, O., Moroz, Y.S. and Stauch, B., 2020. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. Nature, 579(7800), pp.609-614.: https://pubmed.ncbi.nlm.nih.gov/32040955/
------------------------------------------------------------

ID: 283 | MORICIZINE
FDA: Not approved
Описание: Using wild-type C57BL/6J mice, moricizine treatment was found to promote sleep as well as in Per2:LucSV reporter fibroblast cells, alter circadian gene expression in the heart, and show a slight trend of increasing free-running periods. Together, these observations demonstrate novel clock-modulat...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/34633
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: was found to promote sleep, alter circadian gene expression in the heart, and show a slight trend of increasing free-running periods. Together, these
Механизмы: Lenghthen the circadian period, PER gene exspression modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864)
Статьи: Han, C., Wirianto, M., Kim, E., Burish, M.J., Yoo, S.H. and Chen, Z., 2021. Clock-modulating activities of the anti-arrhythmic drug moricizine. Clocks & sleep, 3(3), pp.351-365.: https://pmc.ncbi.nlm.nih.gov/articles/PMC8293187/
------------------------------------------------------------

ID: 284 | Forskolin (Colforsin)
FDA: Not approved
Описание: Incubation of rat-1 cells with forskolin successfully induced the rhythmic expression of Per1, Per2 and dbp. In the initial step of the circadian gene expression, a marked transient induction of Per1 was observed accompanied with CREB phosphorylation. Thus the present study strongly suggests that...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/47936
KEGG: https://www.genome.jp/dbget-bin/www_bget?cpd:C09076
Классы: circadian rhythm modulator
Эффекты: Circadian rhythm induction
Механизмы: PER gene exspression modulation
Цели: Per 1 expression (gene) (https://www.ncbi.nlm.nih.gov/gene/5187), Per 1 (Rat gene) (https://www.ncbi.nlm.nih.gov/gene/287422), Per 2 (gene Rat) (https://www.ncbi.nlm.nih.gov/gene/63840), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864), mPer2 (https://www.rcsb.org/structure/3GDI), mPer1 (https://www.uniprot.org/uniprotkb/O15534/entry)
Статьи: Yagita, K. and Okamura, H., 2000. Forskolin induces circadian gene expression of rPer1, rPer2 and dbp in mammalian rat-1 fibroblasts. FEBS letters, 465(1), pp.79-82.: https://febs.onlinelibrary.wiley.com/doi/10.1016/S0014-5793%2899%2901724-X
------------------------------------------------------------

ID: 285 | Sudachitin
FDA: none
Описание: Using circadian reporter cells, study shows that Sudachitin modulates circadian amplitude and period of Bmal1 promoter-driven reporter rhythms, and real-time qPCR analysis shows that Sudachitin alters expression of core clock genes, notably Bmal1, at both transcript and protein levels. Mass-spec ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/12443122
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: restores normal circadian rhythms
Механизмы: BMAL1 expression modulation, de-repressing BMAL1, Core clock modulation, BMAL1 expression modulation, Activation of CLOCK/Bmal1 mediated transcription, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Mawatari, K., Koike, N., Nohara, K., Wirianto, M., Uebanso, T., Shimohata, T., Shikishima, Y., Miura, H., Nii, Y., Burish, M.J. and Yagita, K., 2023. The polymethoxyflavone sudachitin modulates the circadian clock and improves liver physiology. Molecular Nutrition & Food Research, 67(9), p.2200270.: https://pubmed.ncbi.nlm.nih.gov/36829302/
------------------------------------------------------------

ID: 286 | Cyclocybelide
FDA: NULL
Описание: The extract from the culture filtrate of Cyclocybe cf. erebia showed activity that advanced the circadian rhythm in a bioassay with mouse fibroblasts expressing the LUCIFERASE protein under the control of the Period2 promoter. Bioassay-guided fractionation of the extract resulted in the isolation...
PubChem: NULL
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Advances circadian rhtyhms
Механизмы: Binding with factors affine to Period2 gene promoter, Core clock modulation
Цели: mPer2 (https://www.rcsb.org/structure/3GDI), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864)
Статьи: Kobayashi, Y., Lu, Y., Li, N., Endo, N., Sotome, K., Ueno, K., Tahara, Y. and Ishihara, A., 2024. A new phthalide derivative from the mushroom Cyclocybe cf. erebia culture filtrate affects the phase of circadian rhythms in mouse fibroblasts. Bioscience, Biotechnology, and Biochemistry, p.zbae187.: https://pubmed.ncbi.nlm.nih.gov/39657072/
------------------------------------------------------------

ID: 287 | A190
FDA: none
Описание: A190 is Core Circadian Modulator (CCM) precursor, that targets the cavity in the PASB domain of BMAL1, causing it to expand, leading to conformational changes in the PASB domain and altering the functions of BMAL1 as a transcription factor. Biochemical, structural and cellular investigations vali...
PubChem: NULL
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator, Potential chronodisruptor
Эффекты: directly targets BMAL1, impacting its ability to regulate gene expression within the circadian clock and immune system
Механизмы: Interferes with CLOCK–BMAL1, Targets BMAL1–CLOCK DNA-binding activity, Bmal1, Activation of CLOCK/Bmal1 mediated transcription
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 (https://www.uniprot.org/uniprotkb/O00327/entry)
Статьи: Pu, H., Bailey, L.C., Bauer, L.G., Voronkov, M., Baxter, M., Huber, K.V., Khorasanizadeh, S., Ray, D. and Rastinejad, F., 2025. Pharmacological targeting of BMAL1 modulates circadian and immune pathways. Nature Chemical Biology, pp.1-10.: https://www.nature.com/articles/s41589-025-01863-x
------------------------------------------------------------

ID: 288 | A340
FDA: none
Описание: A340 is Core Circadian Modulator (CCM) precursor, that targets the cavity in the PASB domain of BMAL1, causing it to expand, leading to conformational changes in the PASB domain and altering the functions of BMAL1 as a transcription factor. Biochemical, structural and cellular investigations vali...
PubChem: NULL
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator, Potential chronodisruptor
Эффекты: directly targets BMAL1, impacting its ability to regulate gene expression within the circadian clock and immune system
Механизмы: Bmal1, Core clock modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 (https://www.uniprot.org/uniprotkb/O00327/entry)
Статьи: Zeng, Y., Guo, Z., Wu, M., Chen, F. and Chen, L., 2024. Circadian rhythm regulates the function of immune cells and participates in the development of tumors. Cell death discovery, 10(1), p.199.: https://www.nature.com/articles/s41420-024-01960-1, Pu, H., Bailey, L.C., Bauer, L.G., Voronkov, M., Baxter, M., Huber, K.V., Khorasanizadeh, S., Ray, D. and Rastinejad, F., 2025. Pharmacological targeting of BMAL1 modulates circadian and immune pathways. Nature Chemical Biology, pp.1-10.: https://www.nature.com/articles/s41589-025-01863-x
Синонимы: blob
------------------------------------------------------------

ID: 289 | Core Circadian Modulator (CCM)
FDA: none
Описание: Core Circadian Modulator (CCM) targets the cavity in the PASB domain of BMAL1, causing it to expand, leading to conformational changes in the PASB domain and altering the functions of BMAL1 as a transcription factor. Biochemical, structural and cellular investigations validate the high level of s...
PubChem: NULL
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator, Potential chronodisruptor
Эффекты: directly targets BMAL1, impacting its ability to regulate gene expression within the circadian clock and immune system
Механизмы: Interferes with CLOCK–BMAL1, Targets BMAL1–CLOCK DNA-binding activity, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 (https://www.uniprot.org/uniprotkb/O00327/entry)
Статьи: Zeng, Y., Guo, Z., Wu, M., Chen, F. and Chen, L., 2024. Circadian rhythm regulates the function of immune cells and participates in the development of tumors. Cell death discovery, 10(1), p.199.: https://www.nature.com/articles/s41420-024-01960-1
------------------------------------------------------------

ID: 290 | Psilocin
FDA: Not approved
Описание: Psilocin, the active metabolite of the psychedelic compound psilocybin, has garnered increasing interest for its profound effects on consciousness, perception, and cognition. Recent research suggests that psilocin may also influence circadian rhythms—the endogenous ~24-hour cycles that regulate s...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4980
KEGG: https://www.kegg.jp/entry/C08312
Классы: Potential modulator of circdain rhtyhms, Potential chronodisruptor
Эффекты: led to delayed REM sleep onset and reduced NREM sleep maintenance for up to approximately 3 h after dosing, is a rapidly-emerging treatment for depression
Механизмы: Dopamine receptor binding, Serotoninergic signaling
Цели: 5-HT 2A R (https://en.wikipedia.org/wiki/5-HT2A_receptor)
Статьи: Thomas, C.W., Blanco-Duque, C., Bréant, B.J., Goodwin, G.M., Sharp, T., Bannerman, D.M. and Vyazovskiy, V.V., 2022. Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice. Translational psychiatry, 12(1), p.77.: https://www.nature.com/articles/s41398-022-01846-9, Reid, M.J., Kettner, H., Blanken, T.F., Weiss, B. and Carhartt-Harris, R., 2024. Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action. Current psychiatry reports, pp.1-11.: https://link.springer.com/article/10.1007/s11920-024-01539-8
------------------------------------------------------------

ID: 291 | Scopolamine
FDA: Approved
Описание: Levels of melatonin, acetylcholine (ACh), serotonin (5-HT), and norepinephrine (NE) were measured in four groups of aged rats (control group; light pulse group; scopolamine group, light pulse and scopolamine group). Aged rats exposed to light pulse exhibited a phase shift in the circadian rhythm ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/11968014
KEGG: https://www.kegg.jp/entry/D00138
Классы: Potential chronodisruptor
Эффекты: can disrupt circadian rhythms, can influence various aspects of sleep and wakefulness, including sleep onset, delta sleep, an
Механизмы: Affects melatonin synthesis, Muscarinic receptor binding
Цели: Muscarinic acetilcholine receptror M1 (https://pubchem.ncbi.nlm.nih.gov/protein/P11229)
Статьи: Abdel-Rahman, M., Abdel-Kader, S., El-Masry, H. and El-Hennamy, R.E., 2020. Light exposure during late night attenuates the risk of scopolamine-induced Alzheimer disease in aged rats. Egyptian journal of basic and applied sciences, 7(1), pp.126-140.: https://www.tandfonline.com/doi/full/10.1080/2314808X.2020.1763033
------------------------------------------------------------

ID: 292 | IC261
FDA: NULL
Описание: IC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 μM, 1 μM, 16 μM for Ckiδ, Ckiε and Ckiα1, respectively. Previous studies have shown that thyroid malignancies can alter the transcriptional oscillations of circadian clock genes. The expression of core circadian clock genes in...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5288600
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: can induce a phase delay in circadian rhythms
Механизмы: Targets CK1 epsilon
Цели: CK1 epsilon (https://www.uniprot.org/uniprotkb/P49674/entry)
Статьи: Cheong, J.K., Hung, N.T., Wang, H., Tan, P., Voorhoeve, P.M., Lee, S.H. and Virshup, D.M., 2011. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation. Oncogene, 30(22), pp.2558-2569.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3109269/
------------------------------------------------------------

ID: 293 | SHP656
FDA: NULL
Описание: Synthtic CRY2 ligand. SHP656 lengthens circadian period. Effects on circadian rhythms registered in Bmal1-dLuc and Per2-dLuc U2OS cells. SHP656 is an orally available KL001 derivative. Miller, S., Kesherwani, M., Chan, P., Nagai, Y., Yagi, M., Cope, J., Tama, F., Kay, S.A. and Hirota, T., 2022. ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/91938072
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: disrupts glioblastoma clock
Механизмы: Selectively stabilizes CRY2
Цели: CRY2 (https://www.rcsb.org/structure/7V8Y), Mouse CRY2 with shp656 (https://www.rcsb.org/structure/7v8z)
Статьи: Miller, S., Kesherwani, M., Chan, P., Nagai, Y., Yagi, M., Cope, J., Tama, F., Kay, S.A. and Hirota, T., 2022. CRY2 isoform selectivity of a circadian clock modulator with antiglioblastoma efficacy. Proceedings of the National Academy of Sciences, 119(40), p.e2203936119.: https://www.pnas.org/doi/10.1073/pnas.2203936119
------------------------------------------------------------

ID: 294 | SHP1703 ( (R)-1-(3-(3,6-difluoro-9H-carbazol-9-yl)-2-hydroxypropyl)imid-azolidin-2-one )
FDA: none
Описание: Treatment with SHP1703 effectively reduced GSC viability targeting CRY2. SHP1703, which contained pure R form, showed higher activity than the S form of SHP656 in Per2 repression and a decrease in GSC viability in culture. Due to the selectivity of SHP656 and SHP1703 for CRY2, results indicate C...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/118415358
KEGG: NULL
Классы: Chronodisruptor
Эффекты: disrupts glioblastoma clock, disrupts the circadian clock specifically in cancer cells
Механизмы: Selectively stabilizes CRY2
Цели: CRY2 (https://www.rcsb.org/structure/7V8Y), Mouse CRY2 with shp656 (https://www.rcsb.org/structure/7v8z)
Статьи: Miller, S., Kesherwani, M., Chan, P., Nagai, Y., Yagi, M., Cope, J., Tama, F., Kay, S.A. and Hirota, T., 2022. CRY2 isoform selectivity of a circadian clock modulator with antiglioblastoma efficacy. Proceedings of the National Academy of Sciences, 119(40), p.e2203936119.: https://www.pnas.org/doi/10.1073/pnas.2203936119
------------------------------------------------------------

ID: 295 | Modafinil
FDA: Approved
Описание: Effects of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide), an atypical alerting compound, on circadian rhythms in male Syrian hamsters were detected. Electroencephalogram recordings and video observations confirmed that modafinil dose dependently increases wakefulness at the expense of slow-wa...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4236
KEGG: https://www.genome.jp/dbget-bin/www_bget?drug:D01832
Классы: Potential modulator of circdain rhtyhms
Эффекты: dose dependently increases wakefulness at the expense of slow-wave and paradoxical sleep with no increase in locomotor activity per unit of time awake
Механизмы: DAT interaction (human dopamine transporter)
Цели: DAT ( human Dopamine transporter) (https://www.rcsb.org/structure/9EO4)
Статьи: Kim, D., 2012. Practical use and risk of modafinil, a novel waking drug. Environmental health and toxicology, 27, p.e2012007.: https://pubmed.ncbi.nlm.nih.gov/22375280/, Webb, I.C., Pollock, M.S. and Mistlberger, R.E., 2006. Modafinil [2-[(diphenylmethyl) sulfinyl] acetamide] and circadian rhythms in syrian hamsters: assessment of the chronobiotic potential of a novel alerting compound. The Journal of pharmacology and experimental therapeutics, 317(2), pp.882-889.: https://www.sciencedirect.com/science/article/abs/pii/S0022356524326825, Uyhelji, H.A., Munster, S.K., White, V.L. and Nicholson, S.J., 2023. Gene expression biomarkers of the response to sleep loss with and without modafinil (No. DOT/FAA/AM-23/25). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute.: https://rosap.ntl.bts.gov/view/dot/72388
------------------------------------------------------------

ID: 296 | NCC007
FDA: Not approved
Описание: NCC007 (a derivative of longdaysin) showed stronger period effects (0.32 μM for 5 h period lengthening) in a cell-based circadian assay. The following in vitro kinase assay showed that NCC007 inhibited CKIα and CKIδ with an IC50 of 1.8 and 3.6 μM. We further demonstrated that NCC007 lengthened th...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/138403252
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: showed stronger period effects (0.32 μM for 5 h period lengthening) in a cell-based circadian assay
Механизмы: Inhibits CKIδ, Inhibits casein kinase 1 delta (CKIδ) activity
Цели: CKI delta (https://www.rcsb.org/structure/1CKI)
Статьи: Lee, J.W., Hirota, T., Ono, D., Honma, S., Honma, K.I., Park, K. and Kay, S.A., 2019. Chemical control of mammalian circadian behavior through dual inhibition of casein kinase Iα and δ. Journal of medicinal chemistry, 62(4), pp.1989-1998.: https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01541
------------------------------------------------------------

ID: 297 | Prexasertib
FDA: Approved
Описание: Prexasertib (LY2606368, Chk1/2 inhibitor) has been studied in cancer therapy but may also affect PER2 dynamics via its phosphorilation. GSK3 inhibitor Collis SJ, Boulton SJ. Emerging links between the biological clock and the DNA damage response. Chromosoma (2007) 116:331–9. doi: 10.1007/s00412-...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/46700756
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Механизмы: CK1 Inhibition, Chk1/2 inhibition, PER2 phosphorylation, CHK1 inhibitor crosstalk with caseine kinase 1
Цели: CKI delta (https://www.rcsb.org/structure/1CKI)
Статьи: Collis SJ, Boulton SJ. Emerging links between the biological clock and the DNA damage response. Chromosoma (2007) 116:331–9. doi: 10.1007/s00412-007-0108-6: https://link.springer.com/article/10.1007/s00412-007-0108-6
------------------------------------------------------------

ID: 298 | 17-DMAG
FDA: none
Описание: Drugs like 17-DMAG, a potent HSP90 inhibitor, exhibit time-of-day-specific action on melanoma tumors. Their rhythmic cytotoxicity is mediated by specific isoforms of HSP90 that are cyclically expressed and linked to the cell cycle. Clock-deficient tumors show reduced sensitivity to these drugs, h...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5288674
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: via HSP90 affects the stability of BMAL1 and circadian gene expression.
Механизмы: HSP90-mediated  BMAL1 modulation, HSP90 Binding
Цели: HSP90 (https://www.rcsb.org/structure/2XJX)
Статьи: Schneider, R., Linka, R.M. and Reinke, H., 2014. HSP90 affects the stability of BMAL1 and circadian gene expression. Journal of Biological Rhythms, 29(2), pp.87-96.: https://pubmed.ncbi.nlm.nih.gov/24682203/, Lee, Y., Fong, S.Y., Shon, J., Zhang, S.L., Brooks, R., Lahens, N.F., Chen, D., Dang, C.V., Field, J.M. and Sehgal, A., 2021. Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle. Science advances, 7(7), p.eabd2645.: https://www.science.org/doi/10.1126/sciadv.abd2645
------------------------------------------------------------

ID: 299 | GO289
FDA: not approved
Описание: GO289 disrupts the circadian clock specifically in cancer cells by targeting casein kinase 2 (CK2), an essential regulator of circadian rhythm. This drug slows cancer cell cycles while sparing healthy cells, demonstrating a promising approach for targeting the biological clock of tumors. GO289, ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/136819792
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: disrupts the circadian clock specifically in cancer cells
Механизмы: CK2 inhibition
Цели: CK2 alpha (https://www.rcsb.org/structure/1LP4)
Статьи: Oshima, T., Niwa, Y., Kuwata, K., Srivastava, A., Hyoda, T., Tsuchiya, Y., Kumagai, M., Tsuyuguchi, M., Tamaru, T., Sugiyama, A. and Ono, N., 2019. Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth. Science advances, 5(1), p.eaau9060.: https://pubmed.ncbi.nlm.nih.gov/30746467/
------------------------------------------------------------

ID: 300 | SR1078
FDA: none
Описание: SR1078 is a synthetic small molecule known as an agonist of the nuclear receptor ROR (retinoic acid receptor-related orphan receptor). RORs are key regulators of the circadian clock, influencing the transcription of the core clock gene BMAL1. By activating RORs, SR1078 can modulate circadian rhyt...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/17980288
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: enhancing the expression of the core clock component BMAL1
Механизмы: p53 stabilization and apoptosis induction, BMAL1 expression modulation
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Rahman S, Wittine K, Sedic M, Markova-Car EP (2020) Small molecules Targeting Biological clock; a novel prospective for anti-cancer drugs. Molecules. ;25(21); doi: ARTN 493710.3390/molecules25214937.: https://www.mdpi.com/1420-3049/25/21/4937
------------------------------------------------------------

ID: 301 | Vanillic Acid
FDA: Not approved
Описание: Chrononutrient. May be obtained from Angelica sinensis root, acai oil. Increases amplitude; delays phase. Normalizes circulating lipid peroxidation and antioxidant status. Huang, J.Q., Lu, M. and Ho, C.T., 2021. Health benefits of dietary chronobiotics: beyond resynchronizing internal clocks. F...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/8468
KEGG: https://www.kegg.jp/entry/C06672
Классы: circadian rhythm modulator
Эффекты: Increases amplitude of circadian rhtyhms, Decreases phase
Механизмы: Serine/threonine-protein kinase mTOR, mTOR signaling inhibition, AMPK-PP2A axis suppresses mTOR, advancing circadian phase in muscle., Adenosine Monophosphate-Activated Protein Kinase (AMPK), Nuclear Factor Kappa B (NF- κB), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), Nod-like receptor family protein (NLRP), Toll-like receptors (TLRs), Mitogen-Activated Signaling Proteins (MAPK), Mammalian Target of Rapamycin (mTOR) signaling pathway
Цели: MTOR (Human) (https://www.uniprot.org/uniprotkb/P42345/entry), JAC (Janus kinase) (https://www.rcsb.org/structure/7T6F), AMPK (https://www.rcsb.org/structure/4CFF)
Статьи: Bhavani, P., Subramanian, P. and Shanmugapriya, S., 2016. Modulating effects of vanillic acid on circadian pattern of indices of redox homeostasis in N-Methly-N′-Nitro-N-Nitrosoguanidine induced endometrial carcinoma in rats. Biological Rhythm Research, 47(4), pp.609-619.: https://www.tandfonline.com/doi/abs/10.1080/09291016.2016.1173362, Kiessig, R.S., Herz, J.M. and Sweeney, B.M., 1979. Shifting the phase of the circadian rhythm in bioluminescence in Gonyaulax with vanillic acid. Plant Physiology, 63(2), pp.324-327.: https://pubmed.ncbi.nlm.nih.gov/16660722/, Lashgari, N.A., Roudsari, N.M., Momtaz, S., Abdolghaffari, A.H., Atkin, S.L. and Sahebkar, A., 2023. Regulatory mechanisms of vanillic acid in cardiovascular diseases: a review. Current Medicinal Chemistry, 30(22), pp.2562-2576.: https://pubmed.ncbi.nlm.nih.gov/36045525/, Huang, J.Q., Lu, M. and Ho, C.T., 2021. Health benefits of dietary chronobiotics: beyond resynchronizing internal clocks. Food & Function, 12(14), pp.6136-6156.: https://www.researchwithrutgers.com/en/publications/health-benefits-of-dietary-chronobiotics-beyond-resynchronizing-i
------------------------------------------------------------

ID: 302 | Capsaicin
FDA: Approved
Описание: Found in Chili pepper . Regulates circadian clock disruption.Improves redox imbalance and glucose metabolism. Circadian disorder mouse model induced by constant darkness (CD) was constructed to investigate the regulating effects of capsaicin (CAP) on disturbances of metabolism homeostasis and gut...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/1548943
KEGG: https://www.kegg.jp/entry/C06866
Классы: circadian rhythm modulator
Эффекты: restores normal circadian rhythms
Механизмы: TRPV1 capsaicin site binding
Цели: TRPV1 (https://www.rcsb.org/structure/3J9J)
Статьи: Liu, L. and Tian, Y., 2023. Capsaicin changes the pattern of brain rhythms in sleeping rats. Molecules, 28(12), p.4736.: https://www.mdpi.com/1420-3049/28/12/4736
------------------------------------------------------------

ID: 303 | Caffeine
FDA: Approved as food (400 mg per day)
Описание: Coffee, yerba mate leaves, guarana Extends period; increases amplitude; resets peripheral clocks; delays melatonin rhythm. Promotes wakefulness; reduces and fragments sleep; aids in weight loss; increases photosensitivity; regulates appetite; affects body temperature. Caffeine’s wakefulness-promo...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2519
KEGG: https://www.kegg.jp/entry/C07481
Классы: circadian rhythm modulator
Эффекты: delaying melatonin secretion, particularly when consumed in the evening, and potentially disrupting sleep patterns. It can shift the CCGs rhtyhms
Механизмы: Adenosine Monophosphate-Activated Protein Kinase (AMPK), adenosine receptor binding, Activation of Adenosine Receptors
Цели: Adenosine A1, A2A, A2B, and A3 Receptors (https://www.sciencedirect.com/topics/neuroscience/adenosine-receptor)
Статьи: Burke, T.M., Markwald, R.R., McHill, A.W., Chinoy, E.D., Snider, J.A., Bessman, S.C., Jung, C.M., O’Neill, J.S. and Wright Jr, K.P., 2015. Effects of caffeine on the human circadian clock in vivo and in vitro. Science translational medicine, 7(305), pp.305ra146-305ra146.: https://pubmed.ncbi.nlm.nih.gov/26378246/
------------------------------------------------------------

ID: 304 | Myricetin
FDA: none
Описание: Night alertness drug. The flavonoid myricetin reduces nocturnal melatonin levels in the blood through the inhibition of serotonin N-acetyltransferase. Myricae Cortex (Myrica rubra), Perillae Herba (Perilla sikokiana), and Eriobotryae Folium (Eriobotrya japonica) showed potent inhibition of AANAT ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5281672
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Night alertness, Melatonin level reduction
Механизмы: inhibition of serotonin N-acetyltransferase
Цели: Serotonin N-acetyltransferase (https://www.rcsb.org/structure/1KUY)
Статьи: Shin, J.C., Jung, H.Y., Harikishore, A., Kwon, O.D., Yoon, H.S., Kim, K.T. and Choi, B.H., 2013. The flavonoid myricetin reduces nocturnal melatonin levels in the blood through the inhibition of serotonin N-acetyltransferase. Biochemical and biophysical research communications, 440(2), pp.312-316.: https://www.sciencedirect.com/science/article/abs/pii/S0006291X1301557X
------------------------------------------------------------

ID: 305 | Physcione
FDA: Not approved
Описание: Obtained from Rheum palmatum root (traditional Chinese medicine), lettuce, beans. Exhibits secondary bioactivity in free circadian rhythms Demonstrates hepatoprotective, anti-inflammatory, antimicrobial, and antiproliferative effects; protects the liver; reduces lipogenesis. Physcion affects circ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Physcione
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: upregulate core circadian genes and reverse circadian misalignment caused by ethanol in liver cells., restores normal circadian rhythms
Механизмы: Interferes with CLOCK–BMAL1, BMAL1 expression modulation, Bmal1
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Yao, Y., Zuo, A., Deng, Q., Liu, S., Zhan, T., Wang, M., Xu, H., Ma, J. and Zhao, Y., 2020. Physcion protects against ethanol-induced liver injury by reprogramming of circadian clock. Frontiers in Pharmacology, 11, p.573074.: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.573074/full, Huang, J.Q., Lu, M. and Ho, C.T., 2021. Health benefits of dietary chronobiotics: beyond resynchronizing internal clocks. Food & Function, 12(14), pp.6136-6156.: https://www.researchwithrutgers.com/en/publications/health-benefits-of-dietary-chronobiotics-beyond-resynchronizing-i
------------------------------------------------------------

ID: 306 | Piceatannol
FDA: Not approved
Описание: Piceatannol could advance and delay the phase of PER2::LUC oscillation in vitro. Piceatannol advanced PER2::LUC luminescence rhythm in peripheral organs in vivo. Piceatannol recovered phase change of PER2::LUC disturbed by high-fat diet intake. Piceatannol affects Per2 expression and may prevent ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/667639
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: Piceatannol advanced PER2::LUC luminescence rhythm in peripheral organs in vivo., recovered phase change of PER2::LUC disturbed by high-fat diet intake., affects Per2 expression and may prevent circadian disturbance.
Механизмы: PER gene exspression modulation
Цели: Per 1 expression (gene) (https://www.ncbi.nlm.nih.gov/gene/5187), Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864)
Статьи: Yamamoto, T., Iwami, S., Aoyama, S., Maruki-Uchida, H., Mori, S., Hirooka, R., Takahashi, K., Morita, M. and Shibata, S., 2019. Effect of piceatannol on circadian Per2 expression in vitro and in vivo. Journal of functional foods, 56, pp.49-56.: https://www.sciencedirect.com/science/article/abs/pii/S1756464619301045?via%3Dihub
------------------------------------------------------------

ID: 307 | Puerarin
FDA: none
Описание: Pathological detection demonstrated that sleep disturbances resulted in observable damage to the liver, lung, and kidney. Puerarin reversed multi-organ damage and inflammation. Further, puerarin activated paneth cells, resulting in increased lysozyme and TGF-β production, and stimulating intestin...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5281807
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: increased the expression levels of REV-ERBα target genes Bhmt, Cbs and Cth, restores normal circadian rhythms
Механизмы: Agonist REV-ERB alpha
Цели: REV-ERBα (https://www.rcsb.org/structure/4n73)
Статьи: Chen, M., Zhou, C., Xu, H., Zhang, T. and Wu, B., 2020. Chronopharmacological targeting of Rev-erbα by puerarin alleviates hyperhomocysteinemia in mice. Biomedicine & pharmacotherapy, 125, p.109936.: https://www.sciencedirect.com/science/article/pii/S0753332220301268, Liu, J., Xu, H., Zhang, L., Wang, S., Lu, D., Chen, M. and Wu, B., 2021. Chronoeffects of the herbal medicines Puerariae radix and Coptidis rhizoma in mice: A potential role of REV-ERBα. Frontiers in Pharmacology, 12, p.707844.: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.707844/full
------------------------------------------------------------

ID: 308 | Hesperidin
FDA: none
Описание: Hesperidin (Increases amplitude of circadian rhtyhms; reverses phase delay) acts by different mechanisms including reducing oxidative stress and lowering the apoptotic protein like caspase, Bax, TNF-α, and NF-MB as well as the inflammatory markers such as IL-6, and LOX-2 in preclinical studies. C...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/10621
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Increases amplitude of circadian rhtyhms, reverses phase delay
Механизмы: protect, caspase, Bax, TNF-α, and NF-MB, Antioxidant, PER gene exspression modulation
Цели: Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864)
Статьи: Tayal, R., Munjal, K., Gauttam, V.K., Popli, P., Khurana, L. and Choudhary, N., 2023. Potential role of hesperidin in lifestyle disorders: A scoping review. South African Journal of Botany, 161, pp.542-554.: https://www.sciencedirect.com/science/article/abs/pii/S0254629923004982, Jayapalan, J.J., Subramanian, P., Kani, A., Hiji, J., Najjar, S.G., Abdul‐Rahman, P.S. and Hashim, O.H., 2020. Hesperidin modulates the rhythmic proteomic profiling in Drosophila melanogaster under oxidative stress. Archives of Insect Biochemistry and Physiology, 105(3), p.e21738.: https://pubmed.ncbi.nlm.nih.gov/32924199/, Manjula, A., Subashini, R., Punitha, R. and Subramanian, P., 2017. Modulating effects of hesperidin on circadian pattern indices of rotenone induced redox homeostasis in clock mutant (cry b) of Drosophila melanogaster. Biological Rhythm Research, 48(6), pp.897-906.: https://www.tandfonline.com/doi/abs/10.1080/09291016.2017.1319641
------------------------------------------------------------

ID: 309 | Theanine
FDA: none
Описание: Non-proteinogenic amino acid. l-Theanine apparently reduced the viability of melanoma cells. Further experiments showed that l-theanine attenuated the proliferation and migration, and promoted apoptosis of melanoma cells. l-Theanine significantly enhanced the expression of BMAL1, a clock gene in ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/439378
KEGG: https://www.genome.jp/dbget-bin/www_bget?cpd:C01047
Классы: circadian rhythm modulator
Эффекты: l-Theanine significantly enhanced the expression of BMAL1, a clock gene in melanoma cells.
Механизмы: BMAL1 expression modulation, BMAL1 expression modulation, de-repressing BMAL1
Цели: BMAL1 expression (induction) (https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMAL1)
Статьи: Zhang, R., Liu, M., Lu, J., Lu, S., Wang, Y. and Guan, S., 2024. Fisetin Ameliorates Hepatocyte Lipid Droplet Accumulation via Targeting the Rhythmic Protein BMAL1 to Regulate Cell Death-Inducing DNA Fragmentation Factor-α-like Effector C-Mediated Lipid Droplet Fusion. Journal of Agricultural and Food Chemistry, 72(48), pp.26884-26897.: https://pubmed.ncbi.nlm.nih.gov/39563624/
------------------------------------------------------------

ID: 310 | Theophylline
FDA: Approved
Описание: Direct Effects on the Circadian Clock: Theophylline, a methylxanthine compound similar to caffeine, has been shown to lengthen the circadian period in a concentration-dependent manner in model organisms such as the fungus Neurospora crassa. This effect is observed at the level of core-clock gene ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2153#section=2D-Structure
KEGG: https://www.genome.jp/dbget-bin/www_bget?drug:D00371
Классы: Potential modulator of circdain rhtyhms, Potential chronodisruptor
Эффекты: cause period lengthening in a concentration-dependent manner
Механизмы: Modulation of PI3K/Akt, Nuclear Factor Kappa B (NF- κB), cAMP signaling cascade
Цели: PI3K/Akt (https://www.rcsb.org/structure/4FHJ), NF-kB (https://www.rcsb.org/structure/1NFK)
Статьи: Ehret, C.F., Potter, V.R. and Dobra, K.W., 1975. Chronotypic action of theophylline and of pentobarbital as circadian zeitgebers in the rat. Science, 188(4194), pp.1212-1215.: https://pubmed.ncbi.nlm.nih.gov/1145192/, Szarłowicz, J., Mazur, M., Waz, D., Goliszek, Z., Sobek, K.Ł., Tabin-Barczak, W., Sokołowska, A., Fikas, K., Chwaliszewski, K. and Samuła, S., 2025. Theophylline Revisited. Mechanisms, Challenges, and New Horizons. Quality in Sport, 37, pp.57009-57009.: https://apcz.umk.pl/QS/article/view/57009, Olivares-Yañez, C., Alessandri, M.P., Salas, L. and Larrondo, L.F., 2023. Methylxanthines modulate circadian period length independently of the action of phosphodiesterase. Microbiology Spectrum, 11(4), pp.e03727-22.: https://pubmed.ncbi.nlm.nih.gov/37272789/
------------------------------------------------------------

ID: 311 | Fisetin
FDA: none
Описание: FISETIN alleviates Lipid Droplet accumulation by inhibiting CIDEC-mediated fusion, resulting in smaller LDs that facilitated lipophagy. Additionally, studies indicated that the dysfunction of circadian rhythms is closely related to lipid metabolism. HFD and FFA disrupted circadian rhythm in C57BL...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5281614
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, circadian rhythm modulator
Эффекты: restores normal circadian rhythms, increased protein expression of the core clocks BMAL1 and CLOCK
Механизмы: Interferes with CLOCK–BMAL1, Bmal1
Цели: CLOCK-BMAL1 COMPLEX (https://www.e-enm.org/journal/view.php?doi=10.3803/enm.2014.29.3.379), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), BMAL1 (https://www.uniprot.org/uniprotkb/O00327/entry)
Статьи: Zhang, R., Liu, M., Lu, J., Lu, S., Wang, Y. and Guan, S., 2024. Fisetin Ameliorates Hepatocyte Lipid Droplet Accumulation via Targeting the Rhythmic Protein BMAL1 to Regulate Cell Death-Inducing DNA Fragmentation Factor-α-like Effector C-Mediated Lipid Droplet Fusion. Journal of Agricultural and Food Chemistry, 72(48), pp.26884-26897.: https://pubmed.ncbi.nlm.nih.gov/39563624/, Sulaimani, N., Houghton, M.J., Bonham, M.P. and Williamson, G., 2024. Effects of (Poly) Phenols on Circadian Clock Gene–Mediated Metabolic Homeostasis in Cultured Mammalian Cells: A Scoping Review. Advances in Nutrition, 15(6), p.100232.: https://pubmed.ncbi.nlm.nih.gov/38648895/
------------------------------------------------------------

ID: 312 | Baicalein
FDA: none
Описание: Baicalein, a flavone present in various plants, has gained widespread recognition for its variety of health benefits. It exhibits promising therapeutic potential in conditions like microbial infection, cancer, neurodegenerative diseases, and cardiovascular diseases, acting through intricate pathw...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5281605
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: BMAL1 amplitude enhancement via RORα-dependent pathway.
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA), RORA (https://www.ncbi.nlm.nih.gov/gene/6095)
Статьи: Paul, A., Das, P., Gogoi, M., Islam, M.A., Das, S. and Zaman, M.K., 2024. Baicalein: multiple pharmacological activities, pharmacokinetics, and clinical trials. Revista Brasileira de Farmacognosia, pp.1-15.: https://link.springer.com/article/10.1007/s43450-024-00575-y, Sulaimani, N., Houghton, M.J., Bonham, M.P. and Williamson, G., 2024. Effects of (Poly) Phenols on Circadian Clock Gene–Mediated Metabolic Homeostasis in Cultured Mammalian Cells: A Scoping Review. Advances in Nutrition, 15(6), p.100232.: https://pubmed.ncbi.nlm.nih.gov/38648895/
------------------------------------------------------------

ID: 313 | Chicoric acid
FDA: none
Описание: Cichoric Acid Prevents Free-Fatty-Acid-Induced Lipid Metabolism Disorders via Regulating Bmal1 in HepG2 Cells. Cichoric acid (CA), a polyphenol component from Echinacea purpurea, exhibits preventive effects on liver lipid-metabolism disorders in obesity. This research aimed to determine the role ...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5281764
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: restores normal circadian rhythms
Механизмы: Selective GSK-3β Inhibition:, Circadian Clock Impact, Core clock modulation, inhibits glycogen synthase kinase-3β (GSK-3β), Activation of CLOCK/Bmal1 mediated transcription, Interferes with CLOCK–BMAL1, PGC-1α interaction
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3), CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10), PGC-1α (https://www.rcsb.org/structure/3CS8)
Статьи: Guo, R., Zhao, B., Wang, Y., Wu, D., Wang, Y., Yu, Y., Yan, Y., Zhang, W., Liu, Z. and Liu, X., 2018. Cichoric acid prevents free-fatty-acid-induced lipid metabolism disorders via regulating Bmal1 in HepG2 cells. Journal of agricultural and food chemistry, 66(37), pp.9667-9678.: https://ufl-flvc.primo.exlibrisgroup.com/discovery/fulldisplay?docid=cdi_proquest_miscellaneous_2075545516&context=PC&vid=01FALSC_UFL:UFL&lang=en&search_scope=MyInst_and_CI&adaptor=Primo%20Central&query=null,,iPad&facet=citedby,exact,cdi_FETCH-LOGICA
------------------------------------------------------------

ID: 314 | Curcumin
FDA: none
Описание: Treatment with CUR/12 h. Control (DMSO). Affects expression of PER2:: mPER2::Luc. ↓ Dose causes a rhythmic pattern of mPER2 with an average period of 24.48 h for PER2. Circadian rhythms in cell death were observed in response to low (5 μM) curcumin, reaching a peak several hours before the peak i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/969516
KEGG: https://www.kegg.jp/entry/C10443
Классы: circadian rhythm modulator
Эффекты: Phase-dependent cell death modulation
Механизмы: Per2 expression induction
Цели: Per2 expression (https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=8864)
Статьи: Sarma, A., Sharma, V.P., Sarkar, A.B., Sekar, M.C., Samuel, K. and Geusz, M.E., 2016. The circadian clock modulates anti-cancer properties of curcumin. BMC cancer, 16, pp.1-13.: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2789-9
------------------------------------------------------------

ID: 315 | Bavachalcone
FDA: none
Описание: Bavachalcone, a prenylchalcone, is a major bioactive chalcone isolated from Psoralea corylifolia. This natural ingredient activated RORα1 luciferase reporter activity on drug screening. RAR-related orphan receptor α (RORα), an orphan nuclear receptor, is involved in circadian rhythm regulation, i...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6450879
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Amplitude enhancement in human cells
Механизмы: ROR
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA), RORA (https://www.ncbi.nlm.nih.gov/gene/6095)
Статьи: Dang, Y., Ling, S., Ma, J., Ni, R. and Xu, J.W., 2015. Bavachalcone enhances RORα expression, controls Bmal1 circadian transcription, and depresses cellular senescence in human endothelial cells. Evidence‐based Complementary and Alternative Medicine, 2015(1), p.920431.: https://onlinelibrary.wiley.com/doi/full/10.1155/2015/920431
------------------------------------------------------------

ID: 316 | Genistein
FDA: none
Описание: Dietary Genistein Could Modulate Hypothalamic Circadian Entrainment, Reduce Body Weight, and Improve Glucose and Lipid Metabolism in Female Mice Rat C6. Noradrenaline (NA) or Fsk (10 μM, 1 h). Pretreatment gen/1 h and then NA or Fsk/1 h. Control.↓ PER1 mRNA and protein. Noradrenaline induces cl...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5280961
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: phase advance
Механизмы: Highly selective, ATP-competitive inhibition of GSK-3 (both α and β isoforms), GSK‑3 Inhibition, Selective GSK-3β Inhibition:, inhibits glycogen synthase kinase-3β (GSK-3β)
Цели: GSK-3α/β (https://en.wikipedia.org/wiki/GSK-3)
Статьи: Sulaimani, N., Houghton, M.J., Bonham, M.P. and Williamson, G., 2024. Effects of (Poly) Phenols on Circadian Clock Gene–Mediated Metabolic Homeostasis in Cultured Mammalian Cells: A Scoping Review. Advances in Nutrition, 15(6), p.100232.: https://pubmed.ncbi.nlm.nih.gov/38648895/, Zhou, L., Xiao, X., Zhang, Q., Zheng, J., Li, M., Yu, M., Wang, X., Deng, M., Zhai, X., Li, R. and Liu, J., 2019. Dietary genistein could modulate hypothalamic circadian entrainment, reduce body weight, and improve glucose and lipid metabolism in female mice. International Journal of Endocrinology, 2019(1), p.2163838.: https://pubmed.ncbi.nlm.nih.gov/31139215/
------------------------------------------------------------

ID: 317 | Aminophylline
FDA: Approved
Описание: Likewise, methylxanthines still exert a period effect in several cAMP signaling pathway mutants, including adenylate cyclase (cr-1) and protein kinase A (PKA) (Δpkac-1) mutants, suggesting that these drugs lead to circadian phenotypes through mechanisms different from the canonical PDE-cAMP-PKA s...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Aminophylline
KEGG: https://www.genome.jp/dbget-bin/www_bget?drug:D00227
Классы: circadian rhythm modulator
Эффекты: Period lengthening in fungi
Механизмы: Adenosine receptor A1Antagonist, Adenosine receptor A3Antagonist, cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A, cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A Inhibitor
Цели: Adenosine A1, A2A, A2B, and A3 Receptors (https://www.sciencedirect.com/topics/neuroscience/adenosine-receptor)
Статьи: Olivares-Yañez, C., Alessandri, M.P., Salas, L. and Larrondo, L.F., 2023. Methylxanthines modulate circadian period length independently of the action of phosphodiesterase. Microbiology Spectrum, 11(4), pp.e03727-22.: https://pubmed.ncbi.nlm.nih.gov/37272789/, Manrui, L., Xu, Y., Liu, J., Zhang, X., Yuan, R., Sun, Y., Sun, Y., Yang, Q., Liao, M., Lv, M. and Hu, X., 2025. Aminophylline targets miR-128-3p/Slc7a11 axis to attenuate neuronal ferroptosis after traumatic brain injury. Cellular and Molecular Life Sciences, 82(1), pp.1-23.: https://pubmed.ncbi.nlm.nih.gov/39985589/#:~:text=Aminophylline%20targets%20miR%2D128%2D3p,ferroptosis%20after%20traumatic%20brain%20injury
------------------------------------------------------------

ID: 318 | Salicilic acid
FDA: none
Описание: PLANT CHRONOBIOTIC. Salicylic acid (SA) increased oscillatory robustness and shortened the period. The latter was attenuated by sucrose addition and was also gated, taking place during the first 3 h of the subjective day. Furthermore, the effect of SA on period length was dependent on light quali...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Salicylic-Acid
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Period shortening in plants
Механизмы: Plastoquinone interaction
Цели: Unknown | Multiple plant targets (https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00429/full)
Статьи: Manickam, R., Oh, H.Y.P., Tan, C.K., Paramalingam, E. and Wahli, W., 2018. Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism. International journal of molecular sciences, 19(8), p.2418.: https://pmc.ncbi.nlm.nih.gov/articles/PMC6121908/#sec1-ijms-19-02418
------------------------------------------------------------

ID: 319 | (2S)-N-methyl-1-phenylpropan-2-amine
FDA: Approved
Описание: methamphetamine exposure restores the circadian rhythm, although the frequency of the methamphetamine sensitive circadian oscillator (MASCO) varied considerably compared to the highly regular wild-type circadian rhythm. Additionally, methamphetamine increased multiscale activity and induced a cir...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/10836
KEGG: https://www.kegg.jp/entry/C07164
Классы: chronobiotic, circadian rhythm modulator, Chronodisruptor
Эффекты: Ultradian oscillations induction in Per1/2/3knockout mice, exposure induces atime-varying circadian rhythm, induced a  very long free-running period (~27 h) in heterozygous Gsk3β mutant mice in DD
Механизмы: methamphetamine-sensitive circadian oscillator (MASCO), increase dopamine signalling, Monoamine transporter inhibitor, Non-canonical circadian genes
Цели: SLC6A2 (https://platform.opentargets.org/target/ENSG00000103546)
Статьи: Barnes, S.J., Alanazi, M., Yamazaki, S. and Stefanovska, A., 2025. Methamphetamine alters the circadian oscillator and its couplings on multiple scales in Per1/2/3 knockout mice. PNAS nexus, 4(4), p.pgaf070.: https://academic.oup.com/pnasnexus/article/4/4/pgaf070/8068901?login=false, Mohawk, J.A., Baer, M.L. and Menaker, M., 2009. The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes. Proceedings of the National Academy of Sciences, 106(9), pp.3519-3524.: https://www.pnas.org/doi/10.1073/pnas.0813366106, Genetics and functional significance of the understudied methamphetamine sensitive circadian oscillator (MASCO): https://pubmed.ncbi.nlm.nih.gov/36226037/
------------------------------------------------------------

ID: 320 | TW68
FDA: none
Описание: A new molecule called TW68 that interacts with the primary pockets of mammalian CRY1/2, leading to reduced ubiquitination levels and increased stability. In cell-based circadian rhythm assays using U2OS:Bmal1-dLuccells, TW68 extended the period length of the circadian rhythm. Additionally, TW68 d...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/175816612
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Lengthen perion of circadian rhythm
Механизмы: Selective stabilizer of CRY1, Selectively stabilizes CRY2, CRY 2 Stabilizer
Цели: CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407), CRY2 (https://www.rcsb.org/structure/7V8Y)
Статьи: Surme, S., Ergun, C., Gul, S., Akyel, Y.K., Gul, Z.M., Ozcan, O., Ipek, O.S., Akarlar, B.A., Ozlu, N., Taskin, A.C. and Turkay, M., 2023. TW68, cryptochromes stabilizer, regulates fasting blood glucose levels in diabetic ob/ob and high fat-diet-induced obese mice. Biochemical Pharmacology, 218, p.115896.: https://www.sciencedirect.com/science/article/abs/pii/S0006295223004896
------------------------------------------------------------

ID: 321 | Raloxifene
FDA: NULL
Описание: Raloxifene (RLX) is a selective estrogen receptor modulator (SERM) known for its ability to selectively bind to estrogen receptors. According to the article, raloxifene acts as an antiestrogen in uterine tissue, where it attenuates the effect of estrogen (17β-estradiol, E2) on the circadian rhyth...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5035
KEGG: NULL
Классы: Chronomodulator
Эффекты: Period shortening of the circadian rhythm in the uterus
Механизмы: BMAL1 expression modulation
Цели: PER2 gene expression (https://en.wikipedia.org/wiki/PER2)
Статьи: Nakamura TJ, Sellix MT, Menaker M, Block GD. Estrogen directly modulates circadian rhythms of PER2 expression in the uterus. Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1025-31. doi: 10.1152/ajpendo.90392.2008. Epub 2008 Aug 26. PMID: 18728223; PMCID: PMC2584820.: https://pmc.ncbi.nlm.nih.gov/articles/PMC2584820/
------------------------------------------------------------

ID: 322 | verapamil
FDA: Approved
Описание: Verapamil, a first-line preventive medication for cluster headache, is primarily known as a canonical L-type calcium channel antagonist. However, this study reveals its potent role as a circadian modulator. In both cell-based (Per2::LucSV fibroblasts) and in vivo (C57BL6/J mice) models, verapamil...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2520
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Shortening of circadian period
Механизмы: BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Burish MJ, Han C, Mawatari K, Wirianto M, Kim E, Ono K, Parakramaweera R, Chen Z, Yoo SH. The first-line cluster headache medication verapamil alters the circadian period and elicits sex-specific sleep changes in mice. Chronobiol Int. 2021 Jun;38(6):839-850. doi: 10.1080/07420528.2021.1892127. Epub 2021 Apr 8. PMID: 33829951.: https://pubmed.ncbi.nlm.nih.gov/33829951/
------------------------------------------------------------

ID: 323 | amitriptyline
FDA: approved
Описание: Amitriptyline is a tricyclic antidepressant widely used for depression, chronic pain, and sleep disorders. Its primary action is to inhibit the reuptake of serotonin and norepinephrine, boosting their levels in the synaptic cleft and improving mood.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/2160
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: sleep architecture modulation
Механизмы: BMAL1 expression modulation
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Silva S, Bicker J, Falcão A, Fortuna A. Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression. Pharmaceutics. 2021 Nov 21;13(11):1975. doi: 10.3390/pharmaceutics13111975.: https://pmc.ncbi.nlm.nih.gov/articles/PMC8624696/
------------------------------------------------------------

ID: 324 | Trazodon
FDA: approved
Описание: Trazodone is an atypical antidepressant with dual actions: serotonin transporter inhibition and 5-HT2A/5-HT2C receptor antagonism. It also antagonizes H1-histaminergic and alpha1-adrenergic receptors, conferring significant sleep-promoting properties. Recent studies have demonstrated that chronic...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5533
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Increases expression of circadian rhythm genes (Bmal1, Per1, Per2) in a brain-region-specific
Механизмы: Modulates sleep architecture via H1-histamine receptor antagonism
Цели: CLOCK-BMAL1 (https://www.rcsb.org/structure/4h10)
Статьи: Carboni L, Rullo L, Caputi FF, Stamatakos S, Candeletti S, Romualdi P. Chronic Trazodone and Citalopram Treatments Increase Trophic Factor and Circadian Rhythm Gene Expression in Rat Brain Regions Relevant for Antidepressant Efficacy. Int J Mol Sci. 2022 Nov 14;23(22):14041. doi: 10.3390/ijms232214041.: https://pmc.ncbi.nlm.nih.gov/articles/PMC9698904/
------------------------------------------------------------

ID: 325 | 5‐HEAT
FDA: none
Описание: 5-HEAT was able to differentiate between the high- and the low-affinity receptor states in the mt1 but not in the MT2 receptor. 5-HEAT induced a high level of G protein activation when acting through the mt1 receptor, with a relative intrinsic activity of 0.92. On the contrary, it elicited only m...
PubChem: NULL
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: possesses very different efficacies at the two melatonin receptors, beha full melatonin receptor agonist mt1, as an antagonist MT2 effect not studied
Механизмы: MT1 receptor binding, MT2 receptor ligand, MT2 receptor antagonist
Цели: MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Nonno, R., Lucini, V., Spadoni, G., Pannacci, M., Croce, A., Esposti, D., Balsamini, C., Tarzia, G., Fraschini, F. and Stankov, B.M., 2000. A new melatonin receptor ligand with mt1‐agonist and MT2‐antagonist properties. Journal of pineal research, 29(4), pp.234-240.: https://pubmed.ncbi.nlm.nih.gov/11068946/
------------------------------------------------------------

ID: 326 | 2‐(indolin‐1yl)‐melatonin
FDA: none
Описание: The compound "N-[2-[2-(2,3-dihydroindol-1-ylmethyl)-5-methoxy-1H-indol-3-yl]ethyl]acetamide" is a chemical molecule that can be described as a melatonin derivative with modifications. Specifically, it has an acetamide group, a modified melatonin core structure (including a dihydroindol-1-ylmethyl...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/25210130
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: suggests it could potentially interact with the circadian system, which involves processes like sleep-wake cycles and hormone production
Механизмы: MT2 receptor antagonist
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Zlotos, D.P., Attia, M.I., Julius, J., Sethi, S. and Witt-Enderby, P.A., 2009. 2-[(2, 3-Dihydro-1 H-indol-1-yl) methyl] melatonin Analogues: A Novel Class of MT2-Selective Melatonin Receptor Antagonists. Journal of medicinal chemistry, 52(3), pp.826-833.: https://pubmed.ncbi.nlm.nih.gov/19193160/
------------------------------------------------------------

ID: 327 | 2-methoxy-α,β-didehydro-agomelatine
FDA: none
Описание: Derivative of agomelatine.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/71533431
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: MT1 agonist with poorly described
Механизмы: MT1 receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Morellato, L., Lefas-Le Gall, M., Langlois, M., Caignard, D.H., Renard, P., Delagrange, P. and Mathé-Allainmat, M., 2013. Synthesis of new N-(arylcyclopropyl) acetamides and N-(arylvinyl) acetamides as conformationally-restricted ligands for melatonin receptors. Bioorganic & medicinal chemistry letters, 23(2), pp.430-434.: https://pubmed.ncbi.nlm.nih.gov/23265885/
------------------------------------------------------------

ID: 328 | 5‐Methoxyluzindole
FDA: none
Описание: Luzindole, a melatonin receptor antagonist, disrupts circadian rhythms in animals. It blocks melatonin's effects by binding to melatonin receptors 1 (MT1) and 2 (MT2), particularly MT2 with higher affinity. This disruption can be seen in various animal studies, including those examining sleep pat...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/5-Methoxyindole
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Circadian phase entrainment via MT1/MT2 receptor agonism
Механизмы: MT2 receptor ligand
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Dubocovich, M.L., Masana, M.I., Iacob, S. and Sauri, D.M., 1997. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn-Schmiedeberg's archives of pharmacology, 355, pp.365-375.: https://pubmed.ncbi.nlm.nih.gov/9089668/
------------------------------------------------------------

ID: 329 | AAE‐M‐PBP amine (Isoamyl-agomelatine)
FDA: none
Описание: Isoamyl-agomelatine is aderivative of egomelatine
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/57381997
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Partial agonist MT2 and associated effects, Phase shifting in humans (via MT1/MT2 receptor activation)
Механизмы: MT2 receptor agonist
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Ettaoussi, M., Sabaouni, A., Rami, M., Boutin, J.A., Delagrange, P., Renard, P., Spedding, M., Caignard, D.H., Berthelot, P. and Yous, S., 2012. Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I). European journal of medicinal chemistry, 49, pp.310-323.: https://pubmed.ncbi.nlm.nih.gov/22301214/
------------------------------------------------------------

ID: 330 | benzyloxy-methoxyphenyl-propylamide (Bomppa)
FDA: none
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/71508234
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: Full mt2 rexeptor agonist
Механизмы: MT2 receptor ligand
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Hu, Y., Zhu, J., Chan, K.H. and Wong, Y.H., 2013. Development of substituted N-[3-(3-methoxylphenyl) propyl] amides as MT2-selective melatonin agonists: Improving metabolic stability. Bioorganic & medicinal chemistry, 21(2), pp.547-552.: https://www.sciencedirect.com/science/article/abs/pii/S0968089612008917
------------------------------------------------------------

ID: 331 | Adenosine cyclic phosphate (cAMP)
FDA: Approved
Описание: Metabolite. cAMP is not just a passively regulated molecule; it actively participates in the circadian oscillator. Studies have shown that manipulating cAMP levels, including elevating or reducing them, can affect the rhythmicity of circadian gene expression in the SCN. Circadian rhythms can be ...
PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6076
KEGG: https://www.kegg.jp/entry/C00575
Классы: chronobiotic, circadian rhythm modulator
Эффекты: influencing the expression and stability of key circadian clock genes
Механизмы: HCN1 activator, CNGA3 activation, HCN2 activation, CNGA2 activation, OATP4C1 transportation, Affects melatonin synthesis
Цели: HCN1 (https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=400), CNGA3 (https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=396), HCN2 (https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=401), CNGA2 (https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=395)
Статьи: O'Neill, J.S. and Reddy, A.B., 2012. The essential role of cAMP/Ca2+ signalling in mammalian circadian timekeeping.: https://pmc.ncbi.nlm.nih.gov/articles/PMC3399769/, Levine, J.D., Casey, C.I., Kalderon, D.D. and Jackson, F.R., 1994. Altered circadian pacemaker functions and cyclic AMP rhythms in the Drosophila learning mutant dunce. Neuron, 13(4), pp.967-974.: https://pubmed.ncbi.nlm.nih.gov/7946340/, Ono, D., Wang, H., Hung, C.J., Wang, H.T., Kon, N., Yamanaka, A., Li, Y. and Sugiyama, T., 2023. Network-driven intracellular cAMP coordinates circadian rhythm in the suprachiasmatic nucleus. Science Advances, 9(1), p.eabq7032.: https://www.science.org/doi/10.1126/sciadv.abq7032
------------------------------------------------------------

ID: 332 | CBOBNEA
FDA: Not approved
Описание: CBOBNEA (carboxybiphenyloxy-butoxynaphthalene-ethylacetamide) is a compound that is a selective MT1 receptor ligand, meaning it binds to and activates the MT1 melatonin receptor. Melatonin, a hormone that regulates the sleep-wake cycle, acts through two receptor subtypes, MT1 and MT2. CBOBNEA's s...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9957516
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: MT1 agonist with poorly described, restores normal circadian rhythms
Механизмы: selective MT1A receptor agonist
Цели: MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Jockers, R., Delagrange, P., Dubocovich, M.L., Markus, R.P., Renault, N., Tosini, G., Cecon, E. and Zlotos, D.P., 2016. Update on melatonin receptors: IUPHAR Review 20. British Journal of Pharmacology, 173(18), pp.2702–2725.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4995287/
------------------------------------------------------------

ID: 333 | cyclohexylmethyl-indenofurane-ethylacetamide (CIFEA)
FDA: Not approved
Описание: A novel series of 1,6-dihydro-2H-indeno[5,4-b]furan derivatives were designed and synthesized as MT(2)-selective ligands. This scaffold was identified as a potent mimic of the 5-methoxy indole core of melatonin, and introduction of a cyclohexylmethyl group at the 7-position of this scaffold affor...
PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=53238181
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: Discrupts temporal organization in Candida albicans, Full mt2 rexeptor agonist
Механизмы: MT2 receptor ligand, MT2 receptor agonist
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Koike, T., Hoashi, Y., Takai, T., Nakayama, M., Yukuhiro, N., Ishikawa, T., Hirai, K. and Uchikawa, O., 2011. 1, 6-Dihydro-2 H-indeno [5, 4-b] furan Derivatives: Design, Synthesis, and Pharmacological Characterization of a Novel Class of Highly Potent MT2-Selective Agonists. Journal of medicinal chemistry, 54(9), pp.3436-3444.: https://pubmed.ncbi.nlm.nih.gov/21473625/
------------------------------------------------------------

ID: 334 | Difluoroagomelatine
FDA: Not approved
Описание: Difluoro-agomelatine displays high MT1 binding affinity (Ki = 0.03 nM), acting as a MT1 selective full agonist ([35S]GTPγS test).
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/57381112
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: increases the amplitude of circadian rhythm activity in mice with corticosterone-induced depression/anxiety, MT1 agonist with poorly described
Механизмы: MT1 receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Ettaoussi, M., Sabaouni, A., Rami, M., Boutin, J.A., Delagrange, P., Renard, P., Spedding, M., Caignard, D.H., Berthelot, P. and Yous, S., 2012. Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I). European journal of medicinal chemistry, 49, pp.310-323.: https://pubmed.ncbi.nlm.nih.gov/22301214/
------------------------------------------------------------

ID: 335 | (125I)Div880
FDA: NULL
Описание: Radioligand of MT2.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/86277837
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator
Эффекты: MT2 antagonist; disrupts melatonin signaling (in human receptor models), Partial agonist MT2 and associated effects
Механизмы: MT2 receptor ligand
Цели: MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Legros, C., Brasseur, C., Delagrange, P., Ducrot, P., Nosjean, O. and Boutin, J.A., 2016. Alternative radioligands for investigating the molecular pharmacology of melatonin receptors. The Journal of Pharmacology and Experimental Therapeutics, 356(3), pp.681-692.: https://pubmed.ncbi.nlm.nih.gov/26759496/, Legros, C., Matthey, U., Grelak, T., Pedragona-Moreau, S., Hassler, W., Yous, S., Thomas, E., Suzenet, F., Folleas, B., Lefoulon, F. and Berthelot, P., 2013. New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors. International journal of molecular sciences, 14(5), pp.8948-8962.: https://pubmed.ncbi.nlm.nih.gov/23698757/
------------------------------------------------------------

ID: 336 | EFPPEA
FDA: none
Описание: EFPPEA (N-[2-(2-Ethyl-8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridin-1-yl)ethyl]acetamide) is a synthesized compound that belongs to a class of drugs known as acetyl-substituted pyrazolo[1,5-a]pyridine derivatives. It is not a widely recognized drug and is primarily used in research settings, accor...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/24954989
KEGG: NULL
Классы: hypnotic, chronobiotic
Эффекты: Circadian phase entrainment via MT1/MT2 receptor agonism, Circadian phase modulation via MT1/MT2 agonism, Phase shift induction in mammals via MT1/MT2 receptor agonism, sleep-promoting action in freely moving cats, Phase shifting in humans (via MT1/MT2 receptor activation)
Механизмы: MT1 receptor binding, MT2 receptor ligand
Цели: MT1 (https://www.rcsb.org/structure/7db6)
Статьи: Koike, T., Takai, T., Hoashi, Y., Nakayama, M., Kosugi, Y., Nakashima, M., Yoshikubo, S.I., Hirai, K. and Uchikawa, O., 2011. Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8, 9-dihydrofuro [3, 2-c] pyrazolo [1, 5-a] pyridines as melatonin receptor (MT1/MT2) ligands. Journal of medicinal chemistry, 54(12), pp.4207-4218.: https://pubmed.ncbi.nlm.nih.gov/21568291/
------------------------------------------------------------

ID: 337 | fMet-Leu-Phe
FDA: Not approved
Описание: Abbreviated name: fMLP Synonyms: fMetLeuPhe | fMLF | formyl-Met-Leu-Phe Compound class: Peptide Comment: From the bacterium E.coli Additional information and targets (data relate to human unless otherwise stated) Potency order of endogenous ligands at FPR1 fMet-Leu-Phe > cathepsin G (CTSG, P083...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/443295
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms
Эффекты: fMLP-mediated activation of human eosinophils is influenced by the circadian clock, chemotaxis stimulation, activates G protein-coupled receptors, specifically FPR1, actin polymerization, oxidative burst, Affects circadia nchemotaxis and phagocytosis
Механизмы: FPR2 full agonist, FPR1 full agonist
Цели: FPR2 (https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=223), FPR1 (https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=222)
Статьи: Baumann, A., Feilhauer, K., Bischoff, S.C., Froy, O. and Lorentz, A., 2015. IgE-dependent activation of human mast cells and fMLP-mediated activation of human eosinophils is controlled by the circadian clock. Molecular immunology, 64(1), pp.76-81.: https://pubmed.ncbi.nlm.nih.gov/25466613/
------------------------------------------------------------

ID: 338 | K185 (K-185)
FDA: none
Описание: K185, a melatonin receptor antagonist, is not a therapeutic drug but may be of interest in understanding circadian rhythm disorders and sleep-wake disturbances. Research suggests that melatonin receptor antagonists, in general, might be beneficial in treating circadian rhythm disorders in the eld...
PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5311198
KEGG: NULL
Классы: chronobiotic, circadian rhythm modulator, Chronodisruptor
Эффекты: MT2 antagonist; disrupts melatonin signaling (in human receptor models), Phase shift disruption in mammals via MT1/MT2 receptor antagonism, Normalization of circadian rhythms in elderly, blind and people with social jet lag.
Механизмы: Melatonin receptor binding, antagonist of melatonin receptors, MT2 receptor antagonist, MT1 receptor binding, MT2 receptor ligand, MT1 antagonist
Цели: Melatonin receptor (https://www.uniprot.org/uniprotkb/P48039/entry), MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Sugden, D., Yeh, L.K. and Teh, M.T., 1999. Design of subtype selective melatonin receptor agonists and antagonists. Reproduction Nutrition Development, 39(3), pp.335-344.: https://pubmed.ncbi.nlm.nih.gov/10420436/, Faust, R., Garratt, P.J., Jones, R., Yeh, L.K., Tsotinis, A., Panoussopoulou, M., Calogeropoulou, T., Teh, M.T. and Sugden, D., 2000. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6 H-isoindolo [2, 1-a] indoles, 5, 6-dihydroindolo [2, 1-a] isoquinolines, and 6, 7-dihydro-5 H-benzo [c] azepino [2, 1-a] indoles. Journal of medicinal chemistry, 43(6), pp.1050-1061.: https://pubmed.ncbi.nlm.nih.gov/10737738/
------------------------------------------------------------

ID: 339 | N‐acetyl‐serotonin
FDA: Not approved
Описание: This compound is primarily used in pharmacokinetic and metabolic studies, to track how N-acetyl serotonin is processed in the body. It is not a known selective ligand for the MT3/QR2 site like MCA-NAT, but rather a synthetic, tagged metabolite for research applications.
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/171379315
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: Circadian rhythm modulation
Механизмы: Melatonin receptor binding
Цели: MT1 (https://www.rcsb.org/structure/7db6), MT2 (https://www.rcsb.org/structure/6me7)
Статьи: Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E, Zlotos DP. Update on melatonin receptors: IUPHAR Review 20. Br J Pharmacol. 2016 Sep;173(18):2702-25.: https://pmc.ncbi.nlm.nih.gov/articles/PMC4995287/
------------------------------------------------------------

ID: 340 | 3,4-Methylenedioxymethamphetamine
FDA: Not approved
Описание: MDMA (ecstasy) is an illicit drug that stimulates monoamine neurotransmitter release and inhibits reuptake. MDMA’s acute cardiotoxicity includes tachycardia and arrhythmia which are associated with cardiomyopathy. MDMA acute cardiotoxicity has been explored, but neither long-term MDMA cardiac pat...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3_4-Methylenedioxymethamphetamine
KEGG: NULL
Классы: Potential modulator of circdain rhtyhms, Chronodisruptor
Эффекты: alters the response of the circadian clock to a photic and non-photic stimulus, Disrupts sleep
Механизмы: Synaptic vesicular amine transporter interaction, Sodium-dependent noradrenaline transporter, Sodium-dependent serotonin transporter, 5-hydroxytryptamine receptor 2C binding, 5-hydroxytryptamine receptor 2A binding, 5-hydroxytryptamine receptor 2B binding, Sodium-dependent dopamine transporter binding
Цели: SLC18A2 (https://go.drugbank.com/drugs/DB01454#:~:text=Uniprot%20ID-,Q05940,-Uniprot%20Name), SLC6A2 (http://www.uniprot.org/uniprot/P23975), SLC6A4 (http://www.uniprot.org/uniprot/P31645), HTR2C (http://www.uniprot.org/uniprot/P28335), HTR2A (http://www.uniprot.org/uniprot/P28223), HTR2B (http://www.uniprot.org/uniprot/P41595), SLC6A3 (http://www.uniprot.org/uniprot/Q01959)
Статьи: Koczor, C.A., Ludlow, I., Hight, R.S., Jiao, Z., Fields, E., Ludaway, T., Russ, R., Torres, R.A. and Lewis, W., 2015. Ecstasy (MDMA) alters cardiac gene expression and DNA methylation: implications for circadian rhythm dysfunction in the heart. Toxicological Sciences, 148(1), pp.183-191.: https://pubmed.ncbi.nlm.nih.gov/26251327/, Colbron, S., Jones, M. and Biello, S.M., 2002. MDMA alters the response of the circadian clock to a photic and non-photic stimulus. Brain research, 956(1), pp.45-52.: https://pubmed.ncbi.nlm.nih.gov/12426045/, McCann, U.D. and Ricaurte, G.A., 2007. Effects of (±) 3, 4‐Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms. The Scientific World Journal, 7(1), pp.231-238.: https://onlinelibrary.wiley.com/doi/abs/10.1100/tsw.2007.214
------------------------------------------------------------

ID: 341 | Phencyclidine (PCP)
FDA: Not approved
Описание: PCP resulted in significantly increased distance travelled from 15 to 60 min post injection. Induced stereotyped behaviour and locomotor hyperactivity. Furthermore, PCP significantly enhanced time spent isolated from cage mates and this asociality occured from 60 to 105 min post treatment. PCP c...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/6468
KEGG: NULL
Классы: Chronodisruptor
Эффекты: Disrupts circadian rhtyhms, depressant
Механизмы: Glutamate receptor ionotropic, NMDA 3A antagonist, Glutamate receptor ionotropic, NMDA 2A, Glutamate receptor ionotropic, NMDA 2B, Glutamate receptor ionotropic, NMDA 1, USigma non-opioid intracellular receptor 1, NMDA receptor antagonist
Цели: NMDA receptor (https://www.rcsb.org/structure/5IPQ), NMDA receptor (https://www.rcsb.org/structure/4pe5)
Статьи: Mitchell, E.J., Brett, R.R., Armstrong, J.D., Sillito, R.R. and Pratt, J.A., 2020. Temporal dissociation of phencyclidine: Induced locomotor and social alterations in rats using an automated homecage monitoring system–implications for the 3Rs and preclinical drug discovery. Journal of Psychopharmacology, 34(7), pp.709-715.: https://pmc.ncbi.nlm.nih.gov/articles/PMC7675779/
------------------------------------------------------------

ID: 342 | Riboflavin
FDA: Approved
Описание: Vitamin. Riboflavin restored the circadian oscillations of differentiation-related genes and core clock genes that were reduced by D-galactose. Ribo alleviated oxidative stress by regulating ROS, MDA, catalase, and GPx levels. Riboflavin improved mitochondrial function by increasing ATP productio...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/493570
KEGG: https://www.kegg.jp/entry/D08170
Классы: circadian rhythm modulator
Эффекты: restored the circadian oscillations of differentiation-related genes and core clock genes that were reduced by D-galactose
Механизмы: Restores oscillations of circadian genes
Цели: PER2 gene expression (https://en.wikipedia.org/wiki/PER2)
Статьи: Lee, S., Sim, Y., Lee, M., Choi, Y., Lim, J.Y., Lee, J.H. and Kim, E., 2025. Riboflavin as a circadian modulator mitigates D-galactose-induced muscle senescence via oxidative stress and mitochondrial regulation in C2C12 cells. Journal of Functional Foods, 130, p.106924.: https://www.sciencedirect.com/science/article/pii/S175646462500266X
------------------------------------------------------------

ID: 343 | Protocatechuic Acid
FDA: none
Описание: Protocatechuic acid (PCA) is a naturally occurring compound with antioxidant and anti-inflammatory properties; however, its role in regulating circadian rhythms has not been previously explored. The potential of PCA as a circadian rhythm modulator in human epidermal keratinocytes was investigate...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/72
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: promoted skin barrier integrity by increasing structural protein and ceramide-related gene expression, enhanced cellular longevity markers, such as cyclin-dependent kinase inhibitor 1B (CDKN1B) and telomerase reverse transcriptase (TERT), reduced reactive oxygen species (ROS) levels and upregulated antioxidant enzymes
Механизмы: ROR, Core clock modulation
Цели: RORα (https://www.genecards.org/cgi-bin/carddisp.pl?gene=RORA), RORA (https://www.ncbi.nlm.nih.gov/gene/6095)
Статьи: Lee, J., Kim, J.Y., Lee, J.H. and Lee, K.H., 2025. Protocatechuic acid modulates the circadian rhythm of keratinocytes and maintains skin barrier integrity. Molecular Biology Reports, 52(1), p.765.: https://pubmed.ncbi.nlm.nih.gov/40721875/
------------------------------------------------------------

ID: 344 | Mefloquine
FDA: Approved
Описание: Mefloquine is known as a neuronal gap junction blocker. Administration of mefloquine causes instability in the pulse period and a slight reduction of amplitude in cyclic PER2::LUC expression. Blockade of gap junctions uncouples PER2::LUC-expressing cells, in terms of phase transition, which weake...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/4046
KEGG: NULL
Классы: circadian rhythm modulator, Potential chronodisruptor
Эффекты: causes instability in the pulse period and a slight reduction of amplitude in cyclic PER2::LUC expression, Blockade of gap junctions uncouples PER2::LUC-expressing cells, in terms of phase transition, which weakens synchrony among individual cellular rhythm
Механизмы: Per2 expression alteration
Цели: PER2 gene expression (https://en.wikipedia.org/wiki/PER2)
Статьи: Koo, J., Choe, H.K., Kim, H.D., Chun, S.K., Son, G.H. and Kim, K., 2015. Effect of mefloquine, a gap junction blocker, on circadian period2 gene oscillation in the mouse suprachiasmatic nucleus ex vivo. Endocrinology and Metabolism, 30(3), pp.361-370.: https://pubmed.ncbi.nlm.nih.gov/25491783/
------------------------------------------------------------

ID: 345 | M54
FDA: none
Описание: M54 is a modulator of circadian rhythm at the cellular level via CRY1. M54 specifically binds to CRY1, but not CRY2, reducing its ubiquitination and thereby enhancing its stability. Consequently, M54 lengthens the period of the U2-OS circadian rhythm and decreases the transcription of clock-contr...
PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/71694853
KEGG: NULL
Классы: circadian rhythm modulator
Эффекты: lengthens the period of the U2-OS circadian rhythm, decreases the transcription of clock-controlled genes in a concentration-dependent manner
Механизмы: Selective stabilizer of CRY1, CRY1 stabilizer, binds CRY1 ubiquitination site
Цели: CRY1 (https://www.ncbi.nlm.nih.gov/gene/1407)
Статьи: Gül, Z.M., Aydoğan, S., Sürme, S., Efendi, S.N.H., Özcan, O., Uyanık, E., Baris, I., Gül, S. and Kavakli, I.H., 2025. M54 selectively stabilizes the circadian clock component of CRY1 and enhances the period of circadian rhythm at cellular level. Journal of Biological Chemistry, 301(7).: https://www.sciencedirect.com/science/article/pii/S0021925825021830?via%3Dihub
------------------------------------------------------------

